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(disodium sait)
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HEPES N-2-hydroxyethylpiperazine-N’-2- 
ethanesulphonic acid
HIV(-l) (2) human immunodeficiency virus (type 1) 
(type 2)
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ribonucleoprotein
HTLV(-I) human T-cell lymphotropic virus
(type I)
LB Luria-Bertani medium
LTR retroviral long terminal repeat
Mr relative molecular mass
MHC major histocompatibility complex
MLP Ad major late promoter
NP40 Nonidet P40 detergent
NRE negative regulatory element in HIV 
LTR
nt nucleotides
ORF open reading frame (e.g. Ad5 E4 ORF6)
PAGE polyacrylamide gel electrophoresis
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PCR polymerase chain reaction
pfu plaque forming units
RNA ribonucleic acid (prefixes: 
m * messenger, r —ribosomal, sn = small
X V
nuclear, t=transfer)
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RRE Rev-responsive element
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SV40 simian virus 40
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The compositions of individual buffer solutions given abbreviations (TE, TNE, 
TBE, TD, TS, etc.) arc described in chapter 2. The names given to recombinant 
viruses constructed in the course of the project are listed in table 3.1. Standard 
abbreviations are used for SI units and amino acids.
Virus gene nomenclature
For HIV-1 the standard retroviral structural gene nomenclature, and the regulatory 
gene nomenclature of Gallo et al. (1988) are used throughout the thesis - i.e., gag 
(group-specific antigen gene), pol (polymerase), env (envelope), tat (trans- 
activator), rev (regulator of expression o f  virion proteins), vtf (virion infectivity 
factor), nef (negative factor), vpr (viral protein R), and vpu (viral protein U). The 
corresponding gene products are denoted by Roman script abbreviations (Gag, Pol, 
Env, etc.) or protein/glycoprotein molecular masses (e.g. pl7, gp41). For 
adenovirus, the genes and proteins are named according to the early region (E1A,
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E1B, E2A, E2B, E3, E4) major late region (LI, L2, L3, LA, L5), or minor late 
region (IVa2, IX) of the genome from which they are expressed (fig. 1.4), together 
with the open reading frame number (e.g. E4 ORF6), number of amino acids of the 
predicted gene product (e.g. E1B 495R), molecular mass of the gene product (e.g. 
L3-23K), or a Roman numeral identifying a virion component (e.g. L3 II = hexon 
protein).
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Summary
The human immunodeficiency virus Rev protein is required for the cytoplasmic 
accumulation and probably the translational utilisation of mRNAs encoding the late 
viral structural proteins. Rev function is mediated by direct binding of the protein to 
a c/5-acting RNA sequence, the Rev-responsive element (RRE), carried by these 
mRNAs. Human adenovirus type 5 (Ad5) also encodes a protein, E1B 55K, 
required for the cytoplasmic accumulation of late viral mRNAs. Rev and E1B SSK 
both regulate gene expression post-transcriptionally and directly or indirectly act on 
the mRNA transport pathway. To explore the potential functional analogy between 
these two regulatory proteins, the components of the Rev/RRE system were 
introduced into AdS. By inserting the RRE into Ad5 late region L3 (expression of 
which is normally dependent on E1B 55K), and a rev expression cassette into early 
region E1A, a system was set up where the action of Rev could be directly 
compared with that of E1B 55K.
A series of six recombinant adenoviruses was constructed which, together with two 
viruses already available, contained the rev gene and/or the RRE and/or the Ad5 
E1B SSK gene in all possible combinations. Expression of functional Rev from the 
appropriate recombinants was confirmed by a CAT reporter gene assay. The eight 
viruses were used to study the effects of Rev and the RRE on the expression of Ad5 
late RNAs and proteins. It was shown that the Rev/RRE system can detectably 
increase the cytoplasmic accumulation of certain Ad5 mRNAs in the absence of E1B 
55K. Surprisingly, these included some mRNAs in which the RRE, although 
present in the primary transcripts, was removed from the mature species. A 
mechanism was proposed in which Rev/RRE action in this system may commit an 
RNA to a pathway of facilitated nuclear export before excision of the RRE during 
processing.

21.1« Overview
The aim of this study was to investigate and compare two viral systems that regulate 
gene expression - the Rev/RRE system of human immunodeficiency virus type 1 
(HIV-1), and the E1B 55K/E4 34K complex of human adenovirus type 5 (Ad5).
The HIV-1 rev gene encodes a 13K protein. Rev, required for the synthesis of 
certain viral proteins. Specifically, Rev upregulates the expression of the late 
proteins Gag, Pol, Env, Vif, Vpr and Vpu at the expense of downregulating 
expression of the early viral proteins - Tat, Nef and Rev itself. Rev regulation is 
post-transcriptional, and probably affects more that one level of gene expression. 
Evidence has been presented for effects on mRNA splicing, transport, stability and 
efficient translation. These effects are mediated by specific binding of the Rev 
protein to a m-acting RNA sequence, the Rev-responsive element (RRE) located in 
the coding region of the env gene. The RRE is retained in the unspliced and singly- 
spliced mRNAs encoding the late proteins, but absent from the multiply-spliced 
mRNAs coding for the early proteins. Upregulation of late protein expression 
appears to be a direct consequence of Rev-RRE interaction, while downregulation 
of early protein expression is thought to be an indirect effect of this process.
Ad5 early region IB encodes a protein, E1B 55K, that is also required for efficient 
expression of late viral proteins. E1B 55K has been shown to act in combination 
with a product of early region 4, E4 34K. Together, the two proteins form a 
functional complex. Like Rev, the E1B 55K/E4 34K complex acts post- 
transcriptionally on gene expression, most probably at an intranuclear stage in the 
mRNA transport pathway, and/or on cytoplasmic stabilisation of recently 
transported RNA. Its action results in the selective facilitation of viral late mRNA 
accumulation in the cytoplasm.
There are clear similarities between the roles of Rev and E1B 55K/E4 34K in their 
respective virus life cycles. This thesis presents the results of experiments designed 
to explore the extent of this functional analogy. The functions and possible 
mechanisms of action of the Rev/RRE system and the E1B 55K/E4 34K complex 
within the life cycles of HIV-1 and adenovirus respectively are discussed in detail 
below.
1.2. Replication cycle and gene expression of HIV-1
1.2.1. Introduction
Human immunodeficiency virus type 1 (HIV-1) is the primary aetiological agent of 
the global pandemic of acquired immunodeficiency syndrome (AIDS), a fatal 
disease of the immune system. In the decade since the discovery of the virus (Barr6- 
Sinoussi et al., 1983), extensive research has amassed an enormous amount of 
information on its structure, immunology, pathogenesis, and gene expression, 
although as yet no effective treatment is available for AIDS. This section is limited 
to a brief description of the life cycle of the virus and the regulation of its gene 
expression.
HIV-1 belongs to the family Retroviridae - i.e., its replication cycle involves 
reverse transcription of the RNA virion genome to a DNA provirus which integrates 
in the host cell genome. More specifically, HIV-1 is classed as a member of the 
subfamily Leruivirinae, which also includes such viruses as maedi-visna virus of 
sheep, the simian immunodeficiency viruses (SIVs) and human immunodeficiency 
virus type 2 (HIV-2), a virus closely related to the SIVs that is genetically distinct 
from HIV-1. All the viruses in this group share a similar genetic organisation that 
identifies them as 'complex' retroviruses - i.e., they encode regulatory proteins (in 
addition to the structural proteins found in all retroviruses) that mediate a biphasic 
temporal regulation of gene expression (see review by Cullen, 1991).
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1.2.2. Structure and lire cycle of HIV-1
The structure, replication cycle, and pattern of gene expression of HIV-1 have been 
well characterised (see reviews by Wong-Staal, 1990; Vaishnav and Wong-Staal, 
1991; Cullen, 1991; Kráusslich, 1992, and references therein). The HIV-1 virion 
consists of an outer capsid of Gag (group-specific antigen) matrix protein pl7 
enveloped by a lipid membrane derived from the host cell. On the membrane, knobs 
of Env (envelope) surface glycoprotein gpl20 are noncovalently attached to the Env 
transmembrane glycoprotein gp41. Within the outer shell of pl7 is a cylindrical 
core of Gag capsid protein p24. The core contains two copies of the single-stranded 
RNA genome bound to Gag protein p9, and the viral enzymes required for 
replication - the Pol (polymerase) proteins p66/p51 (reverse transcriptase/RNase H 
heterodimer), pi 1 (protease), and p32 (integrase).
The CD4 cell surface antigen, carried by cells such as T4 helper lymphocytes, has 
been identified as the primary HIV-1 receptor (Maddon et al., 1986). The virus 
binds to CD4 via its gpl20 envelope glycoprotein (McDougal et al., 1986). 
Subsequent features of the establishment of HIV-1 infection are similar to those of 
classical retroviruses. Internalisation of the viral core occurs by membrane fusion 
with the target cell, apparently in a pH-independent process mediated by the gp41 
transmembrane glycoprotein. In the cytoplasm, reverse transcriptase catalyses the 
synthesis of proviral DNA from the RNA template, a process that utilises both the 
DNA polymerase and RNase H activities of the enzyme, and requires a tR N A ^s 
molecule bound to genomic RNA. The 10 kb proviral DNA, probably as a 
nucleoprotein complex, then migrates to the nucleus where it is integrated into the 
host cell genome by the p32 integrase. Gene expression, regulated by both cellular 
factors and viral nonstructural proteins, may then occur (as described below, 1.2.3). 
This culminates in the expression of genomic viral RNA and viral structural proteins 
that are packaged together into new virions - a process dependent on packaging 
signals in the genomic RNA. The structural proteins are expressed initially as
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Fig. 1.1. Organisation and RNA expression of the HIV-1 genome (reproduced 
from Cullen, 1991). (A) Genomic organisation, showing the locations of the gag, 
pol, env, tat, rev, nef, vif, vpu and vpr (R) genes, the Rev-responsive element 
(RRE), /rany-activator response element (TAR), splice donors (D1-D4), splice 
acceptors (A1-A6), and long terminal repeats (LTRs: large rectangles at each end of 
the genome). (B) Exons (E1-E6) found in multiply-spliced mRNAs (E1-E3 are 
noncoding). (C) Early mRNAs (additional species can also be formed by inclusion 
of E2 and E3 in rev and nef mRNAs - not shown). (D) Late mRNAs.
6precursor polyproteins that are cleaved to the mature forms by the p ll  protease. 
Cleavage of the Gag and Pol polyproteins appears to occur at a late stage in virion 
maturation, during or after budding of newly formed virus particles at the cell 
membrane. The Env precursor, gpl60, is cleaved intracellularly to form gpl20 and 
gp41 which are then targeted to the plasma membrane where they become 
associated with budding capsids, presumably by gp41-pl7 interaction. Virions are 
then released from the cell complete with lipid envelopes derived from the host 
plasma membrane.
1.2.3. Organisation and expression of the HIV-1 genome
The organisation of the HIV-1 genome (fig. 1.1) and its pattern of gene expression 
have been reviewed in the references cited in the previous section. All the known 
functional genes of HIV-1 are expressed from a single active promoter located in 
the 5' long terminal repeat (LTR) region. The LTR is a multifunctional unit 
duplicated at each end of the linear proviral form of the HIV-1 genome. The LTR 
contains a variety of signals, some of which are utilised at the 3' end of the 
genome, while others are active at the S' end. At the 3' end, the signals responsible 
for polyadenylation of all HIV-1 mRNAs are active, and sequences encoding the 3’ 
end of the nef gene are utilised. At the 5’ end, sequences in use include the 
promoter, and enhancer, a c/.v-acting negative regulatory element (NRE), the 
response element (TAR) for the viral Tat transactivator protein, and binding sites 
for several cellular constitutive and inducible transcription factors including API, 
NFAT-1, USF (upstream binding factor), NF-kB, Spl, TFIID, LBP (leader binding 
protein) and CTF/NF-I.
HIV-1 primary transcripts extend from an RNA start site in the 5' LTR to a 
termination site in the 3’ LTR. However, differential splicing gives rise to three 
major classes of mRNA from which viral proteins are translated. The regulatory 
proteins Tat, Rev and Nef are translated from small ( » 2  kb) multiply-spliced
mRNAs, the Env structural proteins and the Vif, Vpr, and Vpu accessory proteins 
are translated from » 4  kb singly-spliced mRNAs, and the Gag and Pol structural 
proteins are translated from unspliced, * 9  kb mRNAs. The gag and pol genes 
overlap by 241 nt (fig. 1.1) with pol in the -1 translational reading frame with 
respect to gag; production of the Pol protein is dependent on a low frequency 
ribosomal frame shift that creates a Gag-pol fusion.
The absolute levels of primary transcripts and relative levels of the three classes of 
mRNA in the cytoplasm are linked to the phase of infection. In latently infected 
cells or in the early phase of a lytic infection, transcription levels are low and the 
mRNAs in the cytoplasm are predominantly 2 kb multiply-spliced species. In the 
late phase of lytic infection, the singly-spliced and unspliced species appear in the 
cytoplasm, while levels of the multiply-spliced species fall. Therefore, as in the case 
of adenovirus and other DNA tumour viruses, nonstructural regulatory proteins are 
expressed in the early phase of infection, whereas structural virion proteins are 
synthesised in the late phase. A viral RNA binding protein. Rev, is implicated in 
controlling the cytoplasmic accumulation of viral mRNAs; its activity will be 
reviewed in detail below. Control of viral transcription levels is effected by a 
second RNA binding protein, Tat. Expression of the Tat protein results in a 
powerful transactivation effect on transcription from the HIV-1 promoter.
The possible mechanisms of Tat action are reviewed in Vaishnav and Wong-Staal 
(1991), Cullen (1991), and Krausslich (1992). Tat has been shown to bind the RNA 
form of the TAR element in the LTR directly; this region of the LTR is 
incorporated into the S' end of all HIV-1 transcripts. Binding is mediated by an 
arginine-rich domain of the Tat protein and is dependent on the secondary structure 
of TAR; the RNA element forms a helical stem-loop with a three nucleotide bulge 
that constitutes the Tat binding site. Binding of Tat to HIV RNA is essential for Tat 
function, but activity is retained if the arginine-rich domain and bulged RNA stem-
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loop are replaced by heterologous binding elements. Tat appears to act directly on 
transcription by stabilising inefficiently elongating transcription complexes (anti- 
termination), and possibly by increasing the levels of transcription initiation. Tat 
may also be active at the level of translation.
An additional viral protein, Nef, may also regulate the level of viral gene 
expression, although the data presently available are conflicting (reviewed in 
Cullen, 1991; Vaishnav and Wong-Staal, 1991; Krausslich, 1992). While initial 
experiments suggested that Nef acted as a negative regulator of gene expression, 
this was not confirmed in subsequent studies. Moreover, experiments with SIV 
mutated in the equivalent nef region showed that a functional gene was selected for 
in vivo and was required for normal viral replication. Sequence similarities with G- 
proteins and the location of at least some Nef molecules on the inner surface of the 
plasma membrane suggested that Nef might belong to this class of signal- 
transducing molecules. However, early reports of detectable Nef GTP-binding, 
GTPase and autokinase activities (characteristic of G-proteins) were not confirmed 
in later experiments. Thus the function of Nef is at present enigmatic.
In addition to the proteins discussed above, HIV-1 encodes a number of gene 
products that have been termed accessory proteins (reviewed in Vaishnav and 
Wong-Staal, 1991) since many of them are dispensable for maintenance of virus in 
tissue culture. However, their conservation in natural isolates indicates that they 
have important functions in infections in vivo. The 23K Vif protein appears to 
function as a virion infectivity factor - i.e., it is required for cell-free transmission 
of virus, but not for cell-to-cell infection by membrane fusion. However, Vif is 
apparently not a virion component, and can function in trans when supplied to vif- 
negative mutants from a complementing expression vector. Its mechanism of action 
is at present unclear.
The 15K Vpr protein is a virion component that upregulates gene expression 
synergistically with Tat, possibly at the levels of transcription initiation and 
transcript stabilisation. The Vpu protein, of similar size to Vpr, is expressed in the 
cytoplasm, and is required for extracellular accumulation of virus particles, and may 
therefore have a role in virion assembly or release. Several other polypeptides, 
produced by alternative mRNA splicing and comprising sequence elements from one 
or more of the proteins discussed above, have also been described.
1,3, Activity, properties, and functional domains of the R&y .protein
1.3.1. Discovery of rev function
The rev open reading frame was first identified as a functional gene by Sodroski et 
al. (1986) and Feinberg et al. (1986). These groups showed that mutations distinct 
from those of the tat gene (i.e., mutations that did not affect viral Tat expression, 
or could not be complemented by Tat supplied in trans) altered the pattern of HIV-1 
gene expression. Specifically, rev was found to be required intact for the expression 
of Gag and Env proteins and was therefore necessary for viral replication. 
Conversely, rev was shown to be unnecessary for Tat expression; indeed Feinberg 
et al. (1986) found that the levels of small multiply-spliced RNA species (which 
would include tat and rev RNAs) were reduced in the presence of rev. Although 
both groups suggested that the rev gene functioned post-transcriptionally, different 
mechanisms were proposed for its activity. Sodroski et al. (1986) postulated that rev 
acted to counter the effects of c/s-acting repression sequences that prevented the 
expression of structural genes in the absence of rev - hence their name art 
(antirepression /rum-activator) for the rev gene. This theory was based on the 
observation that tat (and heterologous genes) under the control of the HIV-1 LTR 
did not require rev for expression, whereas the structural genes were rev-dependent. 
However, Feinberg et al. (1986) proposed that the rev gene product functioned as a 
trans-acting regulator of splicing ('trs') since cytoplasmic structural gene mRNA 
was only detected in the presence of rev, whereas predominantly small multiply-
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spliced species were detected in its absence. Since these initial experiments 
considerable progress has been made in clarifying the mechanism of action of the 
rev product, although as yet no single mechanism can unambiguously account for all 
the available data. However, the apparently conflicting suggestions of Sodroski et 
al. (1986) and Feinberg et al. (1986) may represent two aspects of a single 
mechanism (see discussion in 1.7, below).
An important initial stage in the elucidation of rev function was the discovery of its 
gene product, Rev, in HIV-1-infected cells, strongly suggesting that the effects of 
the gene were protein-mediated. Goh et al. (1987) expressed the rev gene in 
bacteria, and demonstrated that the protein expressed was recognised by serum from 
an HIV-1-infected individual. This serum also reacted with a protein found in 
infected cells that, like the bacterially-synthesised Rev protein, had an apparent 
(SDS-PAGE) molecular mass (Mr) of 20K (the disparity with the predicted Mr of 
13K was attributed to the charge or structure of the protein). The two proteins were 
shown to compete for antibody binding, and the protein from infected cells was also 
detected by an antibody to a synthetic Rev oligopeptide. It is clear from these results 
that the rev gene is expressed as a protein in vivo. A second genetic element, the 
Rev-responsive element (RRE), is also crucial for rev function; its presence in an 
mRNA is required for Rev-facilitated cytoplasmic accumulation (see 1.4.1, below, 
and references therein). This sequence is located within the viral env gene and is 
therefore incorporated into the unspliced and singly-spliced viral mRNAs that 
encode the late proteins, but is absent from the multiply-spliced mRNAs that encode 
the early proteins (fig. 1.1). The evidence supporting the current definition of the 
RRE as an RNA structural element is discussed further in section 1.4.
1.3.2. Properties of Rev
The Rev protein has several distinct biochemical properties, some of which are 
crucial for functional activity. Rev binds RRE RNA directly, localises to the
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Fig. 1.2. Domain structure of the Rev protein (reproduced from Malim and 
Cullen, 1991). The three distinct functional domains located within the Rev primary 
structure are indicated. The arginine-rich domain (amino acids 35-50) is required 
for RRE binding and nuclear/nucleolar localisation. Sequences flanking this domain 
between amino acids 56 and 75 (approximately) are required for multimerisation of 
Rev on the RRE. The leucine-rich activation domain (amino acids 75-83) is 
essential for Rev function in vivo and may interact with cellular factors. The N- and 
C-terminal domains are dispensable for Rev function. It should be noted that some 
aspects of this proposed domain structure are still controversial (see text).
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nucleus and nucleolus, is phosphorylated, and has the ability to self-associate into 
multimers (see 1.3.3-1.3.6 and references therein). Numerous attempts have been 
made to map these properties to specific amino acid domains and to correlate them 
with the biological function of Rev. Most of these studies have utilised mutational 
analysis or domain exchange with heterologous proteins to dissect the structure- 
function relationship of Rev. A provisional functional domain map of Rev 
established by these studies is shown in fig. 1.2. The data relevant to the mapping 
of each function are summarised in subsequent sections. One notable and rather 
surprising observation is that the 23 C-terminal residues o f the 116 amino acid 
protein are dispensable for Rev function - deletion of these residues has no effect on 
Rev activity (Cochrane et al., 1989b).
1.3.3. RRE binding domain of the Rev protein
The Rev protein has been shown to bind RRE RNA directly by a variety of methods 
(see 1.4.2., below, and references therein). The initial evidence for the location of 
the RRE-binding domain in Rev was indirect. Several groups (Malim et al., 1989b; 
Perkins et al., 1989; Hope et al., 1990b; Venkatesh et al., 1990) described 
mutations in the region of residues 25-30 that disrupted or abolished Rev function. 
These mutations were centred around an arginine-rich sequence typical of nucleic 
acid binding domains. The direct correlation between binding ability and functional 
activity for mutants in this region was first noted by Olsen et al. (1990b), who 
described a series of mutations between residues 28 and 65 that disrupted RNA 
binding and Rev function. Data consistent with these results were also obtained by 
Berger et al. (1991), Malim and Cullen (1991) and Zapp et al. (1991). 
Subsequently, Kjems et al. (1992) demonstrated that a peptide containing Rev 
residues 34-50 can interact specifically with the RRE. Very recently, Tan et al. 
(1993) have shown that this peptide adopts an a-helical conformation in vivo that is 
required for specific binding to the RRE. The arginine-rich region of Rev has been 
recognised as one of a family of similar motifs (Lazinski et al., 1989) which
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includes the RNA binding domains of bacteriophage antiterminator proteins and 
HIV-1 tat - both of which, like Rev, have been shown to bind to RNA hairpin or 
stem-loop structures. Similar domains are also present in histones, protamines and 
the Adenovirus E4 ORF 4 13K protein (Lazinski et al., 1989).
1.3.4. Multimerisation domain
The ability of Rev to multimerise in the presence or absence of bound RRE is well- 
documented (see 1.5, below, for references and discussion). The domains required 
for multimerisation have been mapped by mutational analysis, but the results from 
different groups have not been in complete agreement. Malim and Cullen (1991) 
found that substitution of residues 23, 25, & 26, or 54-56, prevented the binding of 
multiple Rev molecules to the RRE but did not affect the binding of a single Rev 
molecule. Olsen et al. (1990b) demonstrated that mutations of residues 28-31 or 55- 
57 prevented Rev multimerisation, but these mutations also abolished Rev-RRE 
binding. In contrast, deletion of residues 45-51 or substitution of residues 38-39 in 
the arginine-rich domain was found to abolish RRE binding, but not to affect Rev 
multimerisation. Finally, Zapp et al. (1991) found that substitutions of residues 14- 
lb  or 23, 25 & 26, or 27-29, disrupted both binding and multimerisation, whereas 
mutations of residues 9-11 or 17-18 had no effect on either property. These authors 
also found that multimerisation and binding were severely disrupted by mutations in 
the arginine rich domain, including substitutions of 38-39, 41-43, 41-44, 48 & 50, 
or 54 & 56. Moreover, an individual substitution of Arg 44 by either Trp or Gly, or 
substitution of Trp 45 with Arg, had no effect on oligomerisation but abolished 
binding, whereas substitution of Trp 45 with Gly abolished both oligomerisation and 
binding.
The results of these three studies therefore broadly define the multimerisation 
domain as a sequence between residues 14 and 56, but differ in the importance of
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residues in the arginine-rich domain (35-50) for oligomerisation, and in the 
correlation between multimerisation and RRE-binding ability.
1.3.5. Subcellular localisation domain
Subcellular fractionation and immunofluorescence have demonstrated that Rev is 
located predominantly in the nucleus, where it is localised within the nucleoli 
(Cullen et al., 1988; Rosen and Haseltine, 1988; Felber et al., 1989). Several 
studies have identified nuclear and nucleolar localisation signals, although 
conflicting data on their positions have been reported. According to several groups, 
a conserved arginine-rich sequence located between Asn 40 and Trp 45 is both 
necessary and sufficient for nuclear accumulation of Rev (Malim et al., 1989b; 
Perkins et al., 1989; Venkatesh et al., 1990). However, Hope et al. (1990b) have 
found that introduction of acidic residues in positions 14-16 or 18-20 abolishes 
specific nuclear localisation and inactivates Rev function. The sequences required 
for nucleolar localisation have not been defined unequivocally. Hope et al. (1990a), 
using a Rev protein targeted to the nucleus by fusion with a steroid receptor, have 
found that Rev residues 41-43 are required for specific localisation in the nucleolus. 
Cochrane et al. (1990a) have shown that mutant proteins with amino acid residues 
45-51 deleted, or with Arg 38 and Arg 39 replaced by His and Gly, accumulate in 
the nucleus but do not localise in the nucleolus, implicating these residues in 
specific nucleolar localisation. However, in their experiments a fusion protein of 
Rev residues 38-51 and B-galactosidase failed to localise in the nucleolus, whereas a 
Rev 1-59 - B-galactosidase fusion product did exhibit nucleolar targeting. These data 
suggest that residues in the amino terminal region of the Rev protein are also 
involved in nucleolar localisation, but in a similar experiment, Venkatesh et al. 
(1990) have shown that a Rev 38-52 - B-galactosidase fusion protein can localise in 
the nucleolus (albeit with increased levels in the nucleoplasm compared to wild-type 
Rev), indicating that the residues of the central basic domain may indeed be 
sufficient to confer nucleolar targeting. Moreover, Rev residues 35-50 can
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functionally replace a nucleolar targeting signal located at the amino terminus of the 
analogous Rex protein of HTLV-I (Kubota et al., 1991). It is therefore likely that a 
functional nucleolar localisation signal resides in the 35-50 region of Rev.
Mutations which affect localisation in the nucleolus disrupt Rev function, suggesting 
that nucleolar targeting may be a functional requirement for Rev activity (Malim et 
al., 1989b; Perkins et al., 1989; Cochrane et al., 1990a; Venkatesh et al., 1990). 
However, due to the overlap of the RRE binding and localisation domains, it is 
difficult to draw definite conclusions from these experiments. Recently, McDonald 
et al. (1992) have shown that, in experiments where Rev is bound to RNA via a 
heterologous binding domain/RNA target sequence (phage MS2 coat protein/MS2 
operator sequence), nucleolar localisation is dispensable for Rev activity. A fusion 
protein found in the nucleus, but excluded from the nucleoli, retained Rev function. 
It is therefore possible that nucleolar localisation may simply reflect the ability of 
Rev to bind a nucleolar factor, such as the B23 protein described by Fankhauser et 
al. (1991). However, Kubota et al. (1992) have shown that a mutant Rev protein 
with residues 38-44 deleted (thus abolishing nucleolar accumulation) functionally 
inhibits wild type Rev (possibly by forming heterodimers which cannot target the 
nucleolus). This suggests that targeting to this site is important. The precise 
significance of nucleolar localisation of Rev therefore remains to be determined.
1.3.6. Phosphorylation
Rev is phosphorylated in vivo by a specific nuclear serine kinase (Hauber et al., 
1988; Cochrane et al., 1989a). However, mutant proteins with deletions of Ser 5 
and 8 or Ser 99, or substitutions of Ser 92 or Ser 99, are subject to little or no 
phosphorylation, yet retain approximately wild-type levels of Rev activity, 
indicating that phosphorylation is not a functional requirement (Malim et al., 
1989b; Cochrane et al., 1989b). Moreover, only a small proportion of Rev 
molecules appears to undergo phosphorylation (Cochrane et al., 1989b).
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1.3.7. Activation domain
The existence of an 'activation' domain towards the C-terminal end of Rev was first 
noted by Malim et al. (1989b), who described the effects of several clustered point 
mutations of the rev sequence designed to produce codon substitutions. One mutant, 
M10, in which Leu 78 was substituted with Asp, and Glu 79 was substituted with 
Leu, was found to be phosphorylated and to localise in the nucleus normally, but to 
have a mmj-dominant negative phenotype for Rev function - i.e., the protein lacked 
Rev activity and was able to inhibit the function of wild-type Rev in irons. This 
observation was later confirmed by Hope et al. (1990b) and Olsen et al. (1990b). 
Malim et al. (1989b) suggested that M10 might compete with Rev for its RNA 
substrate, or alternatively form mixed inactive multimers with wild-type protein. 
Subsequently, Mermer et al. (1990) showed that substitutions or insertions in the 
Leu 81-Asp 88 region produced dominant negative Rev mutants. Similarly, Olsen et 
al. (1990b) found that substitution of Leu 75 with Arg, or deletion of Arg 80-Leu 
81-Thr 82 created mutants that retained the ability to oligomerise and bind RNA, 
but had /ra/u-dominant negative phenotypes. Further confirmation of the effects of 
mutations in this region was provided by Venkatesh and co-workers (Venkatesh et 
al., 1990; Venkatesh and Chinnadurai, 1990). They found that a Rev protein 
truncated at residue 73 was nonfunctional, whereas Rev truncated at residue 98 had 
wild-type activity. Subsequent experiments demonstrated that the Leu 73 truncated 
protein had a /ram-dominant negative phenotype, as did individual substitutions of 
Leu 75 or Leu 81 (conserved residues in all known HIV-1 strains) with Asp; 
substitution of Leu 81 had a particularly strong dominant negative effect and 
completely inhibited the Rev response in cotransfection assays.
A more extensive analysis of the putative activation domain was carried out by 
Malim et al. (1991). Using a series of substitution mutants in the residue 67-92 
region of Rev, they showed that leucines at positions 78, 81 and 83 were
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functionally critical - substitutions of any or all of these residues with alanine 
induced a rram-dominant negative phenotype. Taken together with the results of 
Venkatesh and co-workers, these results defined a nine amino acid domain (residues 
75-83) containing four leucines (residues 75 , 78, 81, 83). Malim et al. (1991) also 
found that positioning of the leucine residues was crucial - a mutant in which Leu 
83 and Glu 84 were reversed was dominant negative. Sequence comparisons 
between HIV-1 and six other lentiviruses showed that a nine amino acid domain 
containing four hydrophobic (usually leucine) residues is a conserved feature of 
lentivirus Rev proteins. Furthermore, Tiley et al. (1991) showed that the equivalent 
Rev activation domain of Visna (a lentivirus only distantly related to HIV) could 
functionally substitute for the HIV-1 Rev domain in a chimaeric protein. Similarly, 
Hope et al. (1991) and Weichselbraun et al. (1992) identified a corresponding 
region in the HTLV-I Rex protein, and demonstrated functional substitution of the 
Rev domain by the Rex domain.
Although it is clear that the leucine-rich activation domain is essential for Rev 
activity, the mechanism of action of the sequence is unknown. Presumably (as first 
noted by Malim et al., 1989b), the activation domain is required for interaction 
with a cellular factor, since the sequence is dispensable for RNA binding, 
multimerisation, and nuclear localisation. Fankhauser et al. (1991) have shown that 
Rev specifically binds to the nucleolar protein B23, but did not establish which 
domain of the Rev protein was responsible for binding. The results of Trono and 
Baltimore (1990) suggest that a human cell factor (which might conceivably act by 
binding to Rev) is required for Rev function. In their experiments, Rev was 
nonfunctional in murine cell lines such as NIH 3T3, or in Chinese hamster ovary 
cells, but this defect could be complemented by fusion with uninfected human cells. 
However, in contrast to these results, Malim et al. (1991) have found that Rev is 
functional in avian (quail QC1-3), primate (COS and CV-1), and murine (Ltk* and 
NIH 3T3) cell lines, albeit with reduced efficiency in NIH 3T3 cells. Similarly,
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Ivey-Hoyle and Rosenberg (1990) have shown that Rev-dependent expression of env 
gpl60 can be observed in Drosophila melanogaster cells. These results suggest that 
any Rev cofactors, including potential Rev binding proteins, are likely to be found 
in a wide range of eukaryotic cells.
The identification of /ram-dominant negative mutants of the Rev activation domain 
has led to proposals (first made by Malim el al., 1989b) that such mutants could be 
used as specific and potent antiviral agents. The possible applications of this concept 
of 'intracellular immunisation', using /ram-dominant negative mutants of Rev and 
other HIV proteins, have been reviewed by Feinberg and Trono (1992). Initial 
studies of the feasibility of this approach to somatic gene therapy have already been 
made. Bevec et al. (1992) have shown that HIV-1 replication is inhibited in cells of 
the human T-lymphocyte line CEM previously transduced with a retroviral vector 
expressing a /ram-dominant negative Rev mutant.
The failure of /ram-dominant negative Rev mutants to facilitate the cytoplasmic 
expression of Rev-responsive RNA species is presumably due to the failure of the 
activation domain to interact with a Rev cofactor. However the mechanism of 
inhibition of coexpressed wild-type Rev is less clear. As noted above, inhibition 
could conceivably occur by competition for the RNA substrate, or by the formation 
of inactive mixed multimers between mutant and wild-type proteins. The results of 
Hope et al. (1992) support the latter hypothesis. This group demonstrated that a 
/ram-dominant negative mutant can inhibit wild-type Rev function even when 
confined to the cytoplasm by glucocorticoid receptor localisation signals - an effect 
which they attributed to the formation of inactive mixed multimers in the 
cytoplasm. However, very recently Bogerd and Greene (1993) found that trans- 
dominant negative mutants of the activation domain fail to multimerise in vivo, 
suggesting that inhibition is mediated by nonfunctional monomers. These authors 
suggested that an intact activation domain may be required for interaction with a
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bridging cellular cofactor required (in addition to the intrinsic multimerisation 
domain) for the formation of functional and stable multimers in vivo.
It is becoming increasingly clear that the Rev protein can act at several levels of 
gene expression (1.6 and 1.7.5, below), but it is not yet known at what level(s) the 
function of the activation domain is important. Interestingly, Arrigo et al. (1992) 
have found that a Rev protein mutated in the leucine-rich domain can be co- 
immunoprecipitated with RRE-containing RNAs in both nuclear and cytoplasmic 
extracts, whereas wild-type Rev can only be coprecipitated with RNA in the 
cytoplasm. This suggests that the activation domain is directly involved in a Rev- 
mediated nuclear export mechanism. Kjems et al. (1991b) have shown that a 
peptide containing Rev residues 34-50 (and therefore lacking the activation domain) 
can inhibit splicing at the level of spliceosome formation in an in vitro assay. Thus 
the interaction of the activation domain with cellular factors may not be required for 
inhibition of splicing, but may instead be necessary for other activities such as the 
apparent effect on transport noted by Arrigo et al. (1992).
1.4. The Rev responsive element (RRE)
1.4.1. RRE function and location
Deletion analyses of subgenomic proviral DNA cloned into CAT reporter constructs 
(Dayton et al., 1988; Rosen et al., 1988), of infectious molecular clones 
(Hadzopoulou-Cladaras et al., 1989; Arrigo et al., 1989), and of env and tat gene 
expression vectors (Malim et al., 1989a, Hammarskjdld et al., 1989) defined a cis- 
acting intragenic sequence, the Rev responsive element (RRE), required in 
conjunction with Rev for the expression of viral structural proteins. Complementary 
experiments involving the insertion of sections of the env gene into gag, tat, and 
env-gpl20 expression vectors produced similar results, and also demonstrated that 
RRE function was retained when the element was moved, but not when it was 
inverted (Emerman et al., 1989; Hadzopoulou-Cladaras et al., 1989; Hammarskjdld
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et al., 1989; Malim et al., 1989a). The results of the deletion and insertion 
experiments, combined with RNA secondary structure predictions (Malim et al., 
1989a) localised the RRE to a 234 nt element in the gp41 region (transmembrane 
protein coding sequence) of the env gene, immediately 3' to the gpl20/gp41 
cleavage site.
1.4.2. Rev binding ability of the RRE
Rev protein has been shown to bind the RRE RNA directly by filter binding assays 
(Daly et al., 1989; Heaphy et al., 1990; Holland et al., 1990; Nalin et al., 1990), 
gel mobility shift assays (Daly et al., 1989; Daefler et al., 1990; Heaphy et al., 
1990; Holland et al., 1990; Malim et al., 1990), gel mobility shift following 
ribonucléase protection by Rev (Zapp and Green, 1989; Cochrane et al., 1990b; 
Heaphy et al., 1990), and immunoprécipitation with Rev antisera (Daefler et al., 
1990; Heaphy et al., 1990). The dissociation constant o f the Rev-RRE interaction 
has been variously estimated as 3 x 10"*® M (Daly et al., 1989), 1-3 x 10“^  M 
(Heaphy el at., 1990), 3.5 I  HT* M (Nalin et al.. 1990), and 5 x 10'9 M (Holland 
et al., 1990) from filter binding and immunoprécipitation data. These relatively 
consistent results indicated that Rev-RRE binding is a high affinity interaction.
1.4.3. RRE secondary structure and functional domains
RNA folding algorithms predict that the RRE has a complex secondary structure of 
stem-loops (Malim et al., 1989a; Dayton et al., 1989). Statistical methods (Le et 
al., 1990) have demonstrated that the secondary structure of this region is highly 
stable and conserved in 25 different HIV-1 sequence isolates (with similar structures 
found in HIV-2 and SIV). One predicted structure for the RRE (from Malim et al., 
1990) is reproduced in fig. 1.3. The domain notation and numbering of the RRE 
used in this diagram is used throughout the following discussion for ease of 
comparison between models. Several studies have attempted to refine the RRE 
model by correlating the predicted structure with information from ribonucléase
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Fig. 1.3. Predicted secondary structure of the HIV-1 Rev-responsive element 
(RRE) (a) Reference structure (reproduced from Malim et al., 1990). By 
convention the structure is divided into five RNA domains termed stem I (1-37; 
195-234), stem-loop II (39-104), stem-loop III (107-124), stem-loop IV (133-161) 
and stem-loop V (164-189). Stem-loop II is subdivided into stem-loop IIA (39-48; 
71-77; 98-104), stem-loop IIB (49-70) and stem-loop IIC (78-96). (b) Amended 
structure of the stem-loop II region (reproduced from Heaphy et al., 1991). This 
structure differs from that of Malim et al. (1990) in containing a purine-rich 
'bubble' (outlined) now known to be required for high-affinity Rev-RRE binding 
(see 1.4.4, below). Nucleotide 30 in the Heaphy structure corresponds to nucleotide 
42 in the Malim structure.
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digestion and chemical probing experiments, and by examining the effects of 
specific mutations on RRE function. These studies have generally focused on 
determining the precise location and secondary structure of the primary Rev binding 
site and other potential functional domains of the RRE. The results of Cochrane et 
al. (1990b) indicated that formation of the major stem I domain is required for Rev 
binding. They suggested, however, that stem I need not itself bind Rev, but could 
rather function to allow the formation of the other stem-loops, one of which could 
contain the primary Rev binding site. Heaphy et al. (1990) mapped the Rev binding 
region to a 71 nt section of the RRE including stem-loops IIA, IIB and IIC of the 
structure of Malim et al. (1990); however, they proposed a significantly different 
secondary structure for the domain II region. Holland et al. (1990) and Malim et al. 
(1990) came to similar conclusions on the location of the Rev binding site from 
deletion mapping experiments. Holland et al. (1990) also noted the importance of a 
9 nt sequence (CACUAUGGG) at the 5' end of stem-loop IIA, mutations in which 
were found to abolish the Rev response in vivo and Rev binding in vitro.
Holland et al. (1990) also demonstrated that Rev binding could be divorced from 
Rev response by analysis of an unresponsive Rev-binding RRE truncated at the 3' 
end of stem-loop III. This implied that the RRE contains separate Rev-binding and 
other functional domains. However, Huang et al. (1991) showed that an 88 nt 
truncated RRE, comprising stem-loop II fused to an 8 bp sequence from the base of 
stem I, was capable of mediating the in vivo Rev response. Furthermore, they found 
that two tandem copies of this minimal RRE functioned as efficiently as the full- 
length element, indicating that the other domains (stem-loops III-V, and most of 
stem I) were dispensable for the Rev response. Other investigators (McDonald et 
al., 1992; Venkatesan et al., 1992) have shown that the RRE can be completely 
dispensed with if Rev is bound to HIV RNA via a heterologous binding 
protein/RNA target site: A fusion protein of Rev and phage MS2 coat protein binds 
an HIV RNA in which the MS2 operator sequence replaces the RRE, and
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upregulates cytoplasmic expression of incompletely spliced mRNA (albeit with 
reduced activity compared to the normal system). Nevertheless, the RRE domains 
(III-V) which appear to be dispensable for Rev binding and response may have 
important functions in vivo. For example, Constantoulakis et al. (1993) have 
isolated a cellular interferon-inducible protein, RBP9-27, that specifically binds the 
RRE in the domain III-V region and inhibits Rev-mediated gene expression. 
Intriguingly, they have suggested that HIV may utilise this cellular factor to 
downregulate its own gene expression (possibly maintaining a latent infection).
Olsen et al. (1990a) have mapped a region required for Rev binding in vitro and 
Rev response in vivo to stem-loop IIB, but have suggested that Rev probably has 
several contact points on the RRE, including the major stem I. They also found that 
limited mutations of the RRE which were not predicted to cause changes in the 
secondary structure were generally well tolerated for Rev binding and Rev response 
- indicating that secondary, rather than purely primary structure, is the major 
determinant for Rev-RRE interaction. However, Dayton et al. (1992) found that an 
entirely 'base-switched' RRE was inactive, (i.e., they prepared and analysed a 
construct in which the primary structure was completely changed - generally by 
replacing bases with their respective Watson-Crick pairing partners - but the 
predicted secondary structure was maintained). More limited base switching 
demonstrated that primary structure was particularly important for RRE activity in 
the stem-loops of domain II. Cook et al. (1991) have also produced results which 
identify domain II as the Rev binding region, from experiments which studied Rev 
binding to truncated RRE fragments. They identified a 40 nt minimal Rev binding 
substrate including stem-loop IIB and flanking nucleotides in stem-loop IIA which 
was capable of binding Rev independently (and was contained within the 71 nt Rev 
binding fragment identified by Heaphy et al., 1990).
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1.4.4. Rev binding site
Several groups have attempted to identify precisely the Rev binding site within the 
RRE. Kjems et al. (1991a) probed the RRE with reagents specific to single or 
double-stranded regions in the presence or absence of bound Rev. While largely 
confirming the structure of Malim et al. (1989a), their experiments suggested the 
presence of five potential Rev binding sites in the double-stranded regions of stem- 
loops I, IIA, I1B, IIC, and III. These sites were characterised by the ability of 
bound Rev to protect nucleotides from RNase cleavage or chemical modification, 
and contained a conserved G-C, A-U 2 bp sequence within a 6 bp stem flanked by a 
single-stranded region of 3 nt. Kjems et al. (1991a) also noted a lack of sensitivity 
to double-stranded specific nuclease activity in stem I, and to single-stranded 
specific reagents in the loop of IIA between IIB and IIC. This was attributed to 
tertiary RRE structure - increased accessibility of these regions on Rev binding 
suggested a conformational change of the RRE RNA.
In contrast to Kjems et al. (1991a), most investigators have proposed a single 
binding site in the RRE for Rev. Heaphy et al. (1991), using data from an 
alternative (Zuker) RNA folding prediction algorithm from that used by Malim et 
al. (1989a), combined with a reinterpretation of the results of Kjems et al. (1991a), 
proposed a novel secondary structure for the RRE (fig. 1.3b). This differed 
markedly in the stem-loop II domain from the predicted structure of Malim et al. 
(1989a) and the modified structure originally proposed by Heaphy et al. (1990). In 
the new structure, the Malim stem-loop IIB and part of the single-stranded region of 
stem-loop IIA were replaced by an extended stem-loop starting with paired U45- 
A75 residues (Malim notation), and containing unpaired GG and GUA residues in a 
'purine-rich bubble'. Heaphy et al. (1991) found that the 13 nts (8 paired, 5 
'bulged') of the purine-rich bubble were sufficient to bind Rev with wild-type 
affinity when stabilised within a heterologous RNA hairpin structure. They showed 
that mutations of the bubble nucleotides reduced or abolished Rev binding and,
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noting the stability and resistance of the binding element to chemical modification 
discovered by Kjems et al. (1991a), suggested possible stabilisation of the structure 
(and local helix distortion) by a non-Watson-Crick G47-A73 base pair. Using 
different techniques, Bartel et al. (1991) predicted a similar structure for the RRE, 
including a similar bulged stem-loop domain. This group used Rev binding ability 
to identify residues critical for binding by in vitro genetic selection from a pool of 
1013 artificially generated random variants of the stem-loop II Rev binding domain. 
They obtained results consistent with a bulged stem-loop model, and also noted the 
covariation of conserved residues G48 and G71, which could be functionally 
replaced by adenine at these positions, but not by other bases. This suggested the 
functional requirement for a noncanonical purine base pair in the Rev binding 
domain which, like the G47-A73 base pair suggested by Heaphy et al. (1991), 
Bartel et al. (1991) and Dayton et al. (1992), could act by locally distorting the 
RNA backbone - a possible requirement for protein binding.
The crucial role of the purine residues of the RNA bulge was independently 
confirmed by Tiley et al. (1992). They tested the effects of diethylpyrocarbonate 
(DEPC) modification of purine residues on Rev binding, and showed that the 
residues of the bulge were crucial for Rev binding. This information, combined 
with analysis of the secondary structure of a truncated 29 nt Rev binding fragment 
of the RRE (including the essential purine residues) led them to propose a secondary 
structure for the Rev binding domain essentially identical to that of Heaphy et al. 
(1991). Moreover, the application of phylogenetic analysis and Zuker RNA 
secondary structure prediction to the RREs of 25 different HIV-1 isolates has 
demonstrated that a base pairing scheme consistent with an RNA bubble containing 
a putative A-G base pair is a conserved feature (Dayton et al., 1992).
Recently, Iwai et al. (1992) have found by functional group modification of a 29 nt 
RNA duplex containing the Rev binding bubble, that the G48-G71 base pair exists
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in an anti : syn configuration and is essential for Rev binding; similarly the G47- 
A73 pair exists in either an anti : syn or anti : anti configuration and is also 
required for binding. Both Iwai et ai. (1992) and Kjems et al. (1992) have 
suggested three dimensional structure is important in the Rev-RRE interaction. 
DEPC modification (Kjems et al., 1992) or substitution (Iwai et al., 1992) at the 
N7 position of purines in the bubble region interfered with Rev binding - a 
characteristic of protein interaction with the major groove of a nucleic acid helix. 
Thus the RRE bubble could function by distorting the helix to expose the normally 
inaccessible groove for Rev binding. However, Holland et al. (1992) have 
concluded that the secondary and three dimensional structures of the Rev binding 
element are irrelevant, provided that the CACUAUGGG (nt 40-48) sequence 
(originally identified by Holland et al., 1990 - see above) is preserved, and at least 
one of the G residues remains unpaired. They found that this sequence, optimally 
presented in the context of a stem-bulge-stem structure, is sufficient for Rev 
recognition, and is required for the Rev response.
There is now clear evidence that multiple Rev molecules bind the RRE. Several 
groups have demonstrated the existence of multiple Rev-RRE complexes of 
differing electrophoretic mobilities, which were interpreted as containing a varying 
number of Rev molecules bound to each response element (Daly et al., 1989; 
Heaphy et al., 1990; Olsen et al., 1990b; Cook et al., 1991). Scintillation counting 
of labelled protein and RNA from gel-isolated Rev-RRE complexes (Cook et al., 
1991) and filter binding assays (Daly et al., 1989; Heaphy et al., 1991) have 
confirmed this interpretation - Daly et al. (1989) have estimated that up to 8 Rev 
molecules bind the RRE. Although it is possible that the RRE contains a number of 
discrete Rev binding elements (Kjems et al., 1991a), gel mobility shift assays of 
Rev binding to the stem-loop IIB high affinity site inserted in heterologous RNA 
constructs have shown that the high affinity site is necessary and sufficient for
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binding multiple Rev molecules (Iwai et al., 1992). Similarly, chemical interference 
mapping with diethylpyrocarbonate (Tiley et al., 1992) has shown that binding of 
more than one Rev molecule requires only the stem-loop IIB site - suggesting that 
binding of multiple Rev molecules is mediated by protein-protein interactions.
The intrinsic ability of Rev molecules to multimerise even in the absence of RNA 
has been demonstrated by a variety of methods, and (as noted above, 1.3.4) the 
domains responsible for multimerisation have been mapped. Experiments using gel 
filtration chromatography, chemical cross-linking, and density gradient 
centrifugation (Nalin et al., 1990; Wingfield et al., 1991; Zapp et al., 1991) have 
shown that Rev can exist as stable multimers is solution; Rev species with molecular 
masses consistent with the protein existing as a dimer, trimer and tetramer were 
reported by these groups. Heaphy et al. (1991), using electron microscopy, reported 
the formation of hollow filaments with a diameter of about 14 nm and a length of 
up to 1500 nm in preparations of purified Rev at concentrations greater than 
100 ng/ml, in the presence of RRE RNA, short rod-like ribonucleoprotein 
complexes were formed with a preferred length of 60 nm. Similarly, Wingfield et 
al. (1991) described the formation of hollow filaments with a diameter of 20 nm at 
Rev concentrations above 80 pg/ml; in the presence of RRE RNA, filaments 8 nm 
in diameter and up to 0.12 iim long could be formed at Rev concentrations as low 
as 40 /zg/ml. Both groups have suggested that the ability of Rev to polymerise and 
form ribonucleoprotein complexes could be important in the mechanism of Rev 
action. A 'coating' of Rev molecules on the RNA could directly block splicing 
factor access to splice sites, or alternatively channel the transcripts into a 
ribonucleoprotein transport pathway. In support of this theory, Heaphy et al. (1991) 
found that Rev filaments can extend over hundreds of nucleotides of template RNA 
and coat the entire molecule, a process facilitated by 'nucleation' at an RRE 
sequence and probably by low affinity nonspecific binding to RNA. However, 
observations of filament formation was restricted to in vitro systems.
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At present, it is unclear if prior Rev multimerisation is a prerequisite for RRE 
binding. Cook et al. (1991) have shown by scintillation counting of complexes 
between ^  I-labelled Rev, and a ^P-labelled RRE fragment containing the (high 
affinity) stem-loop IIB binding site, that monomeric Rev can bind the RRE. 
Multiple Rev molecules were shown to bind the complete RRE sequence, but the 
results from the subfragment binding experiment indicated that multimerisation is 
not essential for binding. Furthermore, Malim and Cullen (1991) isolated Rev 
mutants which were able to bind the RRE, but not multimerise. However, Olsen et 
al. (1990b) found that mutants which were unable to multimerise (including one 
mutant with a deletion outside the putative RNA binding domain of Rev) did not 
bind RNA. Similarly, Zapp et al. (1991), in experiments which included the 
mutants isolated by Malim and Cullen, found that Rev molecules which were unable 
to multimerise did not bind RNA. However, both Olsen et al. (1990b) and Zapp et 
al. (1991) assayed Rev-RRE binding by an RNase protection gel mobility shift 
assay, rather than the simple mobility shift assay with undigested RNA employed by 
Malim and Cullen; the RNase protection method may be a more stringent assay for 
efficient Rev binding.
Whether or not multimerisation is necessary for binding, the ability of Rev 
molecules to multimerise is clearly essential for Rev function, since the 
multimerisation-deficient mutants which Malim and Cullen (1991) reported to bind 
the RRE were deficient in Rev activity. It is also probable that Rev multimerisation 
occurs before nuclear import, since Rev mutants of the activation domain with a 
/ram-dominant negative phenotype were able to inhibit wild-type Rev function even 
when the mutant protein was restricted to the cytoplasm by fusion with 
glucocorticoid receptor localisation signals (Hope et al., 1992) - presumably by 
forming inactive protein complexes in the cytoplasm. Similarly, dominant negative 
mutants of the Rev nucleolar localisation signal which retained the ability to
multimerise were able to inhibit Rev function while remaining in the cytoplasm 
(Kubota et al., 1992).
Although there is some conflict in the results summarised above, it is possible to 
suggest a mechanism which is relatively consistent with the published data. After 
translation, Rev molecules associate to form small oligomers which are transported 
to the nucleus. A single molecule is then released from an oligomer on binding the 
RRE at the high affinity site; alternatively the unit RRE binding species may be a 
small Rev oligomer. Additional molecules then bind by protein-protein interactions 
with the initial 'nucleating' molecule at the high affinity site, in the type of ordered 
assembly process proposed by Heaphy et al. (1991), eventually forming a 
multimeric ribonucleoprotein complex. Presumably, this process is facilitated by 
nonspecific RNA binding, and possibly by interaction with the additional binding 
sites described by Kjems et al. (1991a).
1.6. acting repression sequences
Although the RRE is necessary for Rev-facilitated cytoplasmic expression of Rev- 
responsive genes, it is not responsible for repressing expression of these RNAs in 
the absence of Rev. Other less well-defined RNA sequences are responsible for this 
phenomenon. According to one model of the mechanism of Rev action (see 1.7.2, 
below, and reviews by Chang and Sharp, 1990; Cullen and Malim, 1991), 
'inefficient' HIV splice sites are necessary and sufficient to make RNA species 
containing the RRE dependent on Rev for expression. It is envisaged that such 
inefficient splice sites can interact with spliceosome components, but are only 
processed comparatively slowly. This allows intervention by Rev-RRE interaction to 
take place before splicing can occur - Rev binding may lead to premature 
dissociation of spliceosome components, releasing the unspliced mRNA for 
transport. In support of this model, Chang and Sharp (1989) have shown that 
constitutive cytoplasmic expression of spliced B-globin mRNA from a construct
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containing the RRE can be altered to Rev-responsive cytoplasmic expression of 
unspliced mRNA by replacing the 8-globin splice sites with HIV-1 tat splice sites, 
or by introducing specific point mutations in either the 5' or 3' B-globin splice site. 
Similarly, Itoh et al. (1989) have demonstrated that Rev can overcome splice donor 
mediated repression of cytoplasmic expression from a chimaeric HTLV-I construct 
containing the RRE.
Several groups have identified other HIV-1 sequences (termed cis-acting repression 
sequences (CRS) by Dayton et al., 1988) which apparently prevent cytoplasmic 
expression of mRNAs in the absence of Rev/RRE interaction. The existence of such 
sequences was first suggested by Sodroski et al. (1986). Subsequently, it was shown 
by deletion analysis of env-CAT/human growth hormone reporter gene constructs 
(Rosen et al., 1988) and of proviral expression plasmids (Dayton et al., 1988) that 
such sequences appeared to be present in the env and gag genes. The gag gene 
sequence and at least one of the env gene sequences clearly did not overlap with the 
Rev-response element, and the effect of the env gene sequences was retained when 
known splice donor and acceptor sites were deleted. However, Malim et al. (1989a) 
failed to detect truncated Tat expression - the expected product of cytoplasmic 
expression of unspliced RNA in their assay - when the env sequences defined by 
Rosen et al. (1988) were deleted from an expression vector, suggesting that other 
sequences were involved in nuclear RNA retention. Emerman et al. (1989) 
identified an additional cw-acting negative regulatory sequence at the 3' end of the 
env gene by adding env sequences 3' to the stop codon of a truncated env (gpl20 
only) expression vector. Again, the effect was observed in the assumed absence of 
splicing, as the tat/rev 5' splice site was removed. The presence of a novel ex­
acting repression sequence in gag, and of a sequence in env overlapping those 
defined by Rosen et al. (1988) and Emerman et al. (1989) has been reported by 
Hadzopoulou-Cladaras et al. (1989). Maldarelli et al. (1991) have located ex-acting 
regions in a 1295 nt section of gag and a 1932 nt section of pol which can inhibit
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the cytoplasmic expression of a heterologous CAT reporter gene. Cochrane et al. 
(1991) have identified cis-acting repression sequences in both gag and the 3' end of 
pol. Their experiments, based on adding HIV-1 sequences downstream of the CAT 
gene in a reporter construct, showed that the 260 nt pol element had a particularly 
strong repressive effect which could, however, be reversed by the addition of the 
RRE in cis and Rev in irons. In contrast to the other groups, they attributed the 
mechanism of repression to an effect on mRNA utilisation by cellular translation 
machinery, rather than mRNA transport, since the subcellular distribution of viral 
mRNA appeared to be unaffected. Another mechanism of cw-acting inhibition of 
expression has been proposed by Schwartz et al. (1992a, 1992b). These workers 
have found a 218 nt AU-rich inhibitory sequence (INS-1) at the 5' end of gag which 
appears to reduce the stability of gag RNA. They showed that the inhibitory effect 
of the sequence could be reversed either by the presence of Rev and the RRE, or by 
a series of 28 silent point mutations over a 270 nt region of gag. An additional 
element in the gag-pol region was also detected.
It is not yet clear if the specific repression sequence model is compatible with the 
inefficient splice site recognition model. Known splice sites were not excluded by 
all groups which favoured specific repression sequences. For example, although 
Emerman et al. (1989) removed the 5' splice site to prevent splicing, the 3' splice 
site (as shown by Chang and Sharp, 1989) could still mediate nuclear retention of 
RNA. In experiments where all known functional splice sites were removed, it is 
possible that the repression sequences represented cryptic or unused splice sites 
capable of interacting with splicing components. Alternatively, sequences which are 
not themselves splice sites may function by interacting with components of the 
splicing machinery. Olsen et al. (1992) have shown that the pol repressive element 
defined by Cochrane et al. (1991) interacts strongly and specifically with at least 
three cellular factors, including one which cross-reacts with a monoclonal antibody 
to the hnRNP C protein, a factor believed to be involved in the splicing pathway.
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Moreover, this interaction was blocked by the addition of a heterologous intron 
sequence. Possibly a number of elements, including splice sites and more specific 
cri-acting repression sequences, have inhibitory activities which can be countered by 
the Rev/RRE system.
It is more difficult to accommodate the results of Cochrane et al. (1991) and 
Schwartz et al. (1992a, b) within this framework, since the repression sequences 
they defined appeared to act at the levels of mRNA utilisation in the cytoplasm and 
mRNA stabilisation, respectively. However, repression and its Rev-dependent relief 
may act at more than one level of mRNA metabolism. It is possible to envisage a 
situation where the Rev/RRE system counters multiple levels of repression exerted 
by a variety of elements responsible for nuclear retention, destabilisation, and poor 
translatability of RNA in the absence of Rev. There is some evidence that different 
mechanisms predominate in different cell types. For example, Arrigo and Chen 
(1991) have shown that in lymphoid cells, the principal effect of Rev is to allow the 
association of exported unspliced mRNAs with polysomes and their subsequent 
translation. Possibly, an adaptable system able to function by any of several 
different mechanisms is required for HIV tropism in a variety of cells.
1.7. Mechanisms of Rev action
1.7.1. Effects on mRNA transport
A mechanism for Rev action based on a direct effect on the mRNA transport 
pathway has been proposed by several groups. Felber et al. (1989), while noting a 
Rev-mediated effect on mRNA stability, concluded that Rev also functioned at the 
level of mRNA transport. Their results showed that Rev was required for the 
cytoplasmic accumulation of unspliced RNAs carrying the RRE. Rev did not appear 
to affect nuclear levels of these mRNAs. The effect on cytoplasmic accumulation 
was presumed to be independent of splicing since it persisted with proviral 
constructs from which all known functional splice sites were removed. Felber et al.
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(1989) proposed a mechanism in which Rev action channelled unspliced RNAs 
away from splicing (or degradation in the case of unspliceable mutant RNAs) and 
towards nuclear export. Similar conclusions were reached by Malim et al. (1989a), 
who showed that a Rev response was maintained with a non-spliceable env 
construct, and when the RRE was moved to various exonic and intronic locations 
within env. They suggested that Rev functioned to allow the interaction of 
incompletely spliced RNAs with nuclear export machinery. Comparable results 
were also obtained by Arrigo et al. (1989), who noted that the transport facilitation 
effect might be indirect - i.e., Rev might allow transport by blocking spliceosome 
formation, permitting nuclear export (spliceosomes might still be formed even in 
constructs where known splice donors were deleted by the activation of cryptic 
splice sites). A similar mechanism has been suggested by Emerman et al. (1989). 
Direct evidence for this type of mechanism is discussed below (1.7.2). Results 
broadly consistent with those of Felber et al. (1989), Malim et al. (1989a) and 
Arrigo et al. (1989) have been obtained by Hammarskjöld et al. (1989) and 
Emerman et al. (1989). However, Hammarskjöld et al. (1989) found that 
incompletely spliced RNA accumulates in the nucleus in the absence of Rev, rather 
than being unaffected. Either result could be consistent with a facilitation of 
transport mechanism - incompletely spliced RNA could either be further spliced, 
degraded in the nucleus, or retained to accumulate. The differing results may reflect 
the different expression systems and methods of analysis employed by these groups. 
Recently, Arrigo et al. (1992) have demonstrated that RNA containing the RRE 
coimmunoprecipitates with Rev protein in the cytoplasm, but cannot be detected in 
the nucleus unless Rev is replaced by a nonfunctional protein mutated in the 
activation domain. This suggests that Rev is involved directly in rapid nuclear 
export of incompletely spliced RNA; an indirect (splicing inhibition) mechanism 
might be expected to show relatively high levels of incompletely spliced RNA 
bound to Rev in the nucleus.
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1.7.2. Effects on mRNA splicing
A direct effect on pre-mRNA splicing which served to regulate the relative 
proportions of viral transcripts was first proposed as a mechanism for Rev action by 
Feinberg et al. (1986). Subsequently, Gutman and Goldenberg (1988) showed that 
an extract from HIV-1 infected cells specifically inhibited splicing of an Sp6/HiV-l 
env transcript by preventing spliceosome assembly. However, the factor responsible 
for this effect was not identified. As noted above (1.6) Chang and Sharp (1989) 
demonstrated that Rev/RRE-mediated regulation depended on splice site 
recognition. Their results showed that relatively inefficient splice sites that are 
processed comparatively slowly are required for dependence of an mRNA on Rev- 
facilitated cytoplasmic accumulation mediated by the RRE. Itoh et al. (1989) have 
shown that Rev in trans and the RRE in cis can allow cytoplasmic expression of 
incompletely spliced RNA from a chimaeric HTLV/HIV construct; in the absence 
of Rev, expression is prevented by an HTLV splice donor. Thus Rev is capable of 
overcoming splice-site mediated repression of gene expression in a heterologous 
system, suggesting that the protein may have a similar role in HIV. Moreover, Lu 
et al. (1990) have demonstrated that Rev-mediated expression of Env proteins from 
an SV40-based vector requires an intact splice donor.
Kjems et al. (1991b) have shown that Rev can specifically inhibit the splicing of 
RNA containing the RRE by 3- to 4-fold in vitro. A 17 amino acid peptide 
containing the Rev RNA binding domain (residues 34-50) was also functional in the 
splicing inhibition assay - surprisingly with greater activity than the whole protein. 
Rev requires an activation domain (1.3.7) for functional activity in vivo which 
would not be present in the 34-50 peptide, suggesting either that the in vitro 
experiments do not adequately reflect the situation in vivo, or that Rev has a number 
of important activities, one of which can be isolated in the splicing inhibition assay. 
This assay also showed that Rev could inhibit splicing from constructs containing 
the RRE and an adenovirus major late intron, or a B-globin gene with wild-type
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splice sites, a result which contrasts with the in vivo findings of Chang and Sharp 
(1989). Again, these results probably reflected the artificial situation of the in vitro 
system, in which splicing occurs much less efficiently than in vivo.
The precise mechanism by which Rev-RRE interaction might inhibit the splicing 
reaction is not yet clear. Kjems et al. (1991b) found that the Rev 34-50 peptide was 
only an active inhibitor if added before or immediately after adding nuclear extract 
to the splicing reaction. This suggested a role in preventing spliceosome assembly. 
Furthermore, sucrose gradient fractionation demonstrated that complete 60S 
spliceosomes were not formed on transcripts containing the RRE in the presence of 
Rev 34-50. Gutman and Goldenberg (1988) also found that spliceosome formation 
is inhibited in reactions using extracts from HIV 1-infected cells. It is possible that 
Rev blocks spliceosome formation and hence the splicing reaction by directly 
interfering with the binding of splicing components at the splice sites. Indeed, 
Wingfield et al. (1991) and Heaphy et al. (1991) have proposed that an RRE 
nucleated coating o f Rev molecules on incompletely spliced RNA (forming the 
ribonucleoprotein filaments observed by these groups in vitro) could directly block 
the splice sites and protect the RNA from splicing. Equally, the formation of a 
specific ribonucleoprotein might be important in directing the RNA to a facilitated 
nuclear export pathway, rather than (or as well as) blocking splicing. It should be 
noted that Kjems et al. (1991b) saw no decrease in accessibility to RNase T1 of 
RNA bound to the Rev 34-50 peptide, despite significant inhibition of splicing, 
suggesting that the effect observed in vitro was independent of protein coating. An 
alternative possibility is that conformational changes caused by Rev binding may 
directly inhibit splicing or form binding sites for inhibitory factors. Differences in 
the circular dichroism spectra of free RRE RNA and bound Rev-RRE complexes 
(Daly et al., 1990) suggest that such changes do occur.
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1.7.3. Effects on mRNA stability
Evidence for an effect of Rev on HIV mRNA stability has been described by Felber 
et al. (1989). This group found that Rev both promoted the transport (1.7.1, above) 
and increased the half-life of unspliced viral mRNAs carrying the RRE. The effect 
on stability, studied with constructs from which transcription was arrested with 
actinomycin D, was found to be independent of splicing and RNA encapsidation by 
Gag proteins. Schwartz et al. (1992a, b) isolated a 218 ni inhibitory sequence at the 
5' end of the gag gene which appears to act by destabilising gag RNA in the 
absence of Rev. This sequence was found to have an unusually high AU content 
(61.5% AU) compared to tat and most cellular RNAs. Within the inhibitory 
sequence, two very AU-rich subregions were identified; deletion of one of these 
abolished the inhibitory effect, suggesting that AU content may be an important 
determinant of the stability of these RNA species. AU-rich elements have been 
described as determinants of instability in several cellular mRNAs, one example 
being granulocyte-macrophage colony stimulating factor (Shaw and Kamen, 1986). 
If such elements are present in the other incompletely spliced mRNAs, then RNA 
stabilisation may be a mechanism of Rev action.
1.7.4. Effects on mRNA utilisation
A mechanism involving an effect on mRNA utilisation was first proposed for Rev 
action by Sodroski et al. (1986). Subsequently, Knight et al. (1987) concluded that 
Rev acted at a translational level from experiments in which viral RNA was 
quantitated in the presence and absence of Rev expression. However, Knight et al. 
(1987) measured total cellular rather than fractionated nuclear and cytoplasmic RNA 
levels, and therefore did not distinguish translational from transport or splicing 
mechanisms. More recently, Arrigo and Chen (1991), using quantitative PCR 
techniques, showed that in lymphoid 729 cells, Rev had no significant effect on the 
cytoplasmic accumulation of singly spliced (env/vpu, v(f, vpr) mRNA species, and 
an effect on cytoplasmic accumulation of unspliced (gag/pol) mRNA was not
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sufficient to explain observed Rev-mediated increases in Gag protein expression. 
Rev was, however, required for the association of these singly-spliced and unspliced 
RNA species with polysomes. In the absence of Rev, such RNAs were found to be 
associated with a 40S-80S complex which it was speculated might interact with CRS 
elements in HIV RNA, preventing polysome loading unless released by Rev action; 
alternatively, the complexes could simply be single ribosomes or their subunits. 
Consistent with the observations, Cochrane et al. (1991) defined a CRS element in 
thepol gene that acted at the level of mRNA utilisation (1.6, above). D'Agostino et 
al. (1992) have also reported that Rev acts at the level of mRNA utilisation. In their 
experiments, carried out in Tat-expressing HeLa cells, Rev expression caused an 
800-fold increase in the levels of Gag protein expression, but only a 4-16-fold 
increase in the cytoplasmic level of gag mRNA. The gag mRNA produced in the 
absence of Rev was found to be fully translatable in a cell-free system but was not 
associated with polysomes in the absence of Rev. Even in the presence of Rev, a 
notably lower proportion o f the total gag mRNA was polysome-associated than was 
the case for a control 8-globin RNA. This suggested that the HIV RNA might have 
reached the cytoplasm by a (possibly Rev-mediated) transport pathway distinct from 
that followed by cellular RNAs, leading to slower association with translation 
machinery. These authors also examined the subcellular distribution of gag mRNA 
by in situ hybridisation and found that, in the absence of Rev, this species was 
restricted to the nucleus and the area of the cytoplasm surrounding it. This indicated 
that the gag mRNA might be sequestered in a specific cytoplasmic subcompartment, 
perhaps by binding to a cellular factor via a CRS sequence; release from this 
compartment might therefore be mediated by Rev-RRE binding.
The conclusion that Rev is active at the level of mRNA utilisation implies that Rev 
protein remains bound to the RRE in the cytoplasm. This has been confirmed by 
coimmunoprecipitation o f Rev with the RRE from cytoplasmic cell extracts (Arrigo 
eta l., 1992).
1.7.5. Combined mechanisms
It is clear from the preceding sections that the mechanism of action of the Rev 
protein is still a controversial subject. It should, however, be noted that the 
mechanisms discussed above are not necessarily mutually exclusive. As noted in 
1.6, Rev may be a multifunctional protein active at several different levels of 
expression. Indeed, the apparently distinct processes of splicing, nuclear export, 
mRNA stabilisation and translation may be artificially divided stages of a 
continuous, unified process of gene expression.
Given the data discussed above, it is possible to suggest a plausible combined 
mechanism in which Rev functions at more than one level of expression: In the 
absence of Rev, incompletely-spliced transcripts are either further spliced or 
retained in the nucleus by interaction of their splice sites and/or cu-acting repressive 
sequences with cellular factors (which may be components of the splicing 
machinery). However, when the rev gene is expressed, multiple Rev molecules bind 
the RRE and may then cause premature spliceosome dissociation and/or block splice 
sites directly by polymerisation along the transcripts. Alternatively, Rev binding 
may allow transcript release from some other mechanism that prevents nuclear 
export of incompletely-spliced transcripts (possibly involving a distinct cellular 
factor or compartmentalisation within the nucleus). A third (and not exclusive) 
possibility is that Rev packages transcripts for interaction with a facilitated nuclear 
export mechanism (Rev has the potential to interact with splicing components, other 
nuclear factors, or transport machinery via its activation domain). Rev continues to 
be associated with exported RNAs in the cytoplasm where it may stabilise the 
transcripts and/or form part of a translation complex and/or facilitate release from a 
cytoplasmic subcompartment, allowing polysome loading. Alternatively, by 
allowing transport into the cytoplasm through a facilitated nuclear export pathway, 
Rev may locate the RNA in a particularly favourable site for translation.
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1,8, Replication cycle and gene expression of utem alm
1.8.1. Introduction
Adenoviruses are the aetiological agents o f a variety of diseases in mammals and 
birds. In humans, conditions caused by infection with particular adenovirus 
serotypes include a number of acute respiratory illnesses, epidemic 
keratoconjunctivitis, and acute haemorrhagic cystitis (reviewed in Horwitz, 1990b). 
Some human adenoviruses have also been shown to cause malignant tumours in 
rodents, but these viruses do not appear to be oncogenic in humans.
The known serotypes of human adenoviruses have been classified into six subgroups 
(A-F) based on their haemagglutination properties, oncogenic potential in animals, 
ability to transform cells in tissue culture, and GC base content (reviewed in 
Horwitz, 1990a). Human adenovirus serotype 5 (Ad5), the virus used in this study, 
belongs to subgroup C. This group is characterised by partial agglutination of rat 
erythrocytes, a relatively high (57-59%) GC content, the ability to transform cells 
in tissue culture, and the inability to induce tumours in animals. Of the four 
serotypes in this subgroup, two - Ad2 and Ad5 - have been completely sequenced. 
The 35938 bp Ad5 sequence (completed by Chroboczek et al., 1992, and amended 
by Dix and Leppard, 1992) shows 94.7% homology with the sequence of Ad2. 
Detailed sequence comparison has suggested that the Ad2 genome may have 
evolved from the highly related Ad5 sequence, primarily by nucleotide transitions, 
and probably by recombination of the fibre gene (Chroboczek et al., 1992). As 
these two serotypes are so closely related, it is generally assumed in this thesis, as 
elsewhere, that the results of experiments conducted with Ad2 can be applied to 
Ad5; no distinction between the serotypes is usually made in the discussion of these 
results.
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1.8.2. Structure and life cycle of Ad5
The structure and replication cycle of Ad2/5 have been well characterised (see 
review by Horwitz, 1990a, and references therein). The double-stranded DNA 
genome is bound to a 55K terminal protein at each 5 ' terminus. The genome is 
associated with viral core proteins V, VII and /t, and the core is in turn encased in a 
regular nonenveloped icosahedral capsid, 65-80 nm in diameter, which carries 12 
projecting fibres. The major capsid protein is hexon (protein II); the fibres consist 
of 3 molecules of protein IV, and are linked to the capsid via penton base (protein 
III) pentamers at each vertex of the icosahedron. Other virion components include 
the hexon-associated proteins (VI, VIII and IX) and the penton-associated protein
(Ilia).
Attachment of adenovirus to permissive cells is believed to be mediated by binding 
of the fibre proteins to a cell surface receptor. The virus is then internalised at 
clathrin-coated pits by endocytosis, forming a receptosome. The receptosome is 
ruptured, and penton protein lost, in a pH-dependent process. The virus is then 
transported to the nucleus, probably by a mechanism involving hexon interaction 
with microtubules. The remaining capsid proteins appear to be shed as the viral core 
enters the nucleus through the nuclear pores. In the nucleus, viral genomes 
undergoing active DNA replication and transcription appear to exist as distinct 
inclusion bodies associated with the nuclear matrix (described in Omelles and 
Shenk, 1991).
The expression of viral genes depends extensively on host cell mechanisms. A 
number of viral gene products serve to regulate gene expression at transcriptional, 
post-transcriptional and translational levels (see 1.8.4). Viral gene expression can be 
broadly divided into two phases - early (before the onset of viral DNA replication) 
and late (after the onset of viral DNA replication). In general, the genes expressed 
in the early phase encode regulatory and other nonstructural viral proteins, while
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most of the genes expressed in the late phase encode virion components. However, 
the early/late distinction is not rigid - most early proteins continue to be expressed 
in the late phase and limited expression of some late proteins occurs in the early 
phase. Replication requires three viral gene products directly - the DNA 
polymerase, a 72K DNA binding protein, and the SSK terminal protein, the latter as 
an 80K precursor form. Cellular proteins, including nuclear factors (NF) 1 and III 
which bind the Ad origin of replication, and topoisomerase I activity are also 
required. A replication model involving single strand displacement by the nascent 
chain (Lechner and Kelly, 1977) is now widely accepted.
During the late phase of infection, host cell protein synthesis is shut down and 
biosynthetic activity is diverted to the synthesis of viral structural proteins. 
Expression of these late proteins is followed by virion assembly, a process 
dependent on viral scaffold proteins that is initiated in the cytoplasm by the 
formation of multimeric penton and hexon capsomeres and completed in the 
nucleus. Replicated DNA genomes appear to enter hollow preformed capsids in one 
of the late stages of virion maturation. The mechanism o f virus release from the 
dying cell is not well understood.
1.8.3. Organisation and expression of the adenovirus genome
The pattern of gene expression from the adenovirus genome is highly complex (see 
reviews by Flint, 1986, and Horwitz, 1990a, and references therein). This 
complexity is illustrated in fig. 1.4, a transcription and translation map of Ad2.
Early region El A encodes two major proteins of 289 and 243 amino acid residues 
(R), synthesised from 13S and 12S mRNAs respectively. Multiple functional 
domains have been characterised in the 289R protein, and are responsible for 
induction of DNA synthesis, induction of mitosis/transformation, transactivation 
(transcriptional activation) of viral early genes (including E l A itself), and nuclear
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Fig. 1.4. Transcription and translation map of Ad2 (reproduced from Horwitz, 
1990a). Exons are denoted by bold lines, polyadenylation sites by arrowheads, 
nonstructural gene products by their molecular masses (e.g. 55K), and virion 
components by Roman numerals (e.g. II). Some minor RNA species and 
corresponding peptides are not shown at this scale.
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localisation (Moran and Mathews, 1987). The 243R protein which, by differential 
splicing of the RNA encoding it, lacks one of the domains (CR3) involved in 
transactivation, has only a weak effect on transcription but retains the other 
activities (Winberg and Shenk, 1984).
Early region E1B encodes two major proteins of molecular mass 21K and 55K (as 
discussed below, 1.9.1). The role of the 55K protein, a principal focus of this 
thesis, is discussed in detail below (1.9). The 21K protein appears to inhibit the 
apoptosis responses (degradation of host cell DNA and cytolysis) to Ad El A and 
cellular tumour necrosis factor-a proteins (White et al., 1991; 1992), and can 
transactivate the expression of viral early genes (Yoshida et al., 1987).
The proteins encoded by both El A and E1B are involved in the induction and 
maintenance of cell transformation and are therefore classed as the adenovirus 
tumour antigens. Significantly, both E1B 5SK and the El A 289R protein bind the 
products of tumour suppressor genes and modulate their activities. Binding to E1B 
33K has recently been shown to inhibit the transactivation activity of p53 (Yew and 
Berk, 1992), while binding to E1A dissociates the pi 05-retinoblastoma protein from 
complexes with cellular transcription factors (reviewed in Dyson and Harlow, 
1992). A detailed review of the extensive literature on the role of these adenovirus 
early proteins in cell transformation and tumourigenesis is outside the scope of this 
thesis.
Regions E2A and E2B encode proteins required for DNA replication (reviewed in 
Stillman, 1989). E2A encodes a 72K single-stranded DNA binding protein 
necessary for DNA replication whilst E2B encodes the 80K precursor of the 55K 
genome terminal protein and the 140K adenovirus DNA polymerase. The E3 region 
encodes several proteins that modulate the host response to adenovirus infection. 
These include a 19K glycoprotein that blocks cell surface expression of MHC class I
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polypeptides, a 14.7K protein that inhibits tumour necrosis factor-mediated lysis of 
infected cells, and a 10.4K protein that binds the epidermal growth factor receptor 
(reviewed by Wold and Gooding, 1991). The E4 region encodes a number of small 
proteins (Virtanen el al., 1984), at least two of which (the products of ORFs 3 and 
6) are involved in the post-transcriptional regulation of gene expression (as 
discussed below, 1.9.8).
All the genes discussed above - El A, E1B, E2A, E2B, E3 and E4 - are classed as 
early - i.e., are expressed before the onset of viral DNA replication. Early gene 
expression can be further divided into pre-early (El A only) and delayed early (E1B, 
E2A, E3 and E4) phases. The delayed early genes are dependent on ElA-mediated 
transactivation for their expression (reviewed in Flint, 1986). In contrast to E1A, no 
significant expression of the delayed early gene products can be detected in the first 
two hours after infection. Expression of the early genes continues at least into the 
early part of the late phase of infection.
The viral late genes comprise the major late transcription unit (LI, 2, 3, 4, S) 
together with genes for polypeptides IX and IVa2. A distinct late promoter for the 
E2 gene (E2-L) is also active in the late phase. The major late transcription unit 
encodes all the virion components or their precursors except IX and the terminal 
protein (E2B), as well as nonstructural proteins including LI 55K, L4 100K, L4 
33K and L3 23K (the protease responsible for processing precursor proteins to their 
mature forms). The 50K IVa2 protein is also a nonstructural scaffolding protein. 
Expression of the late genes, with the exception of LI, is limited to the period after 
DNA replication; transcription of these genes probably only occurs from a 
replicated DNA template. In the early phase, major late transcription stops in the L3 
region and only LI RNA reaches the cytoplasm. The minor late genes (IX, IVa2) 
are expressed before the major late transcription unit becomes fully activated. The 
IX gene, embedded in the E1B transcription unit but expressed from an autonomous
promoter, encodes a hexon-associated virion component (as noted above). A third 
minor late promoter, E2-L, is responsible for the expression of E2 proteins in the 
late phase of infection. It is distinct from the E2-E control region in position and 
expression kinetics, and controls about a third of E2 expression in the late phase.
1.8.4. Regulation of adenovirus gene expression
Adenovirus gene expression is regulated at several levels (see review by Flint, 
1986, and references therein). A number of viral proteins are involved in regulation 
of transcription (reviewed in Akusj&rvi, 1993). The E1A 289R protein activates 
transcription from several viral and cellular promoters by mechanisms involving its 
conserved amino acid domains CR1, CR2 and CR3. The CR3 domain is involved in 
phosphorylation of transcription factors such as E2F and is required for activation 
by association with TBP (TATA binding protein) and with upstream binding factors 
such as the ATFs (activating transcription factors). CR1 and CR2 (also carried by 
and active in the El A 243R protein) are required for activation by dissociating 
transcription factors and inhibitory proteins (e.g. dissociating the plOS- 
rctinoblastoma protein from E2F, reviewed in Dyson and Harlow, 1992). The E4 
ORF6/7 protein is also a transcriptional activator, specifically of E2A transcription. 
It appears to act by inducing co-operative binding of E2F to the E2A promoter 
(reviewed in Akusjirvi, 1993). Specific mechanisms also exist for repression of 
transcription from particular genes. The E2A 72K DNA binding protein has been 
shown to repress transcription of the E4 region (Handa f t  al., 1983) while both the 
289R and 243R El A proteins have an autorepressive effect on their own 
transcription that may be involved in the general decline in transcription rates of the 
early genes in the latter part of the early phase of infection (Smith et al., 1985).
Regulatory control is also exerted at the level of transcriptional termination. 
Transcription from the major late promoter terminates in L3  in the early phase of 
infection, whereas regions L1-L5 are transcribed in the late phase. This control of
termination is temporally regulated with respect to the phase of infection. 
Moreover, although L2 and L3 sequences are transcribed in the nucleus in the early 
phase, they do not appear to undergo significant polyadenylation and subsequent 
nuclear export. This contrasts with the situation in the late phase, when all the 
major late mRNAs are both transcribed and polyadenylated. Thus control of 
polyadenylation also appears to be an important mechanism in the regulation of 
adenovirus gene expression.
Differential splicing is used extensively by Ad5 to produce multiple RNA species 
from a single primary transcript. The 5' ends of major late mRNAs are generated 
by splicing of tripartite leader sequences to one of several alternative 3' splice 
acceptor sites, e.g., the L3 region forms a template for a family of three major 
RNA species, where the longest (coding for pVI) utilises the most 5' of the 3' 
acceptor sites, the intermediate size RNA (coding for hexon protein II) utilises the 
middle 3' acceptor site, and the shortest (coding for the 23K protease) utilises the 
most 3' of the acceptor sites (fig. 5.2). In some cases, splice site usage is 
temporally regulated - i.e., depends on the phase of infection. This type of 
regulation has been shown to occur in the formation of LI, El A and E1B RNA 
species (see for example Akusjarvi and Persson, 1981; Montell et al., 1984). A 
further mechanism of regulation exists at the level of mRNA transport - i.e., 
between release of mature mRNAs from their processing sites and their appearance 
in the cytoplasm (a multi-step process that could potentially be regulated at several 
points). In adenovirus infections, these processes are regulated by a functional 
complex of the E1B 55K and E4 34K proteins as discussed below.
1.9. E1B55K
1.9.1. Expression
Adenovirus 5 early region E1B encodes two major protein products - a 495 amino 
acid (495R) protein with a molecular mass of 55K, and a 175 amino acid (175R)
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protein with a molecular mass of 21K (Bos et al., 1981; Anderson et al., 1984). At 
early times in infection both E1B 55K and E1B 21K are translated from overlapping 
reading frames in a single 2.2 kb (22S) RNA. Subsequently, the 2 IK protein is also 
expressed from a 1 kb (13S) RNA which is the predominant E1B species produced 
in the late phase of infection (Bos et al., 1981). Although differential stabilisation 
may be a factor in controlling relative levels of the E1B mRNAs, studies of splice 
site mutations (Montell et al., 1984) and staggered superinfection experiments 
(Adami and Babiss, 1991) have shown that the changes in 22S and 13S message 
abundances are due to a c/.v-effect on splice site usage.
A 155 amino acid (155R) 16.6K E1B protein expressed from a minor (1.2 kb) RNA 
species has also been identified (Anderson et al., 1984). This protein is translated in 
the 55K reading frame, with the middle section removed by alternative splicing. 
The 16.6K protein primary structure therefore corresponds to the N- and C-termini 
of E1B 55K. Other minor E1B polypeptides, translated from mRNAs that have 
undergone additional splicing events that truncate the 55K or 2 IK reading frames, 
have also been detected. (Anderson et al., 1984; Virtanen and Pettersson, 1985).
1.9.2. Association with E4 34K protein
Samow et al. (1984) have shown that the E1B 55K protein is physically associated 
with a protein with an apparent molecular mass of 25K. This protein was mapped to 
open reading frame 6 (ORF 6) of early region E4 in the adenovirus genome. E4 
ORF 6 was predicted to encode a 34K protein, indicating that the molecular mass of 
the detected protein could not be determined accurately by SDS-PAGE (or that a 
larger precursor was processed post-translationally). The E1B 55K/E4 34K complex 
is believed to be the functional unit of 55K activity. (Cutt et al., 1987) (see 1.9.8 
for detailed discussion). Thus, in the following discussion of the role of E1B 55K it 
should be noted that E4 34K is also required for the functions described.
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1.9.3. Subcellular localisation
Two recent studies have attempted to define precisely the intracellular localisation 
of the E1B 35K protein in lytically infected cells. Smiley et al. (1990) used 
subcellular fractionation and indirect immunofluorescence techniques to examine the 
subnuclear distribution of the 33K protein by probing with a monoclonal antibody. 
E1B 55K was detected in RNase A-releasable and in pore complex-lamina (nuclear 
envelope) fractions of the nucleus. However, comparisons of the distributions and 
elution profiles of 33K and cellular pore complex proteins indicated that 33K was 
not stably or intimately associated with the pore complex. Free and E1B 55K-bound 
forms of the E4 34K protein were also concentrated in the pore complex-lamina 
fraction, but the presence of the 34K protein was not required for the localisation of 
55K in this fraction. However, Omelles and Shenk (1991) showed that E4 34K was 
required for localisation of E1B 53K in and around the periphery of the nuclear 
viral inclusion bodies in which DNA replication and transcription are believed to 
occur. Using immunoelectronmicroscopy and immunofluorescence, this group 
demonstrated localisation of 35K in cytoplasmic fibrous bodies adjacent to the 
nucleus. The 35K protein was also detected in a diffuse reticular distribution in the 
cytoplasm, in a granular non-nucleolar distribution in the nucleolus, and in discrete 
nuclear spicules. However, only the localisation to viral inclusion bodies required 
the E4 34K protein. Since 55K requires binding of the 34K protein to form an 
active complex, then the 34K-dependent localisation to the inclusion bodies is likely 
to be functionally significant. The possible relevance of this localisation to the 
mechanism of action of the 55K/34K complex is discussed below (1.9.7).
1.9.4. Phosphorylation
The E1B 33K protein is phosphorylated in vivo by a cAMP-independent protein 
kinase. Malette et al. (1983) found that each 55K molecule contains 2-3 phosphates 
on average. The ratio of phosphoserine : phosphothreonine was estimated as 2 : 1 
(with essentially no detectable phosphotyrosine). Taken together, these results
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suggested that 55K is phosphorylated at two serine residues and one threonine. 
However, the exact positions of the phosphorylation sites were not determined and 
the importance of phosphorylation to 55K function was not assessed.
1.9.5. Functional domains
Yew et al. (1990) have attempted to identify the functional domains of the Ad2 E1B 
55K protein. By constructing a series of recombinant viruses with insertion 
mutations in the E1B 55K gene, they were able to show that a mutant could be 
obtained (with an insertion at 55K amino acid 380) that efficiently expressed late 
viral proteins, caused shutoff of host cell synthesis, and replicated in 
noncomplementing HeLa cells, but was deficient in transformation of cloned 
embryo fibroblast (CREF) cells following infection. However, distinct domains in 
the primary sequence required for individual 55K functions were not identified. 
Several regions (at amino acids 180, 262-326 and 443-474) were found to be 
necessary for viral replication. Overlapping with two of these regions, amino acids 
180-354 were shown to be required for efficient shutoff of cellular protein 
synthesis. Numerous regions throughout the sequence were required for late viral 
protein synthesis, and transformation ability in CREF cells was impaired in all the 
mutants studied. These results suggest that E1B 55K may not have a modular 
domain structure of the type found for the El A proteins.
1.9.6. Role of E1B 55K in lytk infection
While earlier studies had focused on the role of E1B 55K in cell transformation, or 
on the effects of the whole E1B region on adenovirus and cellular gene expression, 
Babiss and Ginsberg (1984) were the first workers to study directly the effects of 
specific mutations of the 55K sequence on the phenotype of viral lytic infection. 
They constructed Ad5 insertion or deletion mutants that expressed truncated 55K 
protein. These mutants exhibited greatly reduced yield (10% of wild type) when 
grown in HeLa cells. DNA replication, early and late transcription, cytoplasmic
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accumulation of early mRNAs and early protein synthesis were comparable to wild 
type levels. However, cytoplasmic accumulation of late mRNAs (L3 and L5) and 
late protein expression were greatly reduced in the mutants with respect to the wild 
type. Moreover, the mutants, unlike the wild type, could not efficiently shut off 
host cell protein synthesis. In further studies with these mutants (Babiss et al., 
1985) results were obtained which suggested that the defect in cytoplasmic 
accumulation of late viral mRNA in the presence of truncated 55K was due to a 
failure in both cytoplasmic RNA stabilisation and RNA transport. The rate of 
nuclear export of late RNA, monitored by cellular ^H-uridine labelling and filter 
hybridisation of extracted poly(A)+  RNA to viral DNA sequences, was decreased 
by 30-50% in the absence of full-length 55K, but the cytoplasmic accumulation of 
late RNAs measured by Northern analysis was reduced 5- to 10-fold in mutant 
infections. Thus, the effect could not be explained by a reduction in the rate of 
transport alone, indicating that another process, presumably RNA stabilisation, was 
involved. Furthermore these authors found that an intact E1B region was required to 
block both transport and translation of cellular RNAs.
In a separate study, Williams et al. (1986) investigated the phenotypes of the 
previously isolated Ad5 host-range mutants hr6 and h ^ s13. These viruses possess 
mutations that disrupt E1B 55K by truncating the protein coding sequence, but do 
not affect El B 21K or the minor E1B 55K-related proteins. The mutants were cold- 
sensitive for growth in HeLa cells - i.e., they showed significantly reduced yield at
32.5 °C, compared with the yield at 38.5 °C - but grew normally in complementing 
HEK-293 cells at both temperatures. The only significant differences between
32.5 °C and 38.5 °C infections of HeLa cells by these viruses that were observed 
were in the transport of late RNA from the nucleus to the cytoplasm, and in late 
RNA stability. Transport and stability were measured and compared by pulse-chase 
methods for mutant and wild type at the restrictive temperature. Transport was 
reduced by approximately 5-fold and stability by about 4-fold in the absence of
intact 55K. Moreover, the transport of cellular RNA (B-actin mRNA and 28S 
rRNA) into the cytoplasm, normally blocked by wild type infection, continued in 
the mutant-infected cells. It was therefore concluded that 55K acted primarily at the 
levels of RNA stabilisation and transport.
An extensive analysis of the properties of a mutant virus deficient in E1B 55K was 
also made by Pilder et al. (1986). This group utilised Ad5 deletion variant d/338 - a 
virus with a 524 bp deletion in E1B that removes a large section of the E1B 55K 
gene while leaving the 2 IK gene intact. Results broadly consistent with those of 
Babiss et al. (1985) and Williams et al. (1986) were obtained. They found that E1B 
55K was required for normal growth in HeLa cells (yield was reduced 100-fold in 
the mutant). Viral DNA replication and early gene expression were normal in d/338 
infections, but accumulation of late viral RNAs in the cytoplasm measured by 
Northern analysis was greatly reduced. This effect correlated with a decrease in the 
rate of appearance of late RNAs in the cytoplasm (or increased cytoplasmic 
stabilisation) measured by ^H-uridine continuous labelling. Transcription rates were 
normal for all transcripts at 12 and 16 hours post infection, discounting 
transcriptional effects as an explanation of the reduced late mRNA accumulation 
seen at these times. A reduction in the levels of late transcription was however 
noted at 20 and 24 hr in d/338 infections. Neither transcription rates nor 
cytoplasmic mRNA levels from early genes were affected by the d/338 deletion 
even at late times; in fact transcription from E2A was actually increased twofold at 
20 hr in the mutant infection.
Pilder et al. (1986) also looked at the effect of the d/338 deletion on RNA 
processing. They found by Northern analysis of poly(A)+ nuclear RNA that neither 
the size nor the quantity of a late (L5) RNA species in this fraction were altered in 
the mutant infection, indicating that both splicing and polyadenylation were 
independent of 55K. Moreover, an Ad5 variant carrying a non-spliceable Ad2 late
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(L5) construct was shown to require intact 55K for efficient RNA accumulation in 
the cytoplasm, indicating that the SSK response was not related to splicing. L5 
mRNA reaching the cytoplasm was also shown to have the same half-life in wild 
type and <//338-infected cells at 12 hr post infection, suggesting that SSK did not 
primarily affect this aspect of RNA metabolism.
Studies of cellular RNA metabolism in wild type or J/338-infected cells showed that 
host gene (actin) transcription rates were not affected by 55K, but cytoplasmic 
accumulation and the transport rate / cytoplasmic stabilisation of host-specific RNA 
was severely reduced only in the wild type infection (Pilder et al., 1986). From 
these results, it was concluded that the primary effect of SSK is on RNA transport 
or the stabilisation of RNA immediately after it enters the cytoplasm. However, it 
was not possible to determine whether the reciprocal effects on late viral and 
cellular RNA accumulation were due to the participation of SSK in two distinct 
processes, or whether 55K acts directly on one process and hence indirectly affects 
the other (e.g. efficient facilitation of viral RNA transport might saturate a limited 
capacity for nuclear export, preventing transport of cellular RNA).
The analysis of RNA metabolism in <//338-infected cells was further extended by 
Leppard and Shenk (1989). They showed that <//338 (like the hr mutants analysed 
by Williams et al., 1986) was cold-sensitive for growth - i.e., the yield of d/338 
compared to wild type was further reduced by a factor of 4 at 32 °C, compared to 
the yield at 37 °C, and late (L3, L4 and L5) viral RNA accumulation was more 
severely inhibited at the lower temperature. Qualitatively, however, the effect 
observed on RNA metabolism was similar to that described by Pilder et al. (1986) 
at 37 °C. These results were reflected at the protein level by reduced synthesis of 
late proteins in the mutant infection (exacerbated at the restrictive temperature) 
whilst early (ElA and E2A) protein synthesis in the early phase of infection was 
comparable to wild type; synthesis of these proteins continued at high levels into the
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late phase in the dl338 infection only. Consistent with the results of Pilder et al. 
(1986) at 37 °C, Leppard and Shenk (1989) showed that the effect on RNA 
accumulation at 32 °C could not be attributed to differences in transcription rates. 
Rates were similar for early genes (and the cellular actin gene) at all infection times 
analysed, while the rates for L3, L4 and L5 were also comparable up until 40 hr 
post infection, after which time there was a widening differential in rates between 
mutant and wild type. This as yet unexplained observation could possibly be due to 
the failure of the mutant to produce sufficient quantities of a late protein required 
for stimulation of late transcription.
The increased severity of the dl338 phenotype at 32 °C, coupled to the generally 
lower rate of all molecular processes allowed Leppard and Shenk (1989) to examine 
its basis at the RNA level in more detail than previous studies. One cytoplasmic and 
four nuclear (nuclear membrane, DNase I-soluble, salt-soluble, and nuclear matrix) 
fractions were defined and the levels of RNA species and their kinetics of 
movement between the defined compartments determined. In both wild type and 
dl338 infections, transcription of viral genes, like cellular genes, was found to occur 
in association with the nuclear matrix. In a wild type infection, late RNA then 
moved through the DNase I-soluble and salt-soluble fractions (in an order that was 
not determined) into the nuclear membrane fraction, before arriving and 
accumulating in the cytoplasm. Late viral transcripts synthesised by d/338 were 
found to move out of the nuclear matrix fraction more slowly and less efficiently 
than transcripts synthesised by the wild type. These transcripts also failed to 
accumulate in the DNase I-soluble fraction, indicating that they were degraded 
before or immediately after reaching it. In contrast, early dl338 transcripts from 
both viruses were able to pass through all the nuclear fractions and accumulate 
efficiently in the cytoplasm. Thus the function of the 55K protein appeared to be to 
prevent degradation of late viral transcripts in a nuclear compartment, or to
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facilitate transport between nuclear compartments, thus allowing nuclear export and 
cytoplasmic RNA accumulation.
Several studies have demonstrated that the RNA transport facilitation function of 
E1B 55K is not restricted to products of the adenovirus major late transcription unit. 
Samulski and Shenk (1988) showed that E1B 55K and E4 34K together facilitate 
cytoplasmic accumulation of mRNA encoded by adeno-associated virus (AAV) - a 
parvovirus whose replication is considerably enhanced by coinfection with 
adenovirus. Leppard (1993) demonstrated that the cytoplasmic accumulation of 
mRNAs expressed from minor late promoters (i.e., promoters for IVa2, polypeptide 
IX and late E2-L expression) was dependent on 55K at late times. Conversely, 
accumulation of mRNA expressed from the major late promoter at early times was 
independent of 55K. Similarly, Dix and Leppard (1993) showed that E4 mRNA A, 
one of a number of E4 mRNAs produced by differential splicing and showing late 
expression kinetics, was dependent on E1B 55K and E4 34K for efficient 
accumulation in the cytoplasm. Significantly, this RNA species contains an intron 
and unused flanking splice sites that are utilised to produce other E4 mRNAs 
expressed at late times. It was suggested that these intronic sequences or unused 
splice sites could be acting as signals for RNA retention in the nucleus (presumably 
on the nuclear matrix in association with splicing factors or matrix proteins) in the 
absence of 55K/34K. This would be consistent with the putative role of matrix 
releasing factor ascribed to 55K by Leppard and Shenk (1989). Furthermore, 
detailed analysis of individual mRNAs within the major late transcription unit 
families LI, L2 and L3 (Leppard, 1993) indicated that longer mRNAs were more 
dependent on 55K than the shorter species. Since the longer species contain unused 
splice sites and sequences spliced out of the shorter mRNAs as introns, these 
results, like those of Dix and Leppard (1993), suggest that splice sites or intronic 
sequences may function as nuclear retention signals in these RNAs, to be overcome 
by E1B SSK activity. Thus both the phase of infection and the splicing potential of
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RNA species appear to be important in determining their dependence on 55K 
function.
The results of the studies described above give a consistent picture of E1B SSK 
function in lyrically infected cells. The 55K protein (in combination with E4 34K) 
acts post-transcriptionally on RNA metabolism, probably at the level of RNA 
transport or stabilisation, to allow the cytoplasmic accumulation and subsequent 
translation of late viral mRNAs, including the products of major and minor late 
transcription units. mRNA expressed by adeno-associated virus is similarly 
dependent on 55K for cytoplasmic accumulation. However, mRNA expressed by 
adenovirus early transcription units in the early phase does not require 55K for 
cytoplasmic accumulation. Finally, the E1B 55K/E4 34K complex blocks the 
cytoplasmic accumulation of cellular RNA species.
1.9.7. Mechanism of action of E1B 55K
As noted above, current evidence indicates that the E1B 55K/E4 34K complex is 
active at the levels of RNA transport and possibly stabilisation. To arrive at a more 
precise mechanism of activity it is necessary to consider the individual post­
processing stages of mRNA metabolism. RNA transport, as reviewed in Schröder 
(1987), is a multi-step process that involves release of mature mRNAs from their 
processing sites on the nuclear matrix, movement through nuclear 
subcompartments, translocation through the nuclear pore complex, and binding to 
the cytoskeleton. The 55K/34K complex could potentially act at any of these 
individual steps. However, as noted above, localisation studies have demonstrated 
that 33K is not stably or intimately associated with nuclear pore complexes, but 
significant concentrations are found in and around the matrix-associated viral 
inclusion bodies (in which transcription occurs) only in the presence of the 
functionally essential 34K protein. Moreover, Leppard and Shenk (1989) have 
shown that E1B 55K is required for the efficient movement of late viral mRNAs
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from the nuclear matrix to other nuclear subcompartments and the cytoplasm. These 
experiments suggest that the 55K protein acts at an early stage of the mRNA 
transport pathway - most probably a matrix-releasing event. Any viable model of 
55K function has to take account of the ability of this protein to block nuclear 
export of cellular RNAs, and the 55K-independent expression of viral genes in the 
early phase of infection. Such a model has been proposed (Moore et al., 1987; 
Leppard and Shenk. 1989; Omelles and Shenk, 1991; Leppard, 1993), based on 
elements of the gene gating hypothesis of Blobel (1985). Blobel suggested that the 
eukaryotic genome is organised into a specific three-dimensional structure that is 
reflected in the distribution of pore complexes in the nuclear membrane. Actively 
transcribed regions of the genome, or regions potentially active in that cell type, are 
structurally expanded and linked, or 'gated', to specific pore complexes. Nuclear 
export of RNA can only occur efficiently if the corresponding gene is gated to a 
pore complex. Blobel envisaged that the linkage between the interior of the nucleus 
and the pore complex would take the form of a channel in which transcription and 
RNA processing could take place. Direct microscopic evidence of the existence of 
RNA 'tracks' in which splicing and intranuclear transport occurs has in fact been 
obtained for cellular and Epstein-Barr viral transcripts by Lawrence and co-workers 
(Lawrence et al., 1989; Carter et al., 1993; Xing eta l., 1993).
The Blobel model implies that the cell has a limited capacity for efficient nuclear 
export of RNA. Active cellular genes would be expected to be located in favourable 
sites in the nuclear architecture - facilitated microenvironments linked to efficient 
RNA transport pathways. In the early phase of an adenovirus infection, the 
unreplicated genomes from which early gene expression occurs could potentially 
colonise such favourable sites and make use of the facilitated transport pathways. In 
the late phase the number of replicated viral genomes would be predicted to exceed 
the number of available favourable sites, forcing the new DNA templates to occupy 
microenvironments without efficient transport mechanisms. According to this
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model, E1B 55K/E4 34K function would allow the virus to circumvent this 
situation. The 55K/34K complex might act by recruiting cellular transport factors to 
viral RNA, by displacing cellular genes from favourable sites, or by taking part in a 
virus-specific transport mechanism (in each case allowing release of transcripts from 
the nuclear matrix). By competing for limited supplies of transport factors, 
favourable sites, or some other aspect of transport capacity, the E1B 55K/E4 34K 
complex could facilitate late viral RNA transport at the expense of cellular RNA 
transport. This scenario is consistent with the experimental data, including the 
recent observation that RNAs expressed from both the major and minor late 
promoters in the late phase are 55K-dependent, whereas RNAs expressed from the 
major late promoter in the early phase are 55K-independent (Leppard, 1993).
An implication of this type of mechanism is that 55K dependence might be expected 
to be independent of RNA composition - i.e., no cii-acting sequences would 
necessarily be required. However, as noted above, 55K dependence varies and can 
be correlated with the presence of unused splice sites and intervening sequences in 
the RNA (Dix and Leppard, 1993; Leppard, 1993). Although it has been shown that 
both cellular (Ciejeck et al., 1982) and viral (Mariman et al., 1982) RNAs are 
normally associated with the nuclear matrix, it is reasonable to suppose that unused 
splice sites or intronic signals could act as nuclear retention signals that would 
attach RNA to the matrix more securely by binding to components of the splicing 
machinery. Thus the matrix-releasing activity of the 55K/34K complex may have a 
proportionally greater effect on incompletely spliced RNA species than on fully- 
spliced RNAs.
The mechanism discussed above is also consistent with the results of experiments 
which showed that the export of cellular RNAs whose synthesis is induced by or 
after adenovirus infection is independent of 55K (Moore et al., 1987). Recently 
induced genes could occupy particularly favourable positions in the nuclear
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architecture close to pore complexes and would therefore be more able to compete 
effectively with SSK-mediated export for limited transport resources.
The above discussion has focused on the mechanisms that act at the level of RNA 
transport. As noted previously, SSK may also act at the level of RNA stabilisation. 
However, there is as yet no direct evidence for any specific 55K-mediated 
mechanism of stabilisation so this has not been addressed in any detail.
1.9.8. Interactions of E1B 55K and E4 proteins
As noted above (1.9.2) the E1B 55K protein is physically associated with E4 34K, 
the product of E4 ORF6 , and functions in combination with this protein. The 
existence of an ElB S5K/E4 34K complex was first noted by Samow et al. (1984), 
who demonstrated specific co-immunoprecipitation of the ORF6 protein in the 
presence of E1B 55K with antibodies to the latter. Subsequently, mutants with 
deletions of E4 ORF6 were shown to have similar phenotypes to mutants defective 
in E1B 55K expression (Halbert et al., 1985; Weinberg and Ketner, 1986). Cutt et 
al. (1987) demonstrated that a recombinant with mutations designed to disrupt the 
expression of both E1B 5SK and E4 34K had an identical phenotype to equivalent 
mutants disrupted in only one of the genes. This indicated that the E1B 55K and E4 
34K function in combination, rather than by parallel pathways - consistent with the 
physical association of the two proteins. Conversely, the El B 55K/E4 34K complex 
appears to act in parallel with another product of early region 4, the E4 ORF3 116 
amino acid protein, since mutants deficient in both ORF3 and ORF6 have more 
severely defective phenotypes than either of the equivalent single mutants (Bridge 
and Ketner, 1989, 1990; Huang and Hearing, 1989). Both the ORF 3 and ORF6 
proteins have been implicated in viral mRNA stabilisation in the nucleus, but only 
the ORF 6 protein is involved in the parallel mechanism of facilitating transport of 
late mRNAs into the cytoplasm (Bridge and Ketner, 1990; Bridge et al., 1991). 
Moreover, the ORF3 protein is ineffective in providing the adeno-associated virus
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helper function conferred by ORF6 in combination with E1B 55K (Samulski and 
Shenk, 1988; Huang and Hearing, 1989). According to Bridge et al. (1991), the 
effect on nuclear RNA stabilisation exerted by both ORF3 and ORF6 affects only 
products of the major late transcription unit, whereas the ORF6/E1B SSK-mediated 
effect is also active on mRNA from the minor late promoter, IVa2 (consistent with 
the results of Leppard, 1993, for E1B 55K). However, Bridge et al. (1991) also 
found that polypeptide IX and E2-L minor late mRNAs accumulated efficiently in 
the cytoplasm in the absence of ORF6 . This contrasts with the results of Leppard 
(1993), who showed that cytoplasmic accumulation of these RNA species was 
facilitated by E1B 55K. These results may reflect differences in the phenotypes of 
E1B 55K and E4 ORF6 deletion mutants, or differences in the sensitivities of the 
RNase protection assay used by Leppard (1993) and the SI nuclease assay / primer 
extension analysis employed by Bridge et al. (1991). Recently, Ohman et al. (1993) 
have found that in transient cotransfection experiments (in the absence of E1B 55K) 
the ORF3 protein and the ORF6 protein individually stimulate accumulation of 
mRNAs carrying the tripartite leader. Moreover, in experiments using an 
adenovirus mutant in which all E4 ORFs except ORF1 were deleted, tripartite 
leader assembly was found to be impaired by inefficient splicing out of a fourth 5' 
leader segment, the /-leader. This result suggested that the E1B 55K-independent 
effects of ORF6 and ORF3 may be exerted at the level of alternative RNA splicing. 
It is at present unclear if the apparently separate EIB-independent and ElB-linked 
effects of the E4 ORF6 protein are unrelated activities. In a lytic infection, E4 
function may be a prerequisite for E1B 55K action, or the two proteins may act on 
interrelated steps of the RNA processing pathway rather than co-operating to 
facilitate a single step.
1.10. Comparison of HIV-1 Rev and Ad5 E1B 55K function - project objectives
In the previous sections of this introduction I have discussed the roles of the HIV-1 
Rev and Ad5 E1B 55K proteins in the regulation of viral gene expression. From this
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discussion, certain functional similarities between the two proteins are apparent. 
Both proteins clearly act at a post-transcriptional stage of gene expression, and are 
required for the synthesis of late (generally structural) but not early (generally 
nonstructural) proteins. In both cases modes of action have been proposed that 
involve selective facilitation of RNA transport. Results consistent with a mechanism 
in which transport is facilitated at an intranuclear stage, by catalysing the release of 
transcripts otherwise bound by nuclear factors or retained in a nuclear 
subcompartment, have been obtained for E1B 55K and for Rev. In both systems, 
the presence of intronic sequences or unused splice sites is a factor in making an 
RNA dependent on the appropriate regulatory protein for nuclear export. Finally, an 
additional mechanism involving cytoplasmic stabilisation of late mRNAs has been 
proposed for both regulatory proteins. Thus the activities of Rev and E1B 55K are, 
at least to some extent, analogous.
It is also clear that there are some distinct differences between the Rev and E1B 
SSK regulatory systems. Multiple activities (including direct effects on splicing and 
mRNA utilisation in the cytoplasm) have been attributed to Rev, but not to E1B 
55 K. Moreover, no specific response element analogous to the RRE has been 
defined for 55K; current evidence indicates that the microenvironment of the 
template, rather than a particular cw-acting sequence, is probably the major 
determinant of the 55K dependence of an RNA species. Indeed, it is not known 
whether 55K binds RNA directly, or functions by interacting with a cellular factor. 
Nevertheless, the functional analogy between the two systems is sufficiently strong 
to make a comparative study worthwhile.
It is the purpose of the work described in this thesis to further explore this analogy 
by constructing recombinant adenoviruses in which the effects o f Rev/RRE on Ad 
gene expression can be tested and compared with those o f E1B 55K. The 
construction and isolation of recombinant viruses containing a rev expression
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system, the RRE, and/or the E1B 55K gene in all possible combinations will be 
described in subsequent sections. Data will be presented from experiments in which 
gene expression from these constructs was analysed at the protein and RNA levels, 
and the implications for the potential Rev/EIB 55K analogy will be discussed.
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2.1. Materials
2.1.1 General buffers and solutions
The following buffers and solutions were in general use:
TE: 10 mM Tris.HCl pH 8, 1 mM EDTA pH 8
TNE: 10 mM Tris.HCl pH 8 , 100 mM NaCl, 1 mM EDTA pH 8
TBE: 89 mM Tris base, 89 mM boric acid, 2 mM EDTA pH 8
PBS: 137 mM NaCl, 2.7 mM KC1, 4.3 mM Na2HP0 4 .7H2 0 , 1.4 mM KH2PO4
TD: 8 g/1 NaCl, 0.38 g/1 KC1, 0.1 g/1 Na2P04
TS: 8 g/1 NaCl, 0.38 g/1 KC1, 0.1 g/1 Na2P0 4, 0.1 g/1 CaCl2 , 0.1 g/1 MgCl2 
Chloroform/amyl alcohol: 96% (v/v) chloroform, 4 % (v/v) amyl alcohol 
Phenol/TNE: liquefied phenol (Fisons Tris-washed) equilibrated with excess TNE 
Phenol/chloroform: 50% (v/v) phenol/TNE, 50% (v/v) chloroform/amyl alcohol
2.1.2 Suppliers
Sterile PBS, versene, and tissue culture media including DMEM and 2x DMEM 
were supplied by the media preparation staff of the Biological Sciences Department, 
University of Warwick. Calf serum and foetal calf serum were supplied by 
Northumbria Biologicals Ltd. (Cramlington, Northumbria). Calf intestinal 
phosphatase was supplied by Boehringer Mannheim UK (Lewes, E. Sussex). Other 
DNA modification enzymes, restriction enzymes, T4 DNA ligase and nucleases 
were obtained from Gibco-BRL Life Technologies Ltd. (Renfrewshire, Scotland), 
New England Biolabs (CP Laboratories, Bishops Stortford, Herts.) and Pharmacia 
Ltd (Milton Keynes, Bucks.). Econofluor and ^H-acetyl CoA were supplied by 
DuPont (UK) Ltd (NEN products, Stevenage, Herts.). 32P-UTP and 35S-Met were 
supplied by Amersham International PLC (Bucks.). Nuctrap columns were obtained 
from Stratagene Ltd. (Cambridge). Noble agar, bacto-agar, bacto-tryptone, minimal 
agar and yeast extract were supplied by Difco Laboratories (Basingstoke, Hants.). 
Acrylamide, N.N’-methylene-bis-acrylamide, ammonium persulphate and TEMED 
were obtained from Bio-Rad (Hemel Hempstead, Herts.). Other chemicals, unless
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stated otherwise, were supplied by Sigma Chemical Company Ltd. (Poole, Dorset), 
BDH Laboratory Supplies (Merck Ltd, Poole, Dorset) and Fisons Scientific 
Equipment (Loughborough, Leics.) and were of molecular biology or analytical 
grade.
2.2. Nucleic acid purification
2.2.1. Ethanol precipitation of nucleic acids
DNA and RNA were precipitated from aqueous solutions containing 0.3 M sodium 
acetate or 0.1 M sodium chloride by the addition of 95% (v/v) ethanol (2 volumes 
for DNA, 3 volumes for RNA). The nucleic acid was allowed to precipitate, either 
for 30 min at -20 °C or 10 min at -80 °C, then pelleted by centrifugation in a 
microcentrifuge for 15 min at 12 000 rpm (variations from these conditions used in 
individual procedures are indicated where applicable). The pellet was washed, if 
necessary, in 70% (v/v) ethanol, dried under vacuum, and resuspended in TE, TNE 
or water.
2.2.2. Phenol/chloroforai extraction
An equal volume of phenol/chloroform was added to the DNA solution and the 
phases were mixed by vortexing (or inversion for high molecular weight viral 
DNA). The tube was centrifuged for 2 min at 12000 rpm in a microcentrifuge, and 
the aqueous phase was removed to a fresh tube (variations from this procedure are 
indicated where applicable).
2.2.3. Quantification of nucleic acids
DNA and RNA were quantified in solution by spectrophotometry. Absorbance 
readings were taken at 260 nm (A260) where an absorbance of 1.0 indicates a 
concentration of 50/ig/ml of double-stranded DNA, or 40 /xg/ml of RNA. 
Absorbance readings were also taken at 280 nm (A28O) to assess the purity of the 
samples ^ 2 6 0 ^ 2 8 0  = 1-8 for pure DNA solutions, or 2.0 for pure RNA solutions
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- significantly lower values indicate contamination, preventing accurate quantitation 
by this method)
2 ,}. PNA manipulation Irehniuuts
2.3.1. Digestion by restriction enzymes
Restriction enzyme digests were carried out under the conditions recommended by 
the suppliers. Reaction buffers supplied with the enzymes (usually as lOx 
concentrates) were used where available; otherwise buffers were prepared according 
to the suppliers' instructions. Most reactions were carried out at 37 °C - where 
higher temperatures were required, reactions were carried out under liquid paraffin 
to minimise evaporation. Multiple enzyme digests were done simultaneously, where 
possible, in a buffer which allowed both enzymes to function with adequate 
efficiencies.
2.3.2. Partial digestion by restriction enzymes
Partial digests were used in subcloning when the required enzyme recognition 
sequence occurred more than once in the (circular) DNA to be digested. The 
conditions necessary to linearise the DNA by cleavage at a single site were 
determined in a preliminary reaction: 1 /xg of DNA was digested with 1 unit of 
restriction enzyme in a volume of 10 /¿I for 10 min; 1 n  1 aliquots were removed at 
1 min intervals and added to 2 /xl of 0.25 M EDTA pH 8.0 to stop the reaction. 
Each aliquot was analysed by agarose gel electrophoresis, and the optimum reaction 
time (with the highest proportion of linearised product) was noted. The reaction was 
scaled up to a preparative level by increasing the amounts of enzyme and DNA and 
the overall volume proportionally, but retaining the optimum reaction time. The 
linearised fragments were then isolated by agarose gel electrophoresis. The target 
DNA, either uncut or linearised by complete digestion with an enzyme having a 
single recognition site, provided molecular size markers.
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2.3.3. End-fill reaction and 3' overhang removal
T4 DNA polymerase (BRL) was used to fill 5' protruding cohesive termini when a 
blunt terminus was necessary for further cloning. Reactions contained 33 mM 
Tris.acetate pH 7.9, 66 mM potassium acetate, 10 mM magnesium acetate, 0.5 mM 
DTT, 0.1 mg/ml BSA, 0.2 mM dATP, 0.2 mM dCTP, 0.2 mM dGTP, 0.2 mM 
dTTP and 2 units of enzyme per /xg of DNA. The reaction (typical volume 25 /xl) 
was incubated at 37 °C for 30 min, then extracted with phenol/chloroform. 
Conversely, where blunt ends were produced by removing 3’ protruding cohesive 
termini, the deoxyribonucleotides were omitted from the reaction.
2.3.4. Dephosphorylation
To prevent self ligation of cloning vectors cleaved at a single restriction site (or at 
two sites with compatible termini), the 5' phosphate groups were removed using 
calf intestinal alkaline phosphatase (Boehringer) in a buffer containing 50 mM 
Tris.HCl pH 9.0, 1 mM MgCl2 , 1 mM ZnCl2 , and ImM spermidine. 1 /xg of 
cleaved plasmid DNA was dephosphorylated by 1 unit of enzyme in a 10 /xl 
reaction. For protruding 5' termini, the reaction was incubated at 37 °C for 30 min. 
For blunt or recessed termini, the reaction was incubated at 37 °C for 15 min, a 
second aliquot of enzyme was added, and the reaction was incubated at 55 °C for a 
further 45 min. The enzyme was removed by phenol/chloroform extraction.
2.3.5. Linker kinase reaction
Oligonucleotide linkers were prepared for ligation by treatment with T4 
polynucleotide kinase (BRL). The kinase reaction contained 2 /xg of DNA, 10 units 
of enzyme, 1 mM ATP, 70 mM Tris.HCl pH 7.6, 10 mM MgCl2 , and 5 mM DTT 
in a volume of 10 /xl. The reaction was incubated for 30 min at 37 °C, then the 
enzyme was removed by extraction with phenol/chloroform.
6 7
2.3.6. Ligations
DNA fragments were ligated with BRL T4 DNA ligase in a volume of 15-30 pi 
using the manufacturer's buffer. Typically, a fivefold molar excess of insert DNA 
was ligated into a cloning vector (200-500 ng) previously cleaved at one or more 
restriction sites. Blunt-end ligation reactions were incubated at room temperature for 
at least 5 hr; ligations between cohesive ends were incubated overnight (12-16 hr) at 
15 *C.
2.4 Agarose eel electrophoresis
2.4.1. Separation of restriction fragments
Restriction fragments were separated on horizontal agarose gels containing between 
0.4 and 2.0% agarose and 0.5 /xg/ml ethidium bromide, in 0.5x or lx TBE. 
Samples were prepared for loading by adding 1/5 the volume of 6x loading buffer 
(50% glycerol, 5x TBE, 0.02% bromophenol blue, 0.02% xylene cyanol). 
Electrophoresis was carried out at 150 V in 0.5x or lx TBE running buffer. 
Restriction fragments were visualised on an ultraviolet transilluminator and 
photographed with Polaroid 665 or 667 film.
2.4.2. Purification of fragments from agarose gels
The required fragment was sliced out of the gel with a scalpel and placed in a short 
section of dialysis tubing filled with 0.5x TBE buffer. The tubing was clip-sealed at 
both ends and the DNA was electroeluted from the gel fragment into the buffer for 
30-45 min at 150 V in a minigel tank filled with 0.5x TBE. The polarity of the 
current was reversed for 30 s immediately before removing the tubing from the 
apparatus to ensure that the DNA did not stick to the wall of the tubing. The 
effectiveness of the elution was checked under ultraviolet illumination.
A DEAE-Sephacel or DEAE-cellulose column was prepared (using column matrix 
pre-equilibrated in TNE buffer) in a Pasteur pipette plugged with autoclaved glass
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wool. The column was rinsed with 3 ml of TNE buffer, and the electroeluted DNA 
was transferred to the column. The column was rinsed with 6  ml o f TNE, and the 
DNA was eluted into a microcentrifuge tube with 1 ml of 1 M NaCl in TNE. The 
eluate was extracted with phenol/chloroform and the DNA was precipitated with 
ethanol, dried, and resuspended in water or TE.
2.5.1. Growth and maintenance of bacterial stocks 
(All growth media were autoclaved at 15 lb/in^ before use)
E. coli strain DH1 (host strain for plasmid vectors, Hanahan, 1983) was routinely 
grown in LB (Luria-Bertani) medium containing 10 g of bacto-tryptone, 5 g of 
bacto-yeast extract, and 10 g of NaCl per litre. Cultures were maintained in the 
short term on LB-agar plates (stored at 4 °C) containing 15 g of Bacto-agar per litre 
of LB medium. Where ampicillin selection o f transformed bacteria was required, 
LB medium was supplemented with 50 /xg/ml of ampicillin and LB-agar was 
supplemented with 60 /xg/ml of ampicillin. Bacterial stocks were stored in the long 
term by mixing 0.5 ml of a stationary phase culture with 0.5 ml of 80% (v/v) sterile 
glycerol and placing at -20 °C.
E. coli strain TGI (Gibson, 1984, and described in Sambrook et al., 1989) was 
used as a host strain for M13 phage vectors (Messing et al., 1977). Cells were 
grown in 2YT medium, containing 16 g of bacto-tryptone, 10 g of bacto-yeast 
extract, and 5 g of NaCl per litre. 2YT plates for phage plating were prepared using 
2YT soft agar, which contains 15 g of bacto-agar per litre of 2YT medium. TGI 
cells were maintained in the short term on minimal agar plates to select for retention 
of the F' factor. The minimal plating medium was prepared by autoclaving a 
solution of Difco minimal agar, then adding sterile salt and sugar solutions to give 
final concentrations of 15 g/1 minimal agar, 10.5 g/1 K2HPO4 , 4.5 g/1 KH2PO4 ,
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1 g/1 (NH4 )2SC>4 , 0.5 g/1 sodium citrate dihydrate, 0.2 g/1 MgS0 4 , 0.5 g/1 
thiamine hydrochloride, and 2 g/1 glucose.
2.5.2. Transformation of bacteria with plasmid or M13 replicative form DNA 
(calcium chloride method)
Preparation o f competent cells
A single colony of bacterial cells (DH1 for plasmid transformations, TGI for M l3) 
was grown overnight in 2 ml of the appropriate medium at 37 °C with continuous 
shaking. The overnight culture was added to 100 ml of fresh medium the following 
day and shaken at 37 °C until the absorbance of the suspension at 600 nm was 
approximately 0.4 (1.5-2 hr). The cells were transferred to 50 ml Oak Ridge tubes 
and pelleted in the JA-20 rotor of a Beckman J2-21M centrifuge for 5 min at 
5000 rpm (4 °C). The supernatants were discarded and the tubes were kept on ice 
for the remainder of the procedure. The pellets were gently resuspended (without 
vortexing or hard shaking) in a total of 50 ml of CaCl2  solution (0.1 M for DH1, 
50 mM for TGI), and kept on ice for 20-30 min. The pellets were recentrifuged (as 
above) and resuspended in a total of 1-2 ml of CaCl2 solution. The cells were 
stored on ice for up to 24 hr until required.
Transformation procedure (plasmids)
The plasmid DNA for transformation (typically a ligation product) was diluted to 
100 p\ with sterile distilled water and mixed with 100 p\ of competent DH1 cells. 
The mixture was incubated on ice for 40 min, then transferred to a 42 °C water 
bath for exactly 3 min. Immediately afterwards, the cells were mixed with 0.8 ml of 
LB medium and shaken at 37 °C for 30 min. The bacterial suspension was plated 
out by spreading 10% and 25% of the total volume onto separate ampicillin- 
supplemented LB-agar plates. The plates were incubated overnight at 37 °C. 
Individual colonies were picked the next day for small-scale preparation of DNA.
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Transformation procedure (M13)
The M13 DNA to be transformed was resuspended in a small volume (typically less 
than lOjil) of water or TE and mixed with 200 p\ of competent TGI cells. The 
cells were incubated for 40 min on ice, then transferred to a 42 °C water bath for 
exactly 3 min. Immediately afterwards, 89%, 10% and 1% volume aliquots of the 
suspension were each mixed with 300 p\ of an exponential phase culture of TGI 
cells, then 3 ml of molten 2YT soft agar (45 °C) were added. Each agar mix was 
plated out and incubated overnight at 37 °C. Plaques were picked with a Pasteur 
pipette the next day for small-scale DNA preparation.
2.5.3 Transformation of bacteria with plasmid DNA (electroporation method) 
Preparation o f frozen cell stocks
A single colony of DH1 bacterial cells was grown in 5 ml of LB medium overnight 
at 37 °C with continuous shaking. The overnight culture was added to 500 ml of LB 
the following day and shaken at 37 °C until the absorbance o f the suspension at 
600 nm was in the range 0.5-1.0 (approximately 4 hr). The culture was chilled on 
ice for 15 min, then the cells were pelleted in a Beckman GPR centrifuge (GH 3.7 
rotor) for 10 min at 3000 rpm (4 °C). The supernatants were discarded and the 
pellets were resuspended in a total of 500 ml of sterile distilled water. The 
suspensions were recentrifuged and the pellets were resuspended in a total of 250 ml 
of sterile distilled water. The supernatants were again discarded, the pellets were 
resuspended in a total of 10 ml of sterile 10% (v/v) glycerol, pooled, and 
centrifuged for 10 min at 3000 rpm as before. The final pellet was resuspended in 
500-1000 p\ of 10% glycerol and stored at -70 °C in 40 p\ aliquots.
Electroporation
DNA (typically 100-500 ng) was prepared for electroporation by phenol/chloroform 
extraction, ethanol precipitation, and repeated washing with 70% (v/v) ethanol to 
eliminate salt. After drying, the DNA was resuspended in 10 p\ of water, and
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mixed with a 40 /d aliquot of the frozen DH1 stock (allowed to thaw briefly on ice 
before use). The DNA was electroporated into the cells on ice using a Bio-Rad 
Gene Pulser with a voltage pulse of 2.5 kV at a capacitance of 25 /zF (pulse 
controller resistance 200 0). Immediately after electroporation, the cells were mixed 
with 700-1000 n\ of SCX: medium (2% bacto-tryptone, 0.5% bacto-yeast extract, 
10 mM NaCl, 2.5 mM KC1, 10 mM MgCl2 , 10 mM MgS04, 20 mM glucose) and 
incubated at 37 °C for 30-45 min (with continuous shaking). The bacterial 
suspension was plated out by spreading 25%, 10% and 5% onto separate ampicillin- 
supplemented LB-agar plates. The plates were incubated at 37 °C overnight. 
Individual colonies were picked the next day for small-scale preparation of DNA.
2.5.4. Rapid preparation of plasmid or M13 DNA from bacteria
For plasmid DNA, a bacterial culture was prepared by picking a single colony into 
5 ml of ampicillin-supplemented LB medium, and incubating overnight at 37 °C 
(with continuous shaking). A 1.5 ml aliquot of the culture was transferred to a 
microcentrifuge tube and the remainder was stored at 4 °C to initiate a large-scale 
DNA preparation if required. The bacteria were pelleted in a microcentrifuge for 
1 min and the supernatant was removed by aspiration.
For M13 DNA, a single phage plaque was picked with a Pasteur pipette into 1 ml 
of 2YT medium, vortexed, and heated at 65 °C for 10 min to kill the bacteria. The 
medium was allowed to cool for 10 min and mixed with 1 ml of an early log phase 
culture of TGI cells (previously prepared by diluting an overnight culture of these 
bacteria 1:50 in 2YT medium and shaking at 37 °C for 1 hr). The culture was 
shaken for 5 hr at 37 °C, then the bacteria from a 1.5 ml aliquot were pelleted in a 
microcentrifuge for 2 min. The supernatant was removed and stored at 4 °C (for 
large scale DNA preparation).
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All subsequent manipulations were carried out on ice, using the method of Bimboim 
and Doly (1979), as described in Sambrook et al. (1989). The final nucleic acid 
pellet was resuspended in 50 pi of TE or TNE (pH 8.0) containing 20/xg/ml 
DNase-free pancreatic RNase.
2.5.5. Large-scale preparation of plasmid / M13 DNA
A 500 ml culture was initiated and incubated for 18-20 hr (cultures were 
supplemented with 50 pg/ml chloramphenicol 4-5 hr after initiation in the case of 
plasmid preparations). The cells were pelleted by centrifuging for 15 min at 
5000 rpm in the JA14 rotor of a Beckman J2-21M centrifuge (4 °C). The pellets 
were resuspended in a total of 5 ml of ice-cold 25% (w/v) sucrose, 50 mM 
Tris.HCl pH 8.0. Ice-cold 0.25 M EDTA pH 8.0 (2 ml) was added and the mixture 
was swirled and stored on ice for 5 min, then mixed with 1 ml of lysozyme solution 
(10 mg/ml) in TNE buffer. The mixture was swirled, incubated on ice for 15 min, 
then 8 ml of Triton lytic mixture (50 mM Tris.HCl pH 8, 62.5 mM EDTA, 0.1% 
Triton X-100) were added. The mixture was swirled and stored on ice for a further 
5 min, centrifuged at 17 000 rpm for 40 min (4 °C) in the JA-20 rotor of a 
Beckman J2-21M centrifuge, and the supernatant collected. Nucleic acid was 
purified from the supernatant by the sequential addition of 7 ml of phenol/TNE and 
1 ml of chloroform/amyl alcohol with vigorous shaking. Phases were separated by 
centrifugation (3000 rpm, 10 min, 4 °C, Beckman GPR, GH 4.7 rotor) and the 
aqueous phase was further extracted with 25 ml of chloroform/amyl alcohol as 
before. The nucleic acid in the supernatant was precipitated with ethanol (30 min at 
-70 °C), then pelleted by centrifugation (3000 rpm, 10 min, 4 °C, Beckman GPR, 
GH 4.7 rotor). The pellet was dried and resuspended in 4.5 ml of TNE buffer, to 
which was added 4.72 g of caesium chloride and 0.32 ml of 10 mg/ml ethidium 
bromide. The solution was mixed and centrifuged to equilibrium (60 000 rpm, 18- 
20 hr, 20 °C, Beckman L8-70M, VTi 65.2 rotor) and the purified plasmid or M13
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DNA band was recovered; when necessary faint bands were first located under 
ultraviolet illumination.
Ethidium bromide was removed from the recovered fraction by repeated extractions 
with water-NaCl-saturated propan-2-ol. The final aqueous phase was diluted with 
three volumes of TNE and the DNA was precipitated with ethanol (-70 °C, 1 hr), 
pelleted by centrifuging at 10 000 rpm for 30 min (4 °C) in the Beckman J2-21M 
(JS-13.1 rotor), and washed with 70% (v/v) ethanol. The pellet was dried and 
resuspended in 300-500 /¿I of TE buffer.
2.6. Tissue culture and vims techniques
2.6.1. Maintenance and passage of human cell lines
HeLa, HEK-293 (Graham el al., 1977), and KB8a (Babiss et al., 1983) human cell 
lines were maintained in 90 mm tissue culture dishes containing 10 ml of medium 
(other culture vessels used in experiments contained volumes of medium in 
proportion to their surface areas). HeLa and HEK-293 cells were grown in 
DMEM/10% CS (or occasionally in DMEM/10% FCS); KB8a cell were grown in 
DMEM/10% FCS. All cells were grown at 37 °C in a 5% CO2 humidified 
atmosphere.
KB8a and HEK-293 cells were passaged at an area ratio of 1:3 or 1:4 and HeLa 
cells were passaged at a ratio of 1:8 or 1:10 every 3-4 days. HEK-293 and HeLa 
cell monolayers were washed with TD and passaged with TDE/trypsin (TD 
supplemented with final concentrations of 0.5 mM EDTA and 0.25 g/1 trypsin); 
KB8a monolayers were washed and passaged with versene only.
2.6.2. Freezing and recovery of cell stocks
Long-term cell stocks were prepared by suspending the cells from one 90 mm dish 
in 0.5 ml of 8 % (v/v) dimethylsulphoxide in FCS. The freezing vials were slowly
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cooled to -70 °C, then immersed in liquid nitrogen. Cells were recovered by rapidly 
thawing the contents of one vial and transferring the cells to a dish of pre-warmed 
medium. The medium was changed, or the cells passaged, the following day.
2.6.3. Calcium phosphate transfection for adenovirus reconstruction by in vivo
recombination
The HEK-293 cells from one 90 mm dish were passaged and divided between three 
60 mm dishes 24 hr before transfection. Three hours before transfection the medium 
was changed to DMEM/10% FCS. DNA/calcium phosphate precipitates were 
prepared by mixing 50 pi of 2x HEPES buffer (16 g/1 NaCl, 0.74 g/1 KC1, 2 g/1 
glucose, 10 g/1 HEPES), 3 pi of lOOx phosphate solution (9.9 g/1 Na2HPC>4), and 
DNA solutions +  water to 90 pi, then adding 10 pi of 1.25 M calcium chloride and 
blowing air through the solution. The precipitates were allowed to form for 30 min 
at room temperature, then the medium was removed from the dishes and the cells 
were overlaid with the precipitate suspensions diluted to 1 ml with 
DMEM/5% FCS. The cells were then incubated for 2.5-3 hr at 37 °C (5% CO2). 
with occasional rocking. The medium was removed from each dish, and 1 ml of 
20% (v/v) glycerol in TS buffer was carefully added to each monolayer. This was 
removed after exactly 1 min, and the cells were washed twice with TS, then 
overlaid with DMEM/10% CS. The cells were incubated at 37 °C for 30-60 min, 
then overlaid with semi-solid medium (1) (4% (v/v) CS, 0.375% (w/v) NaHCC>3 , 
1% (w/v) Noble agar, in lx DMEM). After 3-4 days this was supplemented with 
semi-solid medium (2) (1% (v/v) CS, 0.1875% (w/v) NaHCC>3, 1% (w/v) Noble 
agar, in lx DMEM). When plaques became visible (6-9 days) they were stained 
with neutral red semi-solid medium (1% (v/v) CS, 0.1875% (w/v) NaHCC>3 , 
0.01% (w/v) neutral red, 1% (w/v) Noble agar, in lx DMEM) and picked the next 
day with a Pasteur pipette.
7 5
This procedure was similar to 2.6.3, above, with the following exceptions. The 
medium was changed to DMEM/10% FCS 4 hr before transfection. The 
DNA/calcium phosphate precipitate was prepared by slowly adding 500 /d of 
0.25 M CaCl2 containing 5 ng of plasmid DNA and 10 ng of salmon sperm DNA 
to 500 fi\ to a freshly prepared solution containing 490 /¿I of 2x HEPES buffer and 
10 n\ of lOOx phosphate solution, blowing air through the solution, and allowing to 
stand for 30 min at room temperature. The precipitate was added directly to the 
medium in a 60 mm dish, and the cells were incubated for 4 hr. After glycerol 
shock, the cells were retained in DMEM/10% CS.
2 .6.5. Virus infection of cell monolayers
Cell monolayers at 70-100% confluence were gently overlaid with virus suspension 
(diluted, if necessary, in TS/2% CS), and the plates rocked to ensure even 
distribution of virus across the monolayers. Volumes of the suspensions used were 
200 /¿I for 35 mm or 60 mm dishes, 500 /d for 90 mm dishes, or 2.5 ml for 
150 mm dishes. The plates were incubated for 30 min (37 °C), rocked again, and 
incubated for a further 30 min. The virus suspension was removed by aspiration and 
replaced with fresh medium.
2 .6 .6 . Rapid preparation of adenovirus DNA
HEK-293 cell monolayers in 90 mm dishes were harvested when full cytopathic 
effect became visible (usually in 3-4 days) and cells were pelleted by centrifuging 
for 5 min at 1500 rpm in a Beckman GPR (GH 3.7 rotor). The supernatant was 
removed and the pellet was resuspended in 0.4 ml of TE (pH 9)/10 mM spermine 
tetrahydrochloride (Sigma). The suspension was mixed with 0.4 ml DOC lysis 
buffer (20% (v/v) ethanol, 100 mM Tris.HCI pH 9, 0.4% (w/v) sodium 
deoxycholate) and cell debris was pelleted by centrifugation (15 min, 12000 rpm, 
microcentrifuge). The supernatant was collected and 60 ¿d 10% (w/v) SDS, 40 /d
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0.25 M EDTA, and 2 0 /ri 20 mg/ml proteinase K (Boehringer) were added. The 
solution was mixed several times by inversion and incubated at 37 °C for 1 hr.
Residual protein was then extracted with phenol/chloroform and the DNA 
precipitated by adding 30 /il 5 M NaCl and 0.6 ml of propan-2-ol at room 
temperature. The solution was mixed several times by inversion and the DNA was 
pelleted by centrifuging for 15 min at 12 000 rpm in a microcentrifuge (room 
temperature). The pellet was dried and resuspended in 50 pi distilled water or TE.
2.6.7. Large-scale preparation of adenovirus DNA
Infected cells were harvested as described above. A typical preparation used cells 
from ten 90 mm monolayer cultures. The cells were resuspended in 10 ml of 0.1 M 
Tris.HCl (pH 8) and disrupted by sonication on ice (two sets of 10 x 1 s pulses 
separated by 30 s using a Jencons GE375 ultrasonic processor and 3 mm tapered 
microtip). The sonicates were clarified by centrifugation at 6000 rpm for 10 min 
(4 °C) in a Beckman J2-21M centrifuge, (JS-13.1 rotor). The supernatants were 
layered over CsCl step gradients consisting of 2 ml of CsCl in TD (density 1.40 
g/ml) with an overlay of 3 ml of CsCl in TD (density 1.25 g/ml). The gradients 
were centrifuged at 35 000 rpm for 1 hr (15 °C) in a Beckman L8-70M 
ultracentrifuge (SW 41 rotor). The virus formed a clearly visible band (below 
cellular debris) which was recovered by puncturing the bottom of the tube and 
collecting drip fractions. Collected virus was then centrifuged to equilibrium (at 
least 15 hr) in CsCl/TD of density 1.35 g/ml at 40 000 rpm (15 °C, Beckman L8- 
70M ultracentrifuge, SW 50.1 rotor).
The virus band was collected (as above), diluted with two volumes of water and 
precipitated with six band volumes of ethanol at -70 °C for 15 min. The virus was 
pelleted by centrifuging for 20 min at 7000 rpm (4 °C) in a Beckman J2-21M 
centrifuge (JS-13.1 rotor). The pellet was dried and gently resuspended in 2 ml of
7 7
TNE, then 120 p i 10% (w/v) SDS, 40 pi 0.25 M EDTA, and 20 M1 10 mg/ml 
proteinase K were added. The solution was incubated at 37 °C for 1-2 hr then 
extracted with 2 ml of phenol/TNE at room temperature. The tube was gently 
swirled for 1 min, 1 ml chloroform/amyl alcohol was added, and the solution was 
again gently swirled to mix. Phases were separated by centrifuging for 10 min at 
3000 rpm (4 °C) in a Beckman GPR centrifuge, and the organic extraction and 
centrifugation were repeated with the aqueous phase. DNA was precipitated from 
the final aqueous phase by adding sodium acetate solution to 0.3 M and two 
volumes of ethanol. The DNA was allowed to precipitate at -70 °C for 30 min, and 
then pelleted at 7000 rpm for 30 min (4 °C) in a Beckman J2-21M centrifuge (JS- 
13.1 rotor). The DNA pellet was washed with 70% ethanol, dried, and allowed to 
redissolve in 0.5 ml TE at 4 °C overnight.
2.6.8. Preparation of virus stocks
Infected cells were harvested when cytopathic effect was visible (usually in 3 days) 
and pelleted by centrifuging (Beckman GPR centrifuge, GH 3.7 rotor, 1500 rpm, 
3 min). To concentrate the stocks, half the medium was removed by aspiration, and 
the cells were lysed in the remainder by three freeze-thaw cycles. Cell debris was 
pelleted by centrifugation (as before). The supernatant (virus stock) was removed 
and stored in 2-3 ml aliquots at -70 °C.
2.6.9. Titration of virus stocks by plaque assay
Tenfold serial dilutions with TS/2% CS in the range 10‘ 1 to 10‘8 were prepared 
from the virus stock; 200 /¿I aliquots of the appropriate dilutions were used to infect 
duplicate cultures of HEK-293 cells in 60 mm dishes or 35 mm wells in 6-well 
trays. Cells were then overlaid with semi-solid medium (1); after 3-4 days a second 
overlay of semi-solid medium (2) was added (the compositions of semi-solid media 
are given in 2.6 .3). When plaques became visible, they were stained by the addition 
of neutral red semi-solid medium and counted the next day.
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2.7. Analysis of viral protein expression
2.7.1. ^S-m ethionine pulse-labelling of proteins
Cell monolayers on 35 mm dishes were incubated with 0.5 ml of methionine-free 
DMEM for 30 min. This was then replaced with 0.25 ml of similar medium 
supplemented with 2 5 /iCi of -^S-methionine (specific activity >800Ci/mmol, 
Amersham). The dish was incubated for a further 30 min, then placed on ice. The 
labelling medium was removed, the cells were washed with ice-cold PBS, and lysed 
by the addition of 0.2 ml of RIPA buffer (150 mM NaCl, 10 mM Tris.HCl pH 7.6, 
1* (v/v) Triton X-100, 1% (w/v) sodium deoxycholate, 0.1% (w/v) SDS). The 
dish was incubated for 15 min on ice, then the lysate was harvested by pipetting and 
stored at -70 °C.
2.7.2. Quantification of ^S-methionine incorporation into protein
A small aliquot (5-10 /¿l) of labelled cell extract was diluted with 400 n\ of distilled 
water and mixed with 100 pi of 100% (w/v) trichloroacetic acid (TCA) in water. 
The solution was allowed to stand on ice for 15 min, and the precipitate was 
collected on a 2.5 cm Whatman GF/C glass microfibre filter. The filter was washed 
with 1 ml of 5% (w/v) TCA, then with 1 ml of ethanol, and allowed to dry. The 
filter was placed in 5 ml of Optiphase Safe scintillation fluid and the radioactivity 
measured in an LKB Wallac 1219 Rackbeta scintillation counter.
2.7.3. SDS polyacrylamide gel electrophoresis (SDS-PAGE)
Protein samples in 100 mM DTT, 25 mM Tris.HCl pH 6 .8 , 10% (v/v) glycerol, 
2% (w/v) SDS, and 0.005% (w/v) bromophenol blue were heated to 95 °C for 3 
min. Discontinuous SDS-polyacrylamide gels were prepared and run in a BRL 
vertical gel electrophoresis system according to the method of Laemmli (1970). The 
resolving gel contained 0.43 M Tris.HCl pH 8 .8 , 9.98% (w/v) acrylamide, 0.27% 
(w/v) N,N'-methylene-bis-acrylamide, 0.095% (w/v) SDS, 0.67 mg/ml ammonium
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persulphate and 0.20 /d/ml TEMED. The stacking gel contained 0.12 M Tris.HCl 
pH 6 .8, 4.57% (w/v) acrylamide, 0.12% (w/v) N.N'-methylene-bis-acrylamide, 
0.10% (w/v) SDS, 0.95 mg/ml ammonium persulphate and 0.48 /d/ml TEMED. 
Gels were run at variable voltage and current (40 mA, 250 V set maxima) for 2- 
3 hr in a buffer containing 303 g/1 Tris, 1442 g/1 glycine, and 100 g/1 SDS (buffer 
pH 8.3). Gels were fixed for at least 1 hr in 25% (v/v) methanol, 7% (v/v) acetic 
acid, treated for 15 min with Amplify (Amersham) for fluorographic enhancement 
of radioactive emissions, then dried for 1-2 hr at 70 °C under vacuum.
2.8. Analysis of viral RNA expression
2.8.1. Preparation of cytoplasmic and nuclear RNA
(All manipulations were carried out on ice or at 4 °C)
The cells from a 150 mm dish were washed twice in 10 ml of complete PBS buffer 
(PBS supplemented with final concentrations of 0.1 g/1 CaCl2 and 0.1 g/1 MgCl2) 
and pelleted by centrifuging at 1500 rpm for 3 min (4 °C) in a Beckman GPR 
centrifuge (GH 3.7 rotor). The cells were resuspended in 2 ml of isotonic buffer 
(150 mM NaCl, 10 mM Tris.HCl pH 7.6, 1.5 mM MgCl2), then 200 pi of 10% 
(v/v) Nonidet P40 (NP40) were added. The suspension was vortexed, allowed to 
stand for 10 min on ice, then pelleted at 1500 rpm for 3 min (4 °C) in the Beckman 
GPR centrifuge. The supernatant was removed and the pellet was resuspended in 
1 ml of isotonic buffer and pelleted as before. Both supernatants (containing 
cytoplasmic RNA) were combined, then 60 /d of 10% (w/v) SDS and 120 /d of 
0.25 M EDTA were added. The pellet (containing nuclear RNA) was resuspended 
in 1 ml of RSB (10 mM Tris.HCl pH 7.6, 3 mM MgCl2 . 10 mM NaCl), and 2 /d 
of 10 mg/ml DNase I (Gibco BRL, RNase-free) were added. The suspension was 
incubated for 30 min on ice, then 20 /d of 10% SDS and 40 /d of 0.25 M EDTA 
were added to lyse the nuclei. The solutions of both cytoplasmic and nuclear RNA 
were extracted with one volume of phenol/TNE and one volume of 
chloroform/amyl alcohol, then centrifuged for 10 min at 3000 rpm (4 °C)
T » b k  2.1. pGEM  p lu m id i u i td  to lr»n»crlbe  p rn b tl to r R N l«  protection
analyses
N a m e P r o m o t e r L i n e a r i s e d  w i t h A d 5  f r a g m e n t P C E M  s i t e .
p G E M 3 .L 3 - h e x o n T 7 H in d  III H in d  III  1 8 3 1 8  
- S m a  I 1 8 9 2 2
H i n d  III  
S m a  I
p G E M 3 .L 3 - 2 3 K S p 6 E c o R  I B a m H  I 2 1 5 6 2  
- B e l  II 2 1 7 7 5
B a m H  I
p G E M 4 .L 2 -3 7 L 3 - 5 ' T 7 N n i  I K p n  I 1 7 0 6 8  
- H i n d  III  1 8 3 2 3
K p n  I 
H in d  III
p G E M 4 .L 3 /E 2 A T 7 E c o R  I K p n  1 2 2 1 8 8  
- D r a  I 2 2 4 4 4
K p n l
H i n d i
p G E M 3 .L 4 -5 ' T 7 H in d  HI P s t  I 2 3 2 8 6  
- P s t  I 2 4 3 6 9
P s t  I
p G E M 3 .L l - 3 '/ L 2 - 5 ' T 7 H in d  H I H in d  I II  1 3 7 2 1  
- K p n  I 1 4291
H i n d  III  
K p n  1
p G E M 3 .E l  A S p 6 E c o R  I P v u  I I 4 5 5  
- P s t l  1 8 3 8
S m a  I 
P s t  I
p G E M 4 .E 3 /L 4 T 7 E c o R  I E c o R  I 2 7 3 3 1  
- B e l  II 2 8 1 3 7
E c o R  I 
B a m H  I
p G E M 2 .L 5 S p 6 H in d  III H in d  I I I  3 1 9 9 3  
- S m a  I 3 3 0 9 6
H i n d  III  
S m a  I
p G E M 3 .IV a 2 T 7 H in d  III B s t  E 2  5 1 8 6  
X h o  I 5 7 9 2
S m a  I
S a l  I
Notes:
For each clone the enzyme required to linearise the plasmid for transcription and the 
promoter from which an antisense probe was transcribed are indicated. Details of the 
adenovirus DNA inserted into each vector, and the cloning sites utilised in pGEM2, 
pGEM3, or pGEM4 (Promega) are also shown. Plasmids pGEM4.L2-3'/L3-5 and 
pGEM4.L3/E2A were prepared in the course of the project. pGEM3.L3-hexon and 
pGEM3.L3-23K were prepared by P. Dancey; pGEM3.Ll-3'/L2-5' was prepared by 
S. Khandke; pGEM3.L4-5' was prepared by K. Leppard. All other plasmids listed 
were constructed and provided by J. Schaack (Dept Microbiol. & Immunol., 
University of Colorado, Denver, CO, USA).
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(Beckman GPR). The extraction of the aqueous phase was repeated with one 
volume of phenol/TNE and two volumes of chloroform/amyl alcohol, then with two 
volumes of chloroform/amyl alcohol. The final aqueous phase was precipitated with 
ethanol (-70 °C, 1 hr) and the RNA was pelleted by centrifuging for 30 min at 
10 000 rpm (4 #C) in a Beckman J2-21M centrifuge (JS-13.1 rotor). The pellet was 
dried and resuspended in 300-350 pi of water.
2.8.2. Preparation of antisense RNA probes 
Preparation o f template DNA
A 2 pg stock of each linearised probe template (table 2.1) was prepared by 
appropriate digestion of the relevant pGEM vector subclone (i.e. the vector was 
linearised at an enzyme site between the 3' end of the sequence to be transcribed 
and the unused promoter). The template DNA stock was purified by 
phenol/chloroform extraction and ethanol precipitation and dissolved in water at a 
concentration of 0.32 pg/p\.
In vitro transcription in the pGEM Sp6 /  77 system
The components of the in vitro transcription reaction were mixed at room 
temperature, and in the order listed below, to avoid precipitation of the DNA by 
spermidine (a constituent of the 5x transcription buffer)
10 p d /p l  a-32P UTP (Amersham)
5x Spó or T7 buffer (Gibco BRL) 
lOx nucleotide mix 
200 mM DTT (Sigma)
Water
Human placental RNase inhibitor (Gibco BRL) 
Template DNA (0.32 pg/pl)
Volume//*!
2.5
1.25
0.625
0.3125
0.3125
0.25
0.625
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Sp6  or T7 polymerase (Gibco BRL) 0.40
(where lOx nucleotide mix contained 5 mM ATP, 5 mM CTP, 5 mM GTP, 1 mM 
UTP)
The reaction was incubated at 37 °C (for T7 polymerase) or 40 °C (for Sp6 
polymerase) for 1 hr.
Purification o f probe
The reaction was diluted to 50 pi with water, then 2 p\ of vanadyl ribonucleoside 
complex (200 mM Gibco BRL) and 1 p\ of RNase-free DNase I were added. The 
reaction was incubated at 37 °C for 10 min, SDS (0.5 p\ 10% w/v) was added, and 
the solution was extracted with phenol/chloroform. The probe was finally purified 
on a Stratagene Nuctrap push column (according to the manufacturer's instructions) 
and stored at -20 °C.
2.8.3. Ribonucléase protection analysis
Ribonucléase protection assays were carried out according to the method of Melton 
etal. (1984) :
Hybridisation
5 pg of RNA and 5 p\ of antisense riboprobe were co-precipitated in three volumes 
of ethanol for 30 min at -20 °C. The dried RNA pellet was resuspended in 20 pi of 
hybridisation buffer (80% (v/v) deionised formamide; 40 mM PIPES pH 6.7, 
0.4 M NaCl, 1 mM EDTA), heated to 80 °C for 10 min, allowed to cool slowly 
(over several hours) to 56 °C, and incubated at this temperature overnight.
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Ribonuclease digestion
The hybridisation reactions were diluted to 200 p\ in RNase solution (10 mM 
Tris.HCl pH 7.5, 5 mM EDTA, 300 mM NaCl, 100 units/ml RNase T l ,  5 /xg/ml 
pancreatic RNase A) and incubated for 30 min at room temperature. SDS to 0.5% 
and 1 p\ of 20 mg/ml proteinase K were added, the solutions were vortexed 
vigorously, and the reactions were incubated for a further 15 min at room 
temperature. The solutions were extracted once with phenol/chloroform, and RNA 
precipitated with three volumes of ethanol (in the presence of 1 ng of carrier tRNA) 
for 30 min at -20 °C. Dried RNA pellets were resuspended in 6 *tl of formamide 
dye mix (80% (v/v) deionised formamide, 10 mM EDTA pH 8.0, 1 mg/ml xylene 
cyanol, 1 mg/ml bromomphenol blue) and denatured by heating for 2 min at 90 °C, 
then cooled rapidly on ice.
Separation on denaturing acrylamide gel
Using a Bio-Rad SequiGen apparatus, a 5% polyacrylamide denaturing gel was 
prepared in lx TBE buffer, containing 4.75% (w/v) acrylamide, 0.25% (w/v) 
N,N'-methylene-bis-acrylamide, 46% (w/v) urea, 0.8 mg/ml ammonium
persulphate and 0.83 pl/ml TEMED. A 2 pi aliquot of each sample electrophoresed 
on the gel for 2-3 hr in lx TBE buffer at 45 W (running temperature 50 °C). The 
gel was dried for 90 min at 60 °C under vacuum, and the RNA bands were 
visualised by autoradiography.
Preparation o f molecular size markers fo r  denaturing gel
Labelled markers were prepared by digesting 1 /xg of pBR322 DNA with restriction 
enzyme Hpa II, then adding 1 unit of Klenow DNA polymerase and 5 pC\ of a-^P- 
dCTP to the reaction mix and incubating for a further 10 min at room temperature. 
The mix was diluted with 30 p\ of formamide dye mix, and the amount required to 
give clearly visible markers was determined empirically (typically 1-2 p\ when
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freshly prepared, but usable at increased volumes for several weeks when stored at 
-20 °C).
2,9. Autoradiograplu'
Preflashed Fuji RX X-ray film was exposed to dried radioactive gels at -70 °C 
(initially overnight, then for longer periods as required). The preflash distance was 
calibrated by spectrophotometry - the absorbance at 545 nm of preflashed film was 
measured and compared to the A545 for unflashed film. The preflash distance was 
adjusted until the absorbance ratio of preflashed to unflashed was in the range 0 . 1- 
0 .2 , corresponding to a linear response of the film to radioactivity.
Film band intensities were quantified on a Molecular Dynamics scanning laser 
densitometer, using Image Quant 3 analysis software.
2.11. Chloramphenicol Acetyl Transferase (CAT) assays
2 .1 1 .1 .  P re p a ra tio n  o f c y to p lasm ic  e x tra c ts
(All manipulations were carried out on ice or at 4 °C).
Cytoplasmic extracts were prepared from virus-infected or mock-infected HEK-293 
cell monolayers in 60 mm dishes. Each monolayer was washed with 3 ml of ice- 
cold phosphate buffered saline (PBS). The cells were resuspended in 6 ml of PBS 
and pelleted by centrifugation at 1500 rpm for 3 min (4 °C) in a Beckman GPR 
centrifuge (GH 3.7 rotor). Each cell pellet was resuspended in 150 pi ice-cold CAT 
lysis buffer (250 mM Tris.HCl pH 7.8, 5 mM DTT, 10% (v/v) glycerol, 0.25% 
(v/v) Nonidet-P40) and kept on ice for 10 min. The cells were further broken by 
three freeze-thaw cycles. Alternatively, the extracts were stored at -70 °C prior to 
freeze-thaw until required. Cell debris was pelleted in a microcentrifuge at 
15 000 rpm for 12 min and the supernatant (i.e. the cytoplasmic extract) was kept 
on ice until required.
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2.11.2. Assay for protein concentration
The protein content of each cytoplasmic extract was determined using the Bio-Rad 
protein assay reagent (following the manufacturer's microassay procedure derived 
from Bradford, 1976). A small quantity (1-2 pi) of extract was diluted to 800 pi 
with distilled water, mixed with 200 pi of assay reagent and vortexed briefly. The 
colour change was allowed to develop for 5 min, then the absorbance at 595 nm 
was measured against a reagent blank (200 pi reagent +  800 pi water). Where 
necessary, the assay was repeated with diluted samples to give absorbance readings 
in the linear range of the assay (A595 =  0.1-0.6, corresponding to 1-10 pg 
protein).
2.11.3. CAT assay procedure
CAT activity was assayed by the direct scintillation diffusion method (Neumann et 
al., 1987; Eastman, 1987), which relies on the differential solubilities of acetyl 
CoA and acetylated chloramphenicol in a nonaqueous scintillant (4.3, below). Each 
cytoplasmic extract was heated to 65 °C for 15 min to reduce background signal by 
inactivating endogenous acetyltransferase activity (CAT itself is comparatively 
resistant to heat inactivation). Five absorbance units of cytoplasmic extract (where 
one unit is defined as the quantity of extract required to produce an absorbance of 
1.0 in the protein assay) were mixed with 50 pi 5 mM chloramphenicol (aq), 25 pi 
1 M Tris.HCl (pH 7.8), 124 M1 distilled water, and 100 pi 0.1 M Tris.HCl in a 
plastic scintillation vial. The assay reaction was started by adding 1 pi (0.1 pCi) 
■*H-acetyl coenzyme A (DuPont NEN); immediately afterwards the assay mixture 
was covered with 3 ml of a water-immiscible scintillation fluid (Econofluor, DuPont 
NEN) and the vial was placed at 37 °C. The formation of 3H-acetyl 
chloramphenicol (and hence the activity of CAT) was measured in a scintillation 
counter (LKB Rackbeta) for 10 s per reaction every 30 min over a period of 2 hr.


3.1. Introductton
In this chapter I will describe the strategies employed to construct and isolate the 
HIV-adenovirus recombinants used in all subsequent experiments.
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As noted in the general introduction, the aim of this study was to investigate the 
action of the Rev/RRE system in adenovirus, and more specifically to compare the 
effects of this system with those of Ad E1B 55K. The approach taken was to insert 
a rev expression construct and the RRE into suitable locations in the adenovirus 
genome, and analyse their effects on gene expression in either the presence or 
absence of E1B 55K. Several factors were considered before selecting the cloning 
strategy used to insert the foreign DNA into the Ad genome: First, it was clearly 
vital to place the rev gene in a context where it could be expressed at adequate 
levels, and to insert the RRE in a position where it could be incorporated into 
otherwise normal viral transcripts - i.e., to provide the components of a functional 
Rev/RRE system that could be compared with E1B 55K. Second, it was important 
that insertion of heterologous DNA should cause minimal disruption to adenovirus 
gene expression. Third, to facilitate cloning, the availability of suitable restriction 
sites in the genome was evaluated.
In the case of the RRE, examination of the Ad5 sequence showed that suitable sites 
for insertion were strictly limited. In particular, the complexity of the pattern of 
gene expression from both strands of the genome made it difficult to find locations 
that did not disrupt at least one coding sequence. However, a 32 nt sequence was 
located in the L3 region of the major late transcription unit between the translation 
stop signal for the L3 hexon (major capsid) protein, and the ATG start codon of the 
L3 23K protease. This sequence was also non-coding on the opposite strand of the 
genome. Inserting the RRE in this position results in its incorporation into the L3 
RNAs coding for pVI (hexon-associated protein precursor), hexon protein, and 23K 
protease (fig. 3.1). Each L3 RNA normally requires the E1B 55K protein to
Fig. 3.1. rev and RRE insertion sites 
In Ad5
TPt
o p t o  =  Ad early gene 
r  - 1 =  Ad late gene
= Intron
Fig. 3.1. rev and RRE insertion sites in Ad5. The diagram is a simplified version 
of the adenovirus transcription map in chapter 1, with the insertion positions of the 
rev expression cassette (in place of El A) and the RRE (in the 5' untranslated region 
of the L3-23K 3* exon) indicated. MLP-major late promoter; TPL=tripartite 
leader sequence.
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facilitate its expression, so insertion of the RRE in this region makes a direct 
comparison of the two regulatory systems possible. Moreover, this intergenic 
sequence contains a convenient Pvu II restriction site for cloning. Therefore this 
region was chosen as the target for RRE insertion.
In the case of rev, the gene was cloned into an expression construct (based on 
pNL3C - a kind gift of Dr. R Schneider, New York University) containing the 
adenovirus El A enhancer, major late promoter, and tripartite leader, which 
enhances the translatability of mRNA expressed from this promoter (Logan and 
Shenk, 1984). This construct was designed for insertion into the adenovirus genome 
in place of most of early region El A (fig. 3.1). In this context, all the necessary 
elements for efficient expression of the cloned gene are present - upstream 
sequences are supplied by the construct, and El A RNA processing signals from the 
virus can be utilised. The absence of a large section of the E1A frame in such a 
recombinant makes the virus defective in cell lines such as HeLa, since El A 
products are required to transactivate other viral genes. However, if El A is supplied 
in trans from a complementing cell line such as HEK-293 or KB-8a the virus can go 
through a successful infectious cycle. Moreover, for safety reasons, the failure of 
such a virus to infect noncomplementing cells productively is an advantage, since it 
is unclear whether Rev expression has any deleterious effects on host cells which 
might make a replication competent virus hazardous. Therefore, the rev gene was 
inserted in a major late promoter expression construct in this region, in place of 
E1A.
Although adenovirus DNA can be manipulated directly, it is generally more 
convenient to work on smaller fragments of the genome subcloned into plasmid 
vectors. Constructs containing appropriate regions of the Ad5 genome and the RRE 
or rev expression cassette were therefore prepared (diagrams, fig 3.2). Complete 
viral DNA can be reconstructed either by ligation of appropriate cloned and viral
Fig. 3.2. V]ral reconstruction plasmids
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Fig. 3.2. Viral reconstruction plasmids. The diagram illustrates the essential 
features of the plasmids used to insert the rev expression cassette and the RRE into 
adenovirus. The rev cassette plasmids pwtElrev and pdl338Elrev are identical 
except for deletion of the 55K gene (Ad5 2804-3328 Hind III-Bgl II fragment) in 
the latter. Nucleotide numbers in parentheses are relative to the start of the rev 
expression cassette in pwtElrev. All other numbering refers to the unmodified Ad5 
sequence.
Fig. 3.3. 3-fragment ligation 
(e.q. d!309/RRE)
BamHI Eo
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Fig. 3.3. 3-fragment ligation (e.g. rf/309/RRE). The diagram shows the method of 
virus reconstruction by 3-fragment ligation, as exemplified by d/309/RRE.
Fig. 3.4. Overlap recombination in vivo 
(e.q. dl309/rev)
EcoW
EcoR I ^
C otransfect
O verlap  R ecom bination 
o ccu rs  in  v ivo
A d 5  309 /rev
= rev expression 
cassette
9 2
Fig. 3.4. Overlap recombination in vivo (e.g. d/309/rev). The diagram shows the 
method of virus reconstruction by overlap recombination in vivo, as exemplified by 
d/309/rrv.
Fig. 3.5 isolation of adenovirus 
recombinants
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Fig. 3.5. Isolation of adenovirus recombinants. The diagram lists the stages 
involved in isolating recombinant adenoviruses by the methods detailed in chapter 2.
Table 3.1 : Recombinant Adenoviruses
E1B55K RRE rev name
1 + • • 3 09  (WT)
2 - • - 338
3 + + * 309/RRE
4 - + - 338/RRE
5 + + + 309/R R Erev
6 + + 338/R R Erev
7 + - + 309 /rev
8 - - + 338 /re v
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genomic fragments, or by overlap recombination in vivo between such fragments 
(Chinnadurai et at., 1979). These two methods were used to reconstitute complete 
genomes from the RRE and rev cassettes respectively, as illustrated in figs. 3.3 and 
3.4. Since naked viral genomes are infectious, stocks of viable virus can be 
recovered from cells transfected with recombinant viral DNA. In practice, this 
involves an extended process of plaque purification, screening, growth, and titration 
by plaque assay, summarised in fig 3.5. The details of subcloning, virus 
reconstruction, screening and titration are given in the following sections of this 
chapter.
In order to make comparisons between the Rev/RRE and E1B 55K systems, and to 
differentiate any individual effects of the RRE or Rev alone from those of the 
complete Rev/RRE system, it was necessary to construct a series of recombinants - 
i.e., viruses either containing or not containing the RRE, rev construct, and E1B 
55K gene in all possible combinations. The genotypes of the eight possible viruses 
are listed in table 3.1. Two of these - d/309 (effectively wild-type for this purpose) 
and d/338 (lacking E1B 55K) - were already available (Jones and Shenk, 1979; 
Pilder et al., 1986). The other viruses were constructed and isolated in the course of 
this project as described below.
3.2. Insertion of the RRE Into adenovirus - Construction of tf/399/RKE 
3.2.1 Subcloning
(All adenovirus numbering refers to the published complete Ad5 sequence of 
Chroboczek el al., 1992, GenBank accession number M73260, as modified by Dix 
and Leppard, 1992, GenBank accession number D12587).
The following cloning strategy is summarised in fig. 3.6. The starting materials for 
subcloning were plasmids pE2, pGEMRRE and pBR322. Plasmid pE2 (originated 
in the laboratory of Prof. T. Shenk, Princeton, NJ, and obtained from K. Leppard) 
contains a 5769 bp fragment of Ad5 DNA, running from the BamH I site at
Fia. 3.6. Construction of pE2RREx
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Fig. 3.6. Construction of pE2RREx. The diagram summarises the subcloning 
strategy used to construct pE2RREx, the plasmid used to insert the RRE in the Ad5 
genome.
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21562 bp to the EcoR I site at 27331 bp, cloned into pBR322 between the BamH I 
and EcoR I sites. Plasmid pGEMRRE (kindly supplied by Dr. Shaun Heaphy, Dept, 
of Microbiology, University of Leicester) contains a Sty l fragment (7787-8009 bp) 
covering the RRE region from HIV-1 strain ARV2, cloned into pGEMl between 
the Pst I and Sac I sites (Heaphy et al., 1990).
The pE2 plasmid was digested with Pst I, and 3' overhangs were converted to blunt 
ends with T4 polymerase (exonuclease activity). The DNA was further digested 
with BamH I, and the BamH l-Pst I fragment (Ad5 sites 21562-23274 bp) was 
isolated and cloned into pBR322 between the BamH I and Pvu II sites, to make 
plasmid pBR322/E2. The RRE was excised from the polylinker of pGEMRRE as a 
Hind III-EcoR I fragment, and 5' overhangs were filled in with T4 polymerase 
(polymerase activity). The blunted RRE fragment was cloned into pBR322/E2 at the 
Pvu II site (Ad5 site 21722 bp). Recombinants were selected with the RRE in the 
correct 5'-3 ' orientation relative to the Ad5 sequence by restriction analysis 
(plasmid pBR322/E2/RRE). A Bam H l-Sftl (Ad5 21562-22992 bp) fragment was 
excised from pBR322/E2/RRE and cloned back into pE2 in place of the equivalent 
unmodified fragment. The resulting plasmid, pE2RRE, was equivalent to pE2 with 
the RRE inserted at Pvu II site 21722 bp (Ad5 numbering). By inserting the RRE at 
a Pvu II site, the blunted EcoR I site at the 3' end of the RRE cassette was 
regenerated. However, since it was necessary to have only a single EcoR I site in 
the plasmid for use in reconstruction of the virus (see below), the regenerated site 
was removed by partially digesting the plasmid with EcoR I, selecting singly-cut 
DNA, end-filling with T4 polymerase, and religating. The recombinants were 
screened by restriction analysis for clones end-filled at the regenerated site 
(destroying the recognition sequence), but intact at the original site in pE2 (Ad5 site 
27331 bp). The required clone, pE2RREx (fig. 3.2), was used in the reconstruction 
of complete viral DNA (see below).
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3.2.2. Virus reconstruction by ligation
The reconstruction procedure is summarised in fig. 3.3. Full-length adenovirus 
DNA containing the RRE inserted in the Pvu II site at 21722 bp was reconstructed 
from pE2RREx and cleaved genomic DNA from Ad5 deletion variant d/309. The 
dl309 variant (Jones and Shenk, 1979) has an essentially wild-type phenotype, but 
contains unique EcoR I (27331 bp) and Xba I (1339 bp) sites, facilitating virus 
reconstruction by ligation or overlap recombination. Plasmid pE2RREx (5 fig) was 
cleaved at the unique BamH I and EcoR 1 sites (Ad5 sites 21562 and 27331 bp), and 
the 6 kbp adenovirus-RRE fragment was isolated. Ad5 d/309 DNA (3 fig) was 
cleaved at the equivalent genomic BamH I and EcoR I sites (generating three 
fragments), then dephosphorylated with alkaline phosphatase. The 6 kbp fragment 
from pE2RREx was ligated with the cleaved viral DNA (dephosphorylation 
prevented religation of d/309 'wild-type' DNA - a complete viral genome could 
only be generated by incorporation of the phosphorylated RRE-recombinant central 
fragment). The ligation products were extracted with phenol/chloroform/amyl 
alcohol, ethanol precipitated, and resuspended in sterile water for transfection. 
Recombinant virus and viral DNA were isolated by the methods outlined in fig. 3.5 
(see chapter 2 for detailed methodology).
3.3. Insertion of m  expression cassette into adenovirus - Construction of
d1309/rev 
3.3.1 Subcloning
The following cloning strategy is summarised in fig. 3.7. The starting materials for 
cloning the rev expression construct were M13mpl9rev#209 (constructed by Dr. 
Shaun Heaphy and kindly supplied by Dr. Ian Jones, NERC Institute of Virology, 
Oxford), pNL3C, and pwtXhol-C, (originated in the laboratory of Prof. T. Shenk, 
Princeton, NJ, and obtained from K. Leppard). M13mpl9rev#209 contains a 
synthetic rev gene, designed to be translated as a protein identical to the Rev of 
HIV-1 strain BRU, cloned between the Hind III and BamH I sites of the M13mpl9
Fig. 3.7. Construction of pw tE lrev
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Fig. 3.7. Construction of pwtElrrv. The diagram summarises the subcloning 
strategy used to construct pwtElrev, a plasmid used to insert the rev expression 
cassette into the Ad genome.
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polylinker (Heaphy et al., 1990). Plasmid pNL3C contains Ad5 sequences between 
the EcoR I and Sal I sites of the pML2 vector. The Ad5 sequences begin with the 
El A enhancer, located upstream of the major late promoter and the elements of the 
tripartite leader. The leader sequences are fused to the Sma I site at 1008 bp (in 
E1A) with Sal I linkers, making a Sal I site available for cloning. The Ad5 
sequence continues up to the Xho I site at 5788 bp, which is joined via 
complementary cohesive ends to the Sal I site of the vector. Plasmid pwtXhol-C 
contains the Xho I-C fragment of Ad5 (1-5788 bp) cloned into a pBR322 derivative 
between the EcoR I and Nde I (modified with a Xho I linker) sites.
Plasmid pNL3C was linearised by cleavage at the Sal I site (immediately 3' to the 
tripartite leader) and ligated to Hind III linkers. The DNA was digested with 
Hind III, which removed linker multimers and Ad5 sequence in the vector from the 
fused Sma I site at 1007 bp to the Hind III site at 2804 bp (Ad 5 numbering). The 
DNA was religated to form a plasmid, pNL3C-HIII, with a Hind III site 
immediately 3' to the tripartite leader. The pNL3C-HIII DNA was cleaved with 
Hind III and Bgl II, removing a fragment running from the new Hind III site to the 
unique Bgl II site (Ad5 site 3328 bp). The rev gene was excised from 
M13mpl9rev#209 as a Hind \\\-Bam\\ I fragment and cloned into pNL3C-HIII 
between the opened Hind III and Bgl II sites, creating plasmid pNLrcv. The 
promoter-leader-rev gene expression cassette was excised from pNLrev by cleaving 
with AJl II (Ad5 site 3533 bp), end-filling with T4 polymerase, then cleaving with 
EcoR I to release the fragment. Plasmid pwtXhol-C was cleaved with Xba I (Ad5 
site 1339), end filled, and cleaved with EcoR I. The rev cassette was cloned into the 
opened EcoR I and blunted Xba I sites of pNLrev, to form the virus reconstruction 
plasmid pwtElrev (fig. 3.2) - suitable for insertion of the rev cassette in place of the 
El A region of adenovirus.
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3.3.2 Virus reconstruction by overlap recombination in vivo 
The reconstruction procedure is summarised in fig. 3.4. In practice, the method is 
similar to that used for the construction of the RRE virus. It was not however 
necessary to ligate the DNA before transfection, as the rev vector was constructed 
to allow overlap recombination to occur between the 3’ end of the linearised 
construct and the homologous 5' end of viral genomic DNA, if the first 1340 bp of 
the genome were removed by cleavage with Xba I.
Ad5 dl309 DNA (1 ng) was prepared for overlap recombination by cleavage at the 
unique Xba I site (1339 bp) to destroy its infectivity; pwtElrev (5 ^g) DNA was 
linearised at the EcoR I site. Both restriction products were extracted with 
phenol/chloroform, co-precipitated with ethanol and resuspended in sterile water for 
transfection. Recombinant virus and viral DNA were isolated by the same methods 
used for the RRE-virus (above and fig. 3.5).
3.4. Construction of.tfr? other recombinants
The methods used to construct the remaining viral recombinants described in table 
3.1 followed those used to prepare ¿/309/rev. Each virus containing the RRE used 
d/309/RRE DNA as a starting point - the other viruses utilised <//309 DNA in their 
construction. Recombinant d/338/RRE was constructed by overlap recombination of 
d/309/RRE with pdl338XhoI-C, an analogue of pwtXhoI-C that has a Hind III- 
Bgl II deletion of the E1B 55K gene (Ad5 sites 2804-3328 bp) equivalent to that 
found in Ad5 J/338 (Pilder el al., 1986). Recombinant d/309/RRE/rev was 
prepared by overlap recombination of <//309/RRE with pwtElrev. The construction 
of dl33S/rev and <//338/RRE/rev required an additional subcloning stage - the rev 
expression cassette from pNLrev (see above) was cloned into pdl338XhoI-C, rather 
than pwtXhoI-C, making plasmid pdl338Elrev. Recombinant d/338/rev was 
constructed by overlap recombination of pdl338Elrev with dl309\ similarly, 
d/338/RRE/rev was prepared by overlap recombination of pdl338Elrev with
101
¿/309/RRE. In every case the viral DNA was cleaved at the Xba I site prior to 
recombination and the plasmid was linearised at the EcoR I site.
3.5. Restriction analysis of viral recombinants
As outlined in fig. 3.5, new recombinants were screened for the expected 
characteristics by restriction analysis. Restriction enzymes were selected that 
allowed discrimination between recombinant viruses carrying or lacking the rev 
expression cassette, the RRE, and the rf/338 deletion of the 55K gene. The positions 
of the recognition sequences of three representative enzymes in wild type and 
recombinant viruses are denoted in fig. 3.8. The restriction patterns produced from 
viral DNAs by these enzymes are shown in figs. 3.9-3.11.
3.5.1. Restriction analysis of Ad5 recombinants with Hind III
Hind III was selected for analysis of the recombinants since its restriction profile 
allows c//309-derivatives to be readily distinguished from d/338-derivatives and 
permits rev-recombinants to be differentiated from viruses that do not carry the rev 
cassette. More specifically, deletion of the 55K gene in rf/338 destroys the Hind III 
site at 2804 bp and removes 524 bp 3' to this site (fig. 3.8). Therefore the d/309 
Hind III restriction fragments of 2804 bp (1-2804 bp) and 3437 bp (2805-6241 bp) 
are replaced by a single fragment of 5717 bp in <//338 and d/338/RRE. Insertion of 
the rev cassette increases the sequence length 5' to the dt309 Xba I site from 
1339 bp to 1396 bp and introduces a new Hind III site at 821 bp from the new 5' 
end of the genome. Thus the dl309 2804 bp Hind III fragment is replaced by 820 bp 
and 2041 bp fragments in dl309/RRErev and dl309/rev. Similarly, in <//338/RRErev 
and <//338/rev, which have the 55K deletion and carry the rev cassette, the dl309 
2804 bp and 3437 bp Hind III fragments are replaced by 820 bp and 4954 bp 
fragments. Furthermore, insertion of the RRE sequence in the Pvu II site at 
21720 bp increases the size of the 8010 bp (18319-26328 bp) fragment to 8246 bp
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Fig. 3.8. Restriction sites in Ad5 and Ad5 recombinants, (a) Hind III, Sal I and 
Bsu36 I recognition sites in Ad5. (b) Enlarged map showing regions of the Ad 
genome affected by insertion of the rev cassette and RRE, and by the d/338 deletion 
of the 55K gene. All rev-recombinants lack Ad5 sequences 5 ' of the Xba I site at 
1339 bp, but have an additional 1396 bp of rev cassette sequence 5' of this position. 
All d/338 derivatives lack 524 bp between the Hind III site at 2804 bp and the Bgl II 
site at 3328 bp (both sites are abolished by the deletion). All RRE-recombinants 
have an additional 236 bp of RRE sequence inserted in the Pvu II site at 21720 bp. 
Numbers in parentheses are measured from the start of the relevant insert (rev 
cassette or RRE). All other numbering refers to the standard Ad5 sequence. 
E1AE-E1A enhancer; M LP-major late promoter; TPL*tripartite leader.
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FI*. 3.9. Restriction analysis of Ad5 recombinants with Hind III. 0.5 Mg of
DNA prepared from d/338/rrv (lane A), dB09/rev (B), d/338/RRE/rv (C), 
d/309/RRErrv (D), d/338/RRE (E), d/309/RRE (F) and d/309 (G) was digested 
with 5 units of Hind III for 1 hr at 37 °C. The restriction fragments were separated 
by agarose gel electrophoresis and visualised by ethidium bromide staining and 
ultraviolet illumination.
1 0 4
(although the small proportional difference in fragment size makes resolution of the 
wild type and recombinant fragments difficult).
As shown in fig. 3.9, digestion of viral DNA from each recombinant with Hind III 
yielded fragments of 5665 bp, 5324 bp, 4597 bp, 2937 bp, 2081 bp, and 1008 bp 
identical in size to those produced by digestion of dt309 DNA. These fragments 
were derived from regions of the genome unaffected by the 55K deletion or 
insertion of the rev cassette or RRE, and their sizes corresponded to those predicted 
from the (sequence-derived) restriction map in fig. 3.8. The wild type 8010 bp 
fragment was detected in the dl309 (G), d1309/rev (B) and dl33S/rev (A) digests 
whereas a slightly larger fragment, probably corresponding to the 8246 bp fragment 
predicted for the RRE-recombinants, was resolved in the <//309/RRE (F), 
d/338/RRE (E), d/309/RRErrv (D) and d/338/RRErev (C) digests. The predicted 
5717 bp fragment (diagnostic of the 55K deletion) was detected in the î/7338/RRE 
digest, while the smaller 4954 bp fragment (indicating 55K deletion and rev cassette 
insertion) was detected in the d/338/RRErev and dt33S/rev digests. Conversely, the 
wild type 3437 bp fragment was detected in the digests of all the d/309-derivatives. 
A 2804 bp wild type fragment, indicative of an intact 55K gene and a normal left 
end of the genome, was detected in the dl309 and J/309/RRE digests. The predicted 
2041 bp fragment specific for rev cassette insertion in a 55K-intact background was 
detected in the d/309/RRErev and d1309/rev digests. Finally, the 820 bp fragment 
specific for rev cassette insertion was detected in the digests of all four rev- 
recombinants. These results therefore indicate that dl309, dl309/RRE, 
dl309/RRErev and dl309/rev have an intact 55K gene, that J/338/RRE, 
J/338/RRErev and dt33S/rev have the 55K deletion, and that <//309/RRErev, 
d/338/RRErev, d/309/rev and dl33S/rev carry the rev cassette. The data also suggest 
that «//309/RRE, d/338/RRE, d/309/RRE/rv and dl33S/RRErev carry the RRE 
insert.
Fig. 3.10 Restriction analysis of 
Ad5 /ecomblnants with Sal I
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Fig. 3.10. Restriction analysis of Ad5 recombinants with Sal I. 0.3 /xg of DNA
prepared from d/338/rev (lane A), d/309/rev (B), d/338/RRErrv (C), <//309/RRErrv 
(D), (//338/RRE (E), d/309/RRE (F) and dl309 (G) was digested with 5 units of 
Sal I for 1 hr at 37 °C. The restriction fragments were separated and visualised as 
above, (i) Short electrophoresis separation time, (ii) Long separation time.
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3.5.2. Restriction analysis of Ad5 recombinants with Sal I
Sal I was selected to confirm the results obtained by analysis with Hind III. 
Insertion of the rev cassette, as well as increasing the sequence length 5' of the 
Xba I site, introduces a new Sal I site 953 bp from the 5' end of the insert (fig. 
3.8). This generates 953 bp and 8566 bp fragments in place of the wild type 
9462 bp (1-9462 bp) fragment. The size of the 9462 bp fragment is also altered by 
the 55K deletion in ¿/338-derivatives to 8938 bp, or to 8042 bp in ¿/338-derivatives 
that carry the rev cassette. The size of the 19192 bp (16747-35938 bp) fragment is 
increased to 19428 bp in the RRE-recombinants, but this small relative difference is 
difficult to resolve in practice.
As shown in fig. 3.10, the 379 bp and 6905 bp fragments (predicted from the 
restriction map in fig. 3.8) that are unaffected by the changes made in the genome 
are found in the digests from all the viral recombinants. The 953 bp rev cassette- 
specific fragment is, as expected, found only in the ¿/309/RRErev, ¿/338/RRErev, 
¿/309/rev and ¿/338/rev digests. The 8566 bp fragment specific to rev-recombinants 
carrying an intact 55K gene was resolved in the ¿/309/RRErev and ¿/309/rev 
digests. The 8042 bp fragment specific to rev-recombinants with the 55K deletion 
was detected in the ¿/338/RRErev and ¿/338/rev infections. The 8938 bp fragment 
specific to ¿/338-derivatives without the rev cassette was detected in the ¿/338/RRE 
digest. The 236 bp difference in the largest Sal 1 fragment between the RRE- 
recombinants and the other viruses was not resolved. These results therefore 
confirm the conclusions from the Hind III analysis that the putative rev- 
recombinants carry the rev cassette, the ¿/309-derivatives carry an intact 55K gene, 
and the ¿/338-derivatives have the expected 55K deletion.
3.5.3. Restriction analysis of Ad5 recombinants with Jfcu36 I.
Bsu36 I was selected for analysis of the recombinants as its recognition sequence is 
positioned asymmetrically within the RRE, generating junction fragments that
Fig. 3.11. Restriction analysis of 
Ad5 recombinants with Bsu36 I
A B O D E  F G
-------
5298 bp- 
4244 bp-
1290 bp
1 0 7
Fig. 3.11. Restriction analysis of Ad5 recombinants with Bsu36 I. 0.5 ng of 
DNA prepared from d/338/rev (lane A), (11309/rev (B), <//338/RRErev (C), 
d/309/RRE/rv (D), d/338/RRE (E), d/309/RRE (F) and d!3Q9 (G) was digested 
with 5 units of Asm36 I for 1 hr at 37 °C. The restriction fragments were separated 
and visualised as above.
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confirm that the response element is inserted in the genome in the correct 
orientation. Specifically, 1290 bp and 4244 bp fragments are generated in place of 
the wild type 5298 bp (20643-25940 bp) fragment. As shown in fig. 3.11, 1290 bp 
and 4244 bp fragments were detected in the digests of <//309/RRE, d/338/RRE, 
d/309/RRErev and <//338/RRErev DNA, confirming the presence of the RRE in the 
correct orientation in these recombinants.
3.6. Summary
In this chapter I have described the construction and isolation of a series of six 
adenovirus/HIV recombinants designed for use in investigating the operation of the 
HIV-1 Rev/RRE regulatory system in an Ad5 context, and in comparing Rev 
function with that o f the Ad5 E1B 55K gene. Restriction analysis data have been 
presented that confirm the intended presence or absence of a rev expression cassette, 
the RRE, and the Ad5 E1B 55K gene in each virus.
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4.1. Introduction
In this chapter I will describe the approach used to detect the expression of 
functional Rev protein from the rev-recombinant adenoviruses, and present the data 
obtained in the expression assays.
Several methods have been used to detect Rev expression from HIV and from rev- 
recombinant constructs. These can be divided into methods which directly detect the 
products of rev gene expression, and techniques which depend on the functional 
effects of the Rev protein. In the former category, Northern analysis and nuclease 
protection assays have been used to detect expression at the RNA level (see, for 
example, Emerman et al., 1989; Chanda et al., 1990). Assays based on antibody 
binding to Rev have similarly been used to demonstrate expression at the protein 
level (e.g. Goh et al., 1987). Although useful, these methods obviously give no 
information on the biological activity o f the Rev protein expressed. However, a 
number of functional assays for Rev have been developed. Malim et al (1989a) have 
shown that Rev activity can be detected by its /ro/iy-regulatory effect on tat 
expression from a reporter plasmid containing the unspliced tat exons and intron. In 
the absence of functional Rev, spliced tat RNA appears in the cytoplasm and full- 
length Tat protein is expressed; in the presence of active Rev, unspliced tat RNA 
enters the cytoplasm and a truncated Tat protein is translated. Other groups have 
developed assays based on the detection of Gag expression (e.g. by p24 antigen 
capture assay) from a Rev-responsive reporter plasmid (e.g. Chanda et al., 1990). 
A third type of assay utilises Rev-responsive chloramphenicol acetyl transferase 
(CAT) reporter gene constructs (e.g. Rosen et al., 1988). These constructs contain 
the RRE and a CAT gene in an intron. CAT RNA can only enter the cytoplasm and 
be expressed in the presence of functional Rev protein. These assays have the 
advantage that several comparatively simple techniques can be used to detect CAT 
expression. For its ability to detect functional activity rather than simply Rev
expression, and its simplicity and ease of application, such an assay was selected for 
use in this study.
4.2. CAT reporter constructs
The specific constructs used were kindly supplied by Dr Tominori Kimura (now at 
Kansai Medical University, Osaka, Japan). The descriptions of the plasmids are 
derived from T. Kimura (personal communication). The Rev-reponsive reporter 
construct, pTK34, is illustrated in fig. 4.1. It contains a bacterial CAT gene and 
HIV-1 nucleotides 5943-8888 from molecular clone pNL4-3 (Adachi et al., 1986) 
inserted downstream of the HIV-1 gag 5* splice donor site. Transcription from this 
construct is controlled by the SV40 early promoter and enhancer. Functional Rev 
expression is prevented by a frameshift mutation of the rev gene at the BamW I site 
(pNL4-3 nt 8466). A derivative of pTK34, pTK53, was used as a negative control 
in my assays. This construct has a two nucleotide deletion (G 7805-G 7806) 
designed to disrupt the Rev-binding 'RNA bubble' of the RRE (fig. 1.3b) described 
by Heaphy et al. (1991). Since the CAT gene of pTK34 is flanked by a f>af> splice 
donor (SD) and a rev splice acceptor (SA) then, as noted above, CAT RNA can 
only enter the cytoplasm in the presence of Rev protein; in its absence, the CAT 
sequence will be spliced out as an intron. The deletion in pTK53 makes this plasmid 
unresponsive to Rev by disrupting its binding site in the RRE RNA.
4.3. CAT assay
The direct scintillation diffusion method was used to assay CAT expression 
(Neumann et al., 1987; Eastman, 1987). Briefly, in this assay the cytoplasmic 
extract to be tested for CAT expression (and hence Rev activity) is mixed with 
[^HJacetyl CoA and chloramphenicol, and placed under a layer of water-immiscible 
scintillant. CAT catalyses the [^HJacetylation of chloramphenicol. The [^H]acetyl 
chloramphenicol product is more soluble in the scintillant than in the aqueous 
extract, and diffuses into the nonaqueous phase where it can be detected by
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Fig. 4.1. pTK34 CAT reporter construct. This plasmid carries the bacterial 
chloramphenicol acetyltransferase gene and HIV-1 nucleotides 5943-8888 (from 
clone pNL4-3) inserted downstream of the HIV-1 gag 5' splice site. CAT 
expression is controlled by the SV40 early promoter and enhancer. The rev gene is 
disrupted by a frameshift mutation at the BamH I site (8466 nt).
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scintillation counting. This method has the advantage of allowing a single reaction 
to be monitored over an extended time course (unlike other assay techniques which 
require multiple reactions or repeated sampling of aliquots at each time point).
4.4. Demonstration of Rev expression
An experimental protocol was devised to assay Rev expression from each of the 
four recombinant adenoviruses that contain the rev construct:
HEK-293 cells were transfected with CAT reporter plasmid or control plasmid. 
24 hr after transfection, the cells were infected with control or rev-recombinant 
adenovirus at a multiplicity of 10 pfu/cell. 24 hr after infection, the cells were 
harvested and a cytoplasmic extract was prepared. CAT activity was assayed for 
samples of extracts normalised for protein content. pSV2CAT, a construct that 
constitutively expresses the CAT gene (Gorman et al., 1982), was used as a positive 
control for CAT expression. The background level of CAT expression from pTK34 
in the absence of Rev was assessed by mock-infection of transfected cells. 
Conversely, mock-transfected cells were infected with <//309/rev to detect any 
endogenous acetyltransferase activity. To differentiate any general adenovirus- 
mediated effects from Rev-specific effects, pTK34-transfected cells were infected 
with J/309 rather than a rev-recombinant. As a further negative control, cells 
transfected with pTK53 (the Rev-unresponsive construct) were infected with 
<//309/rev. Finally, a reagent control containing no cytoplasmic extract was included 
to monitor the diffusion of ^H-acetyl CoA into the nonaqueous scintillant phase.
4.5. Results
The results of the CAT assays for the four rev-recombinants and controls are 
presented in table 4.1, and in graphical form in fig. 4.2 (all controls except (11309 + 
pTK34 omitted in graph for clarity). The reactions were monitored over a 20 hr 
period. For the first two hours, readings were taken every 30 min; additional
readings were taken at 16 hr and 20 hr. The readings at the zero time point were 
taken immediately after mixing the reactants, but before incubation at 37 °C. All 
time point values refer to incubation time at 37 °C - the time required for 
scintillation counting (at room temperature) was ignored.
From the data, it is clear that the levels of CAT activity in the cytoplasmic extracts 
from cells infected with each of the four nrv-recombinants and transfected with the 
pTK34 reporter construct are significantly higher than the levels in the negative 
control extracts. At 0.3 hr, the levels of tritiated product accumulating in the 
scintillant from the reactions using the nrv-recombinant infected/pTK34 transfected 
extracts are already 6.9-26 times higher than from the dl309 infected/pTK34 
transfected negative control extract. By 20 hr, the equivalent levels are 16.2-49.1 
times higher for the rev-viruses than for the negative controls. The CAT activity of 
the rev-virus +  pTK34 extracts is at all time points comparable to that measured in 
the positive control extract from cells transfected with pSV2CAT. The CAT activity 
of the extract from cells transfected with pTK34 alone (mock infection negative 
control) rises from 1.4 times (0.5 hr) to 4.2 times (20 hr) greater than the diffusion 
control (no cytoplasmic extract), indicating a low level of cytoplasmic CAT 
expression from the reporter construct in the absence of Rev. The slightly higher 
levels of CAT expression at later time points from the dl309 +  pTK34 extract over 
those from the mock infected +  pTK34 extract suggest that adenovirus alone may 
have a small effect on CAT expression from this construct. The CAT activity of the 
extract infected with dl3Q9lrev and transfected with the negative control construct 
pTK53 (predicted to be unresponsive to Rev) is significantly lower than that of the 
equivalent dl309/rev +  pTK34 extract (e.g. at 20 hr, the pTK53 reading is nearly 
eightfold lower than the equivalent pTK34 result). This indicates that specific 
binding of Rev to an intact RRE is required for high level cytoplasmic expression of 
CAT. However, the CAT activity in the <//309/rev -f pTK53 extract is significantly
Fig. 4.2. CAT assay of cytoplasmic extracts 
(virus + pTK34)
(a) 0 -20 hr incubation
(b) 0-2 hr incubation (detail)
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Fig. 4.2. CAT assay of cytoplasmic extracts (virus +  pTK34). Cytoplasmic 
extracts were prepared from cells infected 24 hr previously with d/309/RRErev, 
d/338/RRErev, d/309/rev, d/338/rev or d/309, and transfected 48 hr previously with 
pTK34. The CAT activities of the extracts were assayed by the direct scintillation 
diffusion method over a 20 hr period, (a) Plot of scintillation counts versus 
incubation time for 0-20 hr incubation, (b) Plot for 0-2 hr incubation (enlarged 
scale).
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greater than that in the J/309 +  pTK34 extract (more than threefold greater at the 
20 hr time point). If pTK53 were completely unresponsive to Rev, the levels of 
CAT from these two controls would be expected to be comparable. Therefore these 
results suggest that the pTK53 construct retains a residual Rev response. The 
scintillation counts for the extract from cells infected with d/309/rev alone (mock 
transfection) are only slightly higher than those for the diffusion control, showing 
that virus infected cells have little or no endogenous acetyltransferase activity that 
survives the heat inactivation step of the CAT assay.
4*6, Discussion
The level of CAT activity from cytoplasmic extracts of cells transfected with pTK34 
and infected with <//309/RRE/*v, d/338/RRE^v, d/309/rev, or d/338/rev 
demonstrates that each rev-recombinant expresses functional Rev protein. The 3-5 
fold variation in the CAT activities o f the different nrv-virus extracts in this 
experiment suggests that the level of Rev expression from individual recombinants 
varies. However, the rf/338/RRErrv >  dI3Q9/rev -  <//338/rev > d/309/RRErev 
order of Rev expression levels suggested by this experiment was not reproducible: 
In a similar experiment an order of <//309/RRErev > «//338/RRErev > d 1309/rev 
*  ¿/338/rev (within a 2.5 fold range of variation) was obtained. Differences in 
transfection efficiency of the reporter construct may account for small variations in 
the CAT activity of individual samples. In contrast, in repeated experiments the 
larger difference between the rev-recombinants as a group and the negative controls 
was fully reproducible. It was therefore concluded that each of the four rev- 
recombinants expresses functional Rev at similar levels.
C h a p te r  5
A nalysis o f  th e  effects o f  R R E  
in se rtio n  on  gene exp ression  
fro m  reco m b in an t adenov iru ses
In this and the following two chapters I present the results of a series of experiments 
in which gene expression from the recombinant viruses described in chapter 3 was 
analysed at the protein and RNA levels. It was originally intended that expression 
from all the recombinants and wild type virus would be examined in KB8a cells 
(Babiss el al., 1983). These cells stably express the Ad5 El A region and should 
therefore be suitable for complementing the El A defect in the rev-recombinants (see 
chapter 3). However, initial experiments (7.2.1) indicated that complementation 
was poor. Subsequently, studies of E1A mRNA levels during infections of these 
cells suggested that the complement of El A mRNAs expressed was incomplete, 
with little or no 13S mRNA detected (data not shown). Thus valid comparisons 
between the ElA-deficient rev-recombinants and the other ElA-intact viruses could 
not be made in this cell line. To circumvent this difficulty, different aspects of the 
problem were studied in different cell lines.
The major question to be addressed by this section of the thesis - does the Rev/RRE 
system affect the pattern of gene expression in adenovirus? - can conveniently be 
divided into three lines of enquiry:
(a) Does insertion of the RRE alone in L3 affect Ad5 gene expression?
(b) Does insertion of the Rev expression construct affect Ad5 gene 
expression?
(c) Can Rev and the RRE together regulate Ad5 gene expression, and is this 
effect similar to regulation by E1B 55K? - i.e., can Rev and the RRE 
complement deletion of the E1B 33K gene?
(a) and (b) are essentially controls for (c), designed to eliminate the possible cis- 
acting effects on gene expression introduced by RRE insertion, or nonspecific trans­
acting effects of Rev expressed from a major late promoter on Ad5 genes. Since 
investigating (a) requires only the RRE single recombinant d/309/RRE and wild 
type (11309, no complementation for El A deficiency is required, and the question
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can conveniently be addressed in HeLa cells (this chapter). These cells have the 
advantage of growing rapidly in tissue culture, are relatively easy to manipulate, 
and are known to produce high yields of extractable nuclear and cytoplasmic viral 
RNA.
To answer (b), E1A complementation is required, since gene expression from the 
rev recombinants must be monitored. HEK-293 cells (a human embryonal kidney 
cell line described in Graham et al., 1977) efficiently express high levels of Ad5 
El A and E1B proteins. This makes them suitable for testing the effect of Rev on 
adenovirus gene expression using viruses d/309, d/309/RRE, d/309/RRErev and 
(11309/rev. However, since HEK-293 cells constitutively express E1B 55K, few 
useful comparisons can be made with the <//338 (55K-deficient) derivatives of these 
viruses, making these cells unsuitable for answering (c). To address this last 
question, it is necessary to employ KB8a cells, accepting the limitation of poor E1A 
complementation. This prevents direct comparisons being made between the rev- 
recombinants as a group and the other viruses, but allows comparisons between the 
individual rev viruses to be made. As discussed in chapter 7, poor complementation 
also slows the replication cycle of the virus, so that reasonable quantities of viral 
protein and RNA can only be harvested at relatively late times post-infection.
5,2. Analysis af tiril protein expression in infected HeLa crib
The effect of inserting the RRE into region L3 of the adenovirus genome was 
assessed by comparing viral protein expression in HeLa cells infected with either 
recombinant d/309/RRE or wild type dl3Q9 virus. The profile of proteins observed 
in parallel infections by these viruses is shown in fig. 5.1. Comparable levels of the 
major viral proteins were detected in the extracts from dl309- and J/309/RRE- 
infected cells at each time point. Thus insertion of the RRE does not lead to gross 
changes in the pattern of viral gene expression. This result is consistent with the
Fig. 5.1 Analysis of viral protein 
expression In Infected HeLa cells
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Fig. 5.1. Analysis of protein expression in infected HeLa cells. HeLa cell 
monolayers were infected at a multiplicity of 10 pfu/cell with dl309 (lanes A, C), 
d/309/RRE (B, D), or mock-infected (U). Proteins were labelled in vivo with -^S- 
Met for 30 min immediately before harvesting by RIPA lysis at 12 hr (U, A, B) or 
16 hr (C, D) time points post-infection. Samples of each cell extract were 
standardised to 50 000 counts per minute by scintillation counting of TCA- 
precipitated aliquots, analysed by SDS-PAGE, and visualised by fluorography.
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ability of the recombinant to grow efficiently in tissue culture to a high titre. At a 
given time point, the level of each of the viral proteins consistently appears slightly 
higher in the d/309/RRE lane. This may be due to small differences in the 
multiplicities of infection. If RRE insertion in L3 does have any effect on viral gene 
expression, the most probable observable consequence in this experiment would be 
an alteration in the levels o f proteins encoded by L3. The L3 23K protein is 
expressed at too low a level to be detectable by this method; L3 pVI levels are also 
relatively low and it is difficult to resolve the protein from L4 pVIII. However, L3 
structural protein II - i.e., hexon, the major capsid protein - is readily detectable. 
Assessment of hexon levels by inspection at the 16 hr time point does not suggest a 
significant difference between dl309 and <//309/RRE hexon expression. - i.e., RRE 
insertion does not appear to exert a differential effect on gene expression in cis that 
is detectable at this level.
To evaluate the relative levels of viral proteins more rigourously, film band 
intensities at 16 hr were quantified by densitometry. The hexon (protein II) band 
density ratio measured between the d/309/RRE and d/309 lanes was 1.14. Slightly 
higher ratios were measured for the 100K product of L4 (1.25), the penton (protein 
III) product of LI (1.45), and the fibre (protein IV) product of L5 (1.62). Within 
the limits of accuracy of quantitation, these results indicate that insertion of the RRE 
in L3 has little or no effect on the levels of L3 hexon expression, since the density 
ratio for hexon (1.14) differs only slightly from the average density ratio (1.34) 
calculated for the four late viral proteins quantitated.
5.3. Analysis of viral RINA expression in infected Hill cells
These experiments were intended to complement and extend the analysis of viral 
protein expression discussed above. The RNase protection method employed enables 
specific viral RNA species to be detected with a high degree of sensitivity. Using 
this method, it was possible to select riboprobes that allowed discrimination between
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Fig. 5.2. Map of regions that protect L3 riboprobes. Viral and probe transcripts 
are denoted by solid lines. Directions of transcription are indicated by arrowheads. 
The positions of the L3 and L2 genes within the adenovirus genome are represented 
by the scale (in nucleotides from the left end). Polyadenylation of all the L3 RNAs 
occurs at 22399 nt; polyadenylation of 12 RNAs occurs at 17970 nt.
Fig. 5.3. Analysis of L3 RNA species 
from Infected HeLa cells: 3’ terminus
A B
L 3 -3 ' (2 12  nt)
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Pig, 5 .3 . Analysis of U  R N A  species from infected HeLa cells: 3' terminus. 
HeLa cells were infected with ¿009 (lane A) or d/309/RRE (B) at a multiplicity of 
10 pfu/cell. RNA was extracted from the cytoplasm at 16 hr post infection. 5 pg of 
RNA were hybridised with excess o32P-UTP-labelled antisense riboprobe 
transcribed from the Ad5 22188-22444 nt Kpn ¡-Dm I fragment in pGEM4.L3/E2A 
(table 2.1). The fragments protected from digestion by single-strand-specific 
ribonucleases were separated on a denaturing polyacrylamide gel and visualised by 
autoradiography.
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each of the individual L3 RNA species, whose expression might be expected to be 
affected by RRE insertion. The regions protected by the probes employed and the 
positions of the processing sites in L3 are illustrated in fig. 5.2. The characteristics 
of the plasmids encoding all of the probes used in chapters 5-7 are summarised in 
chapter 2 (table 2.1).
5.3.1. Analysis of L3 RNA species from infected HeLa cells: 3' terminus.
To assess the overall levels of L3 mRNAs, aliquots of cytoplasmic RNA extracted 
from dl309- and J/309/RRE-infected cells were analysed using a riboprobe designed 
to be protected by sequences common to the 3’ termini of all the L3 RNA species - 
i.e., a 212 nt fragment of this probe is protected by pVI, hexon and 23K RNAs 
(fig. 5.2). As shown in fig. 5.3, the cytoplasmic levels of these mRNAs in the 
t//309 and J/309/RRE infections are similar. Thus insertion of the RRE appears to 
have no gross effect on the overall level of RNA expression from L3.
5.3.2. Analysis of specific L3 RNA species from infected HeLa cells.
Although overall L3 mRNA expression was not found to be affected by RRE 
insertion, it was possible that levels of individual L3 species were differentially 
altered in the recombinant. Further riboprobes were therefore selected that would 
give distinct protection profiles specific to each L3 mRNA (fig. 5.4). The riboprobe 
transcribed from pGEM3.L3-hexon (table 2.1) spans the hexon splice acceptor at 
18805 nt. A 117 nt fragment of the probe is therefore protected by the 5' end of the 
hexon mRNA 3' exon, and a 600 nt fragment by the body of the pVI mRNA (fig. 
5.2). Protection by the hexon RNA gives rise to two pairs of closely spaced bands 
with sizes of between 110 and 130 nt rather than the single expected band of 117 nt. 
This pattern is characteristic of hexon mRNA as detected by this probe, and may 
reflect heterogeneity in splice site usage or instability of the probe : mRNA hybrid. 
The cytoplasmic RNA levels appear similar for both the dl309 and «//309/RRE 
infections, indicating that the appearance of hexon mRNA in the cytoplasm is
Fig. 5.4 Analysis of specific L3 
from Infected HeLa cells
(a)
A B
pVI (600 nt)
Haxon 
( 1 1 7  nt)
(b)
A B
#
species
pVI/hexon 
(2 14  nt)
2 3 K  (17 0  nt)
pVI/hexon 
(16 3  nt)
2 3 K  ( 1 1 9  nt)
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Fig. 5.4. Analysis of specific L3 RNA species from infected HeLa cells. HeLa 
cells were infected with dl309 (lane A) or d/309/RRE (B) at a multiplicity of 
10 pfu/cell. RNA was extracted from the cytoplasm at 16 hr post infection, (a) pVI 
and hexon probe: 5 fig of RNA were hybridised with an antisense riboprobe 
transcribed from the Ad5 18318-18922 nt Hind III-Sma I fragment in 
pGEM3.L3-hexon (table 2.1). All other details were as for fig. 5.3. (b) 23K 
probe: 5 ng of RNA were hybridised with an antisense riboprobe transcribed from 
the Ad5 21562-21775 nt BamH l-Bglll fragment in pGEM3.L3-23K (table 2.1). 
All other details were as for fig. 5.3.
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unaffected by the presence of the RRE in L3. This result is consistent with the SDS- 
PAGE experiments described above. The cytoplasmic levels of pVI RNA (which 
will also contain the RRE in d/309/RRE) are also similar in both the dl309 and 
d/309/RRE infections.
The riboprobe transcribed from pGEM3.L3-23K (table 2.1) spans the 23K splice 
acceptor at 21605 nt. A 170 nt fragment of the probe is therefore protected by the 
5' end of the 23K mRNA 3' exon, and a 214 nt fragment by both the hexon and 
pVI mRNAs (fig. 5.2). However, the pattern of protection is complicated for 
«//309/RRE, since the RRE was inserted at 21724 nt - i.e., within the sequences that 
protect the probe. By interrupting these sequences, RRE insertion could split the 
predicted 170 nt fragment into 119 and 51 nt fragments, and the 214 nt fragment 
into 163 and 51 nt fragments. Alternatively, the inserted RNA may form an 
unpaired loop at the insertion site, allowing uninterrupted protection of the probe by 
base pairing with the RNA flanking the insert. The most prominent species in this 
analysis (fig. 5.4) is the predicted pVI/hexon 214 nt fragment, which is present in 
both lanes at comparable intensity. A band at the position predicted for the specific 
170 nt 23K fragment is also visible in each of the lanes. Thus, looping out of the 
RRE allowing protection of the normal length fragment does occur. However, the 
d/309/RRE lane also contains unique species that appear to correspond to the 
predicted 163 nt, 51 nt (not shown) and (at low levels) the U 9nt protected 
fragments formed by cleavage at the RRE insertion site. Since both protection and 
cleavage apparently occur at this site, it is difficult to make direct quantitative 
comparisons between the d/309 and <//309/RRE lanes. There is however no gross 
difference in the levels of 23K mRNA discernible in this assay.
5.3.3. Analysis of L4 and E3 species from infected HeLa cells
To complement the L3 analysis, control experiments were carried out in which the 
cytoplasmic levels of L4 and E3 species in dl309- and d/309/RRE-infected cells
Fig. 5.5 Analysis of L4 and E3 species 
from Infected HeLa cells
(a) A B
L4 (802 nt) 
4 »  E3 (570 nt)
gQ E 3  (372 nt)
(b) __________ /
pGEM4.ES/L4
M U T T
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Pig. 5.5. Analysis of L4 and E3 species from infected HeLa ceils, (a) HeLa cells 
were infected with dl309 (lane A) or d/309/RRE (B) at a multiplicity of 10 pfu/cell. 
RNA was extracted from the cytoplasm at 16 hr post infection. 5 ng of RNA were 
hybridised with an antisense riboprobe transcribed from the Ad5 27331-28137 nt 
EcoR I-Bgl II fragment in pGEM4.E3/L4 (table 2.1). All other details were as for 
fig. 5.3. (b) Map of viral mRNA regions that protect pGEM4.E3/L4 riboprobe. 
Directions of transcription are indicated by arrowheads. Viral and probe transcripts 
are denoted by solid lines.
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were examined. No cis-acting effects of RRE insertion on these mRNAs were 
expected since none of the species detected carry the RRE. The pGEM4.E3/L4 
riboprobe (table 2.1) produces a fragment of 802 nt due to protection by LA 
mRNAs; 372 nt and 570 nt fragments are generated from protection by E3 mRNAs 
(fig. 5.5b). As shown in fig. 5.5a, all the predicted species were detected in the 
protection assay, and the cytoplasmic levels of each were similar in the d/309 and 
d/309/RRE infections.
5A , Discussion
The results presented in this chapter show that RRE insertion has no significant 
effect on the pattern of viral gene expression detectable by the methods employed. 
<//309 and dl309/RRE infections displayed similar profiles of viral protein 
expression, with comparable relative levels of each of four late proteins quantified 
by densitometry. This result is consistent with the viability of the recombinant 
virus, which grows efficiently in tissue culture to a high titre. It was expected that 
any potential differential effect on gene expression resulting from RRE insertion 
would most probably be exerted on the L3 genes, since the position of the insertion 
site results in incorporation of the response element into L3 mRNAs (see chapter 3 
and fig. 5.2). Of the three L3 proteins, only hexon (viral protein II) was readily 
detectable in the SDS-PAGE analysis; the relative level of this protein with respect 
to the other quantified late proteins was not significantly altered by RRE insertion. 
Cytoplasmic levels of L3-3', L3-her.on, L3-pVI, L4-3' and E3 mRNA species were 
similar in dl309 and d/309/RRE infections, again suggesting that RRE insertion has 
no significant effect on gene expression from L3 or the other regions probed as 
controls (L3-23K mRNA could not be accurately quantified but no gross difference 
was apparent).
C h a p te r  6
A nalysis o f  th e  effects o f  
a  rev  expression  cassette  
o n  A d5 gene expression
1 3 0
6.1. Introduction
In this chapter I present the results of experiments in which gene expression from 
AdS recombinants containing the rev expression construct was analysed at the 
protein and RNA levels, to determine whether Rev alone has any effect on this 
process. For reasons discussed in chapter 5, these experiments were conducted in 
HEK-293 cells and only included d/309/RRErev and (¡1309/rev as the viruses to be 
tested, with dl3Q9 and/or <//309/RRE as controls. In general, no useful purpose 
would be served by including rf/338 and its recombinant derivatives since the 3SK 
deletion in these viruses is complemented by the HEK-293 cells. However, a 
d/338/rev infection was employed as a control for an anomalous effect on Ad 
protein expression resulting from d309/rev infection (see below).
6.2. Analysis of protein expression In Infwted HEK-293 « lb
The effects of inserting the rev expression construct into the adenovirus genome 
were analysed by comparing viral protein expression in cells infected with rev- 
recombinants dl309/rev or <//309/RRErrv with expression in cells infected with 
dl309 or <//309/RRE. The profile of proteins observed in parallel infection by these 
viruses is shown in fig. 6. la. A similar pattern of viral protein expression is visible 
in all the infections. Although there is some variation in band intensity between 
lanes, for example between d/309 and d/309/RRE, this appears to affect all the viral 
bands in a lane equally - i.e., it is a general effect probably due to slight differences 
in infection multiplicity, similar to that observed in HeLa cells (chapter 5). In terms 
of relative band intensities within an individual lane, the dl309, «//309/RRE and 
d309/RRErev lanes appear similar, suggesting that Rev expression (even in the 
presence of the RRE) has no effect on adenovirus gene expression detectable by this 
type of experiment in HEK-293 cells. However, the pattern of expression in the 
d3Q9/rev lane is slightly anomalous. One viral protein of approximately 33K is 
reduced in or absent from the d309/rev lane but present in the other lanes. This 
band cannot be identified conclusively from these data, but it may correspond to the
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Fig. 6.1. Analysis of protein expression in infected HEK-293 cells, (a) HEK-293 
cell monolayers were infected at a multiplicity of 10 pfu/cell with dl309 (lane A), 
J/309/RRE (B), d/309/RRErrv (C). dB09/rev (D), d/309/RRE +  d/309/rrv (each at 
a multiplicity of 10 pfu/cell, lane E) or mock-infected (lane U). Proteins were 
labelled in vivo with ^S-M et and harvested at 16 hr post-infection; preliminary 
experiments (not shown) had indicated that sufficient viral protein for analysis was 
synthesised at this time point. Proteins were separated by SDS-PAGE. (b) 
Conditions and experimental procedures were as for (a), above. Cells were infected 
with d 1309/rev (lane A) or dl33S/rev (B).
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L3 pVI or L4 pVIII protein (precursors of hexon-associated virion components). 
Furthermore, an additional band of approximately 28K is present in the (11309/rev 
lane, but appears to be absent from the other lanes. It is possible that this additional 
band represents a truncated form of the missing protein. If this is the case, the 
truncation does not affect the viability of the virus, since it grows efficiently to a 
high titre in tissue culture with normal cytopathic effect. An alternative explanation 
is that the additional protein represents the processed form of one of the virion 
protein precursors (pVI or pVIII). However, there is no evidence in the protein 
profiles of accelerated processing of other viral protein precursors normally subject 
to processing by the 23K protease, and it is difficult to envisage a mechanism by 
which such processing could be facilitated selectively. The d/309/rev infection is 
also characterised by unusually high levels of hexon, 100K, penton, fibre and other 
late proteins. It is unclear if this effect is connected with the anomalous pattern of 
protein expression in the 25-40K region of the gel. As noted above, some variation 
in band intensity between the lanes can probably be explained by minor differences 
in infection multiplicity; this factor may also explain the particularly intense bands 
in the <11309/rev lane. Alternatively, these features may reflect an accelerated 
replication cycle for this virus.
Since neither the effect on late protein expression nor the anomalous pattern of 
expression in the 25-40K region is evident in the <//309/RRErev lane, they are 
unlikely to be Rev-specific effects. However, it is a formal possibility that the 
presence of the RRE target sequence in the double recombinant d/309/RRErev 
prevents Rev interacting1 with adenovirus gene expression to cause these effects, 
possibly by high-affinity binding of all available Rev molecules. When this 
possibility was tested by using a d/309/RRE +  <11309/rev coinfection to provide Rev 
in irons (fig. 6.1a) the same anomalous pattern of protein expression was observed, 
indicating that this effect is independent of the presence of RRE transcripts. 
Moreover, infection of HEK-293 cells with the d/338/rev single recombinant results
T»bk 6,1)1 a m a t i t i «  i l  virai P a tt in i  fr»|n m:K-?93 a l  inftttipn; larfritrary 
units)
V irtù
Prolein:
M 309 4O 09/RRE <O309/RKE>rv M 309 /rev ¿Ì309/RRE
+ d lìW I r e v
IV (fibre) 19.1 26.9 18.4 30.4 33.9
III (penton) 9.2 14.2 9.5 15.9 19.8
100K 15.3 20.8 17.9 25.7 31.0
II(h e io n ) 45.1 52.7 37.0 63.5 64.2
Tablc 6,lb Rati»» pf band d tn iiliti in rtcpmbinam inlcctiom lo tguivaknt b»nd 
drnaitin in f//3Q9 infcdion
V ira i
Protein:
i//309/RRE <tf309/RRErrv d IM M re v iì
IV (fibre) 1.41 0.96 1.60 1.78
III (pentoa) 1.54 1.03 1.73 2.15
100K 1.34 1.15 1.66 2.00
II (heson) 1.17 0 8 2 1.41 1.42
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in a similar pattern of expression to that obtained with dl309, ¿/309/RRE and 
d/309/RRErev at a 16 hr time point (fig. 6.1b). Hence the anomalous pattern of 
expression is unique to dl309/rev. The cause of this effect is unclear; 
uncharacterised changes in the viral genome that were not detected by restriction 
analysis may have occurred spontaneously during the construction of this virus.
To test more rigourously the observation that the presence of the rev construct does 
not appear to affect the overall pattern of late viral gene expression (with the 
exception of the probably rev-independent effect on proteins in the 25-40K Mr size 
range from ¿/309/rev) the film band densities of four major late proteins were 
quantified by densitometry (table 6.1a). To facilitate comparisons between lanes, 
the density ratios between each of the bands in the d/309/RRE, <//309/RRErev, 
dl309/rev and d/309/RRE +  dl3Q9/rev lanes and the equivalent bands in the dl309 
lane were calculated (table 6.1b). From these results, it is evident that the small 
variation in band intensity between lanes occurs by about the same degree for 
proteins IV, III, and 100K - i.e., the relative proportions of these proteins in each 
cell extract are approximately equal. The variation in hexon levels is consistently 
slightly smaller between the dl309 and recombinant lanes than are the variations in 
the levels of the other proteins. This suggests that relative levels of hexon are lower 
in the recombinant infections than in the dl309 infection (which has the lowest 
absolute levels of each of the viral proteins). However, this small effect, even if 
significant, is nonspecific since it occurs in the <//309/RRE, dl309/rev, and 
d/309/RRErev lanes.
6.3. Analysis of RNA expression in infected HEK-293 cells
As in chapter 5, the analysis of gene expression at the protein level was extended by 
experiments at the RNA level, using the RNase protection assay described 
previously. Although Rev synthesis in d1309/rev or dl33S/rev could potentially 
affect gene expression from any region of the adenovirus genome, possible effects
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Fig. 6.2. Analysis of L3 RNA species from infected HEK-293 cells: 3' terminus.
HEK-293 cells were infected with d/309/RRE (lanes A, D), <//309/RRErev (B, E) 
or dl309/rev (C, F) at a multiplicity of 10 pfu/cell. RNA was extracted from the 
cytoplasm (A-C) and nuclei (D-F) at 16 hr post infection. 5 ng of RNA were 
hybridised with excess a-^P-UTP-labelled antisense riboprobe transcribed from the 
Ad5 22188-22444 nt Kpnl-D ral fragment in pGEM4.L3/E2A (table 2.1). The 
fragments protected from digestion by single-strand-specific ribonucleases were 
separated on a denaturing polyacrylamide gel and visualised by autoradiography.
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on L3 were of particular interest since the RRE was inserted in this region in the 
d/309/RRE/rv and <//338/RRErev double recombinants. Therefore, riboprobes were 
selected that were protected by several RNA species synthesised from L3. Control 
probes that were protected by other late viral species were also included in the 
analysis.
6.3.1. Analysis of L3 RNA species from infected HEK-293 cells: 3' terminus.
To assess the overall levels of L3 mRNAs, aliquots of cytoplasmic RNA from 
d/309/RRE-, <//309/RRErrv- and «//309/rrv-infected cells were analysed using the 
riboprobe synthesised from pGEM4.L3/E2A (table 2.1), from which all L3 RNA 
species protect a 212 nt fragment (fig. 5.2) («//309/RRE was utilised as a control 
virus since insertion of the RRE was shown not to affect viral gene expression in 
chapter 5). As shown in fig. 6.2a, the cytoplasmic level of the L3 mRNA varies 
between the infections. Levels in the «//309/RRE and d/309/RRErrv infections are 
comparable, suggesting that insertion of the rev construct does not affect overall 
levels of L3 expression. However, the level in the d/309/rrv infection is markedly 
higher than in the «//309/RRE and <//309/RRErev infections. This might suggest that 
insertion of the rev construct does have an effect on L3 gene expression that is for 
some reason limited to d/309/rrv. However, an analysis of the corresponding 
nuclear RNA samples (fig. 6.2b) shows a similar lane to lane variation in levels of 
the 212 nt species, implying a transcriptional, rather than post-transcriptional, effect 
that is unlikely to be due to Rev function. This effect may be the cause of the 
J/309/rrv-specific aberration of protein synthesis noted in section 6.2, wherein 
possible explanations were discussed.
6.3.2. Analysis of specific L3 RNA species from infected HEK-293 cells. 
Although overall expression of L3 mRNA was not specifically affected by the rev 
construct, it was possible that the levels of individual L3 species were differentially
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affected in the rev-recombinants. Further assays were therefore performed using 
riboprobes transcribed from pGEM3.L3-hexon and pGEM3.L3-23K (table 2.1).
As noted in 5.3.2, several fragments of the pGEM3.L3-hexon probe in the 110- 
130 nt size range are protected by sequences at the 5' end of the hexon mRNA, and 
all 600 nt are protected by pVI mRNA (fig. 5.2). As shown in fig. 6.3a, 
approximately equal levels of the pVI species and similar levels of the group of 
hexon species are present in the <//309/RRE and i//309/RRErev lanes, but the levels 
in the dt309/rev lane are somewhat elevated. The equality of band intensity in the 
<//309/RRE and <//309/RRErev lanes suggests that rev expression does not affect 
expression of the pVI and hexon mRNAs from E1B 55K-intact virus in an RRE- 
dependent manner. The reason for the increase in the levels of hexon and pVI 
species in the dl309/rev infection (consistent with the increase in overall L3 levels 
noted in 6.3.1) is unclear. Since this effect does not occur with <//309/RRErev it is 
unlikely to be Rev-specific. However, as noted above, dl309/rev has an anomalous 
phenotype at the protein level which may be a result of uncharacterised genome 
alterations. Such changes could alter the structure of hexon and pVI mRNAs.
A 170 nt fragment of the pGEM3.L3-23K probe (table 2.1) is protected by the 5' 
end of the 23K mRNA 3' exon and a second 214 nt fragment is protected by both 
the pVI and hexon mRNAs (fig. 5.2). When these mRNAs carry the RRE insert, 
the 170 nt species is partially further digested to 119 and 51 nt fragments and the 
214 nt species is partially further digested to 163 and 51 nt fragments, preventing 
direct comparisons between the RRE recombinants and the other viruses. However,
Fig. 6.3. Analysis of specific L3 RNA 
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Fig. 6.3. Analysis of specific L3 RNA species from infected HEK-293 cells.
HEK-293 cells were infected with <//309/RRE (lane A), d/309/RRErev (B), or 
dl309/rev (C) at a multiplicity of lOpfu/cell. RNA was extracted from the 
cytoplasm at 16 hr post infection.
(a) pVI and hexon probe: 5 ng of RNA were hybridised with an antisense 
riboprobe transcribed from the Ad5 18318-18922 nt H indlll-Sm al fragment in 
pGEM3.L3-hexon (table 2.1). All other details were as for fig. 6.2.
(b) 23K probe: 5 ng of RNA were hybridised with an antisense riboprobe 
transcribed from the Ad5 21562-21775 nt BamH I-Bgl II fragment in pGEM3.L3- 
23K (table 2.1). All other details were as for fig. 6.2.
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comparisons can be made between the ¿//309/RRE and d/309/RRErev infections if it 
is assumed that the proportion of each species that is further digested in the 
protection assay is constant. For d/309/RRE and d/309/RRErev, the cytoplasmic 
levels of 23K mRNA are most easily assessed from the levels o f the 119 nt 
fragment. As shown in fig. 6.3b, these levels are similar in both infections, 
indicating that Rev expression does not affect 23K mRNA expression in this system.
6.3.3. Analysis of LI, L2 and L4 RNA species from infected HEK-293 cells
To complement the L3 analysis, experiments were carried out in which cytoplasmic 
levels of L I, L2 and L4 RNA species were examined. The probe transcribed from 
pGEM3.Ll-3'/L2-5' (table 2.1) spans the LI polyadenylation site at 14118 nt and 
the L2 splice acceptor at 14154 nt. A 393 nt fragment is therefore protected by LI 
sequences, and a 137 nt fragment by L2 sequences (fig. 6.4c(i)>. An additional LI 
fragment, of approximately 350 nt, is also detected using this probe. This fragment 
is believed to result from cleavage of the LI : probe hybrid at an RNase-sensitive 
site. An oligo A : oligo T region is predicted approximately 40 nt upstream from 
the LI polyadenylation site and RNase sensitivity at a similar sequence has been 
noted within E4 (Dix and Leppard, 1993). As shown in fig. 6.4a, bands 
corresponding to both LI species and the L2 species were detected in the assay. 
Similar levels of each of the three fragments were detected in assays of <//3Q9/RRE, 
d/309/RRErev and dl309/rev cytoplasmic RNA.
A single 312 nt fragment of the probe transcribed from pGEM3.L4-5' (table 2.1) is 
protected by sequences in L4 extending from the L4 100K splice acceptor at 
24057 nt to the Pst I recognition sequence at 24369 nt (fig. 6.4c(ii)). Similar levels 
of this species were detected in the d/309/RRE, <//309/RRErrv and J/309/rrv lanes; 
(fig. 6.4b). The equivalence of the cytoplasmic levels of LI, L2 and L4 species in
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Fig. 6.4. Analysis of L I, L2 and L4 RNA species from infected HEK-293 cells.
HEK-293 cells infected with d/309/RRE (lane A), d/309/RRErrv (B), or d009/rev 
(C) at a multiplicity of 10 pfu/cell. RNA was extracted from the cytoplasm at 16 hr 
post infection.
(a) L1/L2 probe: 5 ng of RNA were hybridised with an antisense riboprobe 
transcribed from the Ad5 3721-14291 nt Hind III-Kpn I fragment in pGEM3.Ll- 
37L2-5' (table 2.1). All other details were as for fig. 6.2.
(b) L4 probe: 5 ng of RNA were hybridised with an antisense riboprobe 
transcribed from the Ad5 23286-24369 nt Pst l-Pst I fragment in pGEM3.L4-5'. All 
other details were as for fig. 6.2.
(c) Map of viral mRNA regions that protect L1/L2 and L4 riboprobes. (i) L1/L2. 
(ii) L4. Directions of transcription are indicated by arrowheads. Viral and probe 
transcripts are denoted by solid lines.
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the J/309/RRE, d/309/RRErev and d/309/nev infections indicates that the presence 
of Rev does not affect the expression of these mRNAs.
6,4. Discussion
The results presented in this chapter show that expression of Rev from the rev 
cassette inserted in place of El A has no specific effect on adenovirus gene 
expression detectable by the methods employed. Although an effect on the 
expression of proteins in the 23-40K region was noted in infections with 
recombinant dBQ9rev, a similar effect was not observed in <//309/RRErev or 
dl33S/rev infections, indicating that the effect was not Rev-specific. Similarly, 
experiments conducted at the RNA level did not provide any evidence of Rev- 
specific effects. The cytoplasmic levels of individual viral RNA species were 
generally similar in the d/309/RRE and d/309/RRE/rv infections. Some differences 
were noted between the levels of species expressed from dl309/rev and the other 
viruses, but these may have been due to other uncharacterised changes introduced 
into the genome during virus construction (as suggested by the protein experiments), 
or to small differences in infection multiplicities (such differences would be 
expected to be minor since the stocks of recombinant viruses were titred repeatedly 
in parallel). Overall, there was no evidence for any Rev-specific effect.
C h a p te r  7
A nalysis o f  th e  effects o f  a 
rev  expression  casse tte  a n d  the  
R R E  on A d5 gene expression
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7.1. Introduction
In this chapter, I describe experiments in which the effects on adenovirus gene 
expression of inserting the rev expression construct into the Ad5 genome together 
with the RRE were evaluated. These experiments were conducted in KB8a cells 
which, for reasons discussed in chapter 5, allow direct comparisons to be made 
between recombinants with an intact or deleted E1B 55K gene (derivatives of dBQ9 
and dl338 respectively). Thus these experiments address the question of whether the 
Rev/RRE system can substitute for the E1B 55 K system in the facilitation of Ad late 
gene expression.
7.2. Analysis of protein expression In Infected KB8a cells
7.2.1. Protein analysis at 12, 16.5 and 19 hr post-infection
The objective of this experiment was to examine the patterns of protein expression 
in cells infected with a range of the recombinant viruses described in chapter 3, and 
to assess the suitability of this cell line for comparisons of expression between the 
recombinants. As shown in fig. 7.1, little expression of the indicated viral proteins 
is apparent at 12 hr post-infection. However, by 16.5 hr, several viral proteins are 
detectable in the dl309 and d/309/RRE lanes. Lower intensity bands are visible in 
the dl338 and d/338/RRE lanes (as would be expected from the 55K' genotypes of 
these viruses). However, little or no expression of viral proteins is detectable in the 
t//309/RRErev and ¿/338/RRErev lanes, even at the 19 hr time point. This indicates 
that the complementation of El A function required by the rev recombinants is at 
best incomplete in this cell line.
7.2.2. Protein analysis at 49 hr and 72 hr post-infection
The range of data obtained in the previous analysis was extended in a second 
experiment. This experiment had two objectives: first, to determine if the apparent 
lack of El A complementation observed at 19 hr and earlier in infection extended to 
later time points (i.e., to establish whether the viral replication cycle of the El A"
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Fig. 7.1. Analysis of protein expression in infected KB8a cells at 12, 16.5 and 
19 hr post-infection. KB8a cell monolayers were infected at a multiplicity of 
10 pfu/cell with d/309 (lanes A, G, M), dl338 (B, H, N) dl309/RRE (C, I, O), 
J/338/RRE (D, 1, P), d/309/RRErev (E, K, Q), d/338/RRErrv (F, L, R), or mock- 
infected (U). Proteins were labelled in vivo with -^S-Met and harvested at 12 hr (A- 
F, U), 16.5 hr (G-L) and 19 hr (M-R) post-infection, then analysed by SDS-PAGE 
and visualised by fluorography.
viruses was delayed, or completely halted); second, assuming sufficient 
complementation, to compare the patterns of gene expression from 55K- viruses in 
the presence and absence of the complete Rev/RRE system, using the incomplete 
system in the d/338/nev recombinant as the negative control (since Rev alone was 
not found to affect adenovirus gene expression in chapter 6). In this experiment 
<0312 (an E1A" virus derived from dl309, Jones and Shenk, 1979) was included as 
a negative control in place of dl309; E1A+  viruses were not used as their 
replication cycles would be much further advanced at these time points, preventing 
direct comparisons. As shown in fig. 7.2a, viral protein expression is clearly visible 
from all the ElA-deficient d/309 derivatives at both time points tested. This 
demonstrates that the replication cycles of these viruses are delayed, rather than 
arrested, and indicates that the KB8a cells provide a degree of complementation 
sufficient to allow experiments to be conducted in these cells at late time points. 
Levels of viral protein expression that are reduced compared to their <//309 
counterparts are visible from the <0338 derivatives at both 49 and 72 hr. The 
atypical pattern of protein expression from <0309/rev noted at the 16 hr time point 
of the HEK-293 cell experiment (i.e., the absence of a 35K band and presence of an 
additional 28K band, as described and discussed in 6 .2) is again apparent.
If the Rev/RRE system is able to compensate for deletion of the E1B 55K gene, 
then levels of hexon protein expression might be expected to be elevated in the 
<0338/RRErev infection with respect to levels in the <0338/rev infection, since 
hexon RNA from the former but not the latter should carry the RRE. However, 
comparison of the hexon band intensities 72 hr post-infection from the <0338/rev 
(lane J) and <0338/RRErev (lane H) infections shows no significant elevation in the 
double recombinant (fig. 7.2a); in both lanes only very low levels of hexon 
expression are apparent. A gel artefact prevents assessment of hexon band 
intensities in the 48 hr lanes of fig. 7.2a, but comparison of the equivalent bands in 
the 48 hr lanes (A, B) of a repeat experiment (fig. 7.2b) also shows no significant
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Fig. 7.2. Analysis of protein expression in infected KB8a cells at 49 h r and 
72 h r post-infection, (a) KB8a cell monolayers were infected at a multiplicity of 
10 pfu/cell with d li\2  (lanes A, F), d/309/RRE/rv (B, O), d/338/RRErrv (C, H), 
dn09/rev (D, I). d/338/rrv (E, J), or mock-infected (U). Proteins were labelled in 
vivo with 35S-Met, harvested at 49 hr (A-E, U) and 72 hr (F-J) post-infection, 
analysed by SDS-PAGE, and visualised by fluorography. (b) Infections with 
d/338/RRErrv (lane A), and d/338/rev (B) harvested at 49 hr. Conditions and 
experimental details as for (a ), above.
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elevation of hexon levels in <//338/RRErev. Thus no efficient complementation of 
the 55K defect by the Rev/RRE system as assessed by hexon expression at this level 
of analysis is evident (low band intensities and high background levels prevent 
accurate quantitation by densitometry).
7,3. Analysis of RNA expression in infected KB8a cells
As in chapters 6  and 7, the analysis of gene expression was extended to the RNA 
level using RNase protection assays. To obtain a complete picture of RNA 
expression, cytoplasmic and nuclear RNAs were analysed using riboprobes to all 
regions of the major late transcription unit, and to E1A, E3 and IVa2 species (i.e., 
all the probes listed in table 2.1). Since no gross changes in the pattern of protein 
expression in the presence of the complete Rev/RRE system were detected at the 
protein level, it was expected that any effect at the RNA level was likely to be small 
and limited in scope. Moreover, such an effect is more likely to be detectable when 
comparing expression from <//338/RRErev and dl33%/rev than when examining 
expression from d/309/RRErev and d 1309/rev. The rev-recombinants derived from 
dl309 already express viral genes relatively efficiently; any small additional effect 
resulting from the action of the Rev/RRE system is likely to be swamped by normal 
levels of expression. Since Rev appears to be inactive in the absence of the RRE 
(chapter 6), d 133%/rev serves as a negative control for any effects evident in the 
d/338/RRErev infection. The interpretation of results in the following sections 
concentrates on comparisons between gene expression in these two recombinant 
viruses, although other viruses were included in the analyses.
7.3.1. Analysis of L3 RNA species from infected KB8a cells: 3' terminus
Overall levels of L3 mRNAs were assessed using the pGEM4.L3/E2A probe (table 
2.1) from which a 212 nt fragment is protected by all L3 RNAs (fig. 3.2). As 
shown in fig. 7.3, the dt309/RRErev and df309/rev infections give rise to similar 
levels of L3 mRNAs in the cytoplasm; levels in the <//312 infection are slightly
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Fig. 7.3. Analysis of L3 R N A  species from infected KB8a cells: 3' terminus. 
RNA was extracted at 44 hr post infection from the cytoplasm (lanes A-E) and 
nucleus (F-J) of KB8a cells infected at a multiplicity of 10 pfu/cell with dl312 (A, 
F), d/309/RRE/iev (B, G), <//338/RRErrv (C, H), dO09/rev (D, I), or dtSW rev  (E, 
J). 5 /xg of RNA were hybridised with excess antisense a-^P-UTP-labelled 
riboprobe transcribed from the Ad5 22188-22444 Kpn l-Dra 1 fragment in 
pGEM4.L3/E2A (tabic 2.1). The fragments protected from digestion by single­
strand-specific ribonucleases were separated on a denaturing polyacrylamide gel and 
visualised by autoradiography.
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lower. Predictably, the cytoplasmic levels of L3 mRNAs in the ElB-55K-deficient 
¿/338/RRErev and d/338/rev infections are very markedly reduced in comparison 
with the levels in the 55K-intact infections. Moreover, cytoplasmic levels in the 
rf/338/RRErev infection are significantly higher than in the d/338/rev infection, 
suggesting a response to the presence o f the complete Rev/RRE system. However, 
the levels of L3 mRNAs in the cytoplasm appear to be mirrored by their levels in 
nuclei from each of the five infections - i.e., the cytoplasmic : nuclear (C/N) ratio 
for total L3 mRNA is apparently similar for each infection. This suggests that the 
Rev/RRE system has no gross effect on L3 mRNA expression, since functional Rev 
activity would be expected to increase the C/N ratio by promoting the cytoplasmic 
accumulation of responsive RRE-containing mRNAs However, the intensity of 
adjacent bands prevents accurate comparisons and quantitation of the d/338/RRErev 
and d/338/rev bands, and could mask a small effect on overall L3 levels.
7.3.2. Analysis of specific L3 RNA species from infected KB8a cells
Although the Rev/RRE system did not appear to affect significantly the cytoplasmic 
level of total L3 mRNA, it was possible that smaller or compensating effects were 
being exerted on one or more of the individual L3 species. Probes specific for 
single L3 species were therefore employed. A 322 nt fragment of the pGEM4.L2- 
37L3-5' probe (table 2.1) is protected by pVI mRNA (fig. 5.2). As expected, the 
nuclear and cytoplasmic levels of pVI RNA (fig. 7.4a) were lower in cells infected 
with the ElB-55K-deficient viruses (dl338 derivatives) than in cells infected with 
the ElB-intact viruses. The cytoplasmic : nuclear ratio for pVI mRNA appeared 
slightly higher for the d/338/RRErev infection than for the d/338/rev infection. 
However, the proximity of strong bands in the adjacent d/309/RRErev and 
dl309lrev lanes again made precise quantitation difficult and prevented clear 
reproduction of the original autoradiograph in fig. 7.4a (it should be noted that all 
comparisons of relative band intensities were made directly from the
L3
 a
nd
 L
2 
R
N
A
 s
pe
ci
es
 fr
om
1 4 9
Fig. 7.4. Analysis of specific L3 and L2 RNA species from  infected KB8a cells.
(a) pVI probe: RNA was extracted at 44 hr post infection from the cytoplasm 
(lanes A-D) and nucleus (E-H) of KB8a cells infected with d/309/RRErev (A, E), 
d/338/RRErrv (B, F), d/309/rrv (C, G), or d/338/rrv (D, H). 5 fig of RNA were 
hybridised with excess antisense riboprobe transcribed from the Ad5 17068-18323 
Kpn l-Hind III fragment in pGEM4.L2-37L3-5' (table 2.1).
(b) pVI and hexon probe: RNA was extracted at 44 hr post infection from the 
cytoplasm (lanes A, C, E, G, I) and nucleus (B, D, F, H, J) of KB8a cells infected 
with <//309/RRErrv (A, B). dB09/rev (C, D), d/312 (E, F), d/338/RRE/*v (G, H), 
or d/338/rev (I, J). 5 fig o f RNA were hybridised with excess antisense riboprobe 
transcribed from the Ad5 18318-18922 Hind lll-Sma I fragment in pGEM3.L3- 
hexon (table 2 . 1)
(c) 23K probe: RNA was extracted at 44 hr post infection from the cytoplasm 
(lanes A-E) and nucleus (F-J) of KB8a cells infected with dl3\2 (A, F), 
<//309/RRE/*v (B, G), rf/338/RRE/*v (C, H), dOQ9/rev (D, I), or dl338/rev (E, J). 
S f i g  o f RNA were hybridised with excess antisense riboprobe transcribed from the 
Ad5 21562-21775 nt BamH I-Bgl II fragment in pGEM3.L3-23K (table 2.1).
All other details were as for fig. 7.3.
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autoradiographs). There was no apparent difference in cytoplasmic : nuclear ratio 
between pVI RNA levels in the d/309/RRErev and dti09/rev infections.
pVI mRNA protects a 600 nt fragment and hexon mRNA several fragments of 110- 
130 nt derived from the pGEM3.L3-hexon probe (table 2.1; fig. 5.2). The 
cytoplasmic and nuclear levels of the pVI mRNA (600 nt) are, as in the cases of the 
other L3 species assayed for (above), highest in the infections with dl309 
derivatives, slightly lower in the d ti\2  infection, and greatly reduced in the 
infections with d/338 derivatives (fig. 7.4b). Comparing d/338/RRErev and 
d/338/rev assays, higher levels of pVI mRNA are apparent in the cytoplasmic assay 
for d/338/RRErev than for d/338/rev, whereas the corresponding nuclear levels for 
these two infections are comparable. This suggests that the complete Rev/RRE 
system in this virus is capable of partially complementing the 55K' defect in 
cytoplasmic accumulation of pVI mRNA. Comparison of the levels o f the hexon- 
specific species detected in the d/338/RRErev and d/338/nrv infections shows only a 
small increase in the cytoplasmic : nuclear ratio for the d/338/RRErev infection 
over that observed for the d/338/rev infection.
All 214 nt of the probe transcribed from pGEM3.L3-23K (table 2.1) are protected 
by pVI and hexon mRNAs, while a 170 nt fragment is specifically protected by the 
23K RNA. The difficulties in RNA quantitation caused by the partial cleavage of 
these fragments into 163 nt, 119 nt and 51 nt fragments due to the RRE have been 
described above (section 5.3.2). However, assuming that the extent o f cleavage is 
similar for cytoplasmic and nuclear RNA assays of a particular infection, the C/N 
ratio will not be affected and these ratios can be compared between infections. 
Comparing <//338/RRErev and d/338/rev infections (fig. 7.4c), the cytoplasmic : 
nuclear ratios for the 214 nt hexon and pVI species are greater for the 
<//338/RRErev double recombinant. The levels of the 170 nt (L3-23K) fragment
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from J/338/RRE/rv and d/338/rrv, and the levels of the 119 nt and 51 nt cleavage 
products from d/338/RRE/rv were too low for quantitation.
Taken together, these data suggest that a small RRE-dependent, Rev-mediated 
enhancement of accumulation o f both L3 pVI and L3 hex on mRNAs is detected, 
when the Ad5 E1B 55K function is inactivated and late mRNA accumulation is very 
inefficient. The individual results obtained with the L3-hexon probe suggested that a 
greater effect was exerted on pVI than on hexon mRNA.
7.3.3. Analysis of LI and L2 R N A  species from infected KB8a cells
As controls for the L3 analysis, the relative levels o f LI and L2 species in cells 
infected with the rrv-recombinants were assessed (processed LI and L2 mRNAs do 
not carry the RRE, so their expression would be expected to be independent of 
Rev/RRE-specific effects). The pGEM4.L2-37L3-5' probe (table 2.1) is protected 
by the 3' end of L2 mRNAs, (fig. 5.2) yielding protected fragments of 296 nt (pre- 
M) and 379 nt (all other L2 mRNAs). As shown in fig. 7.4a, the general pattern 
noted previously - increased levels of viral RNA in the J/309-derived recombinant 
infections, compared with lower levels in the <//338-derived recombinant infections - 
was again obtained. As discussed in 7.3.2, the very large variation in band 
intensities made precise quantitation of d/338/RRErev and <//338/rrv bands difficult 
and prevented clear reproduction of the autoradiograph in fig. 7.4a (nuclear pre-/t 
levels are not visible for <//338/nev in the figure). However, within these limitations 
there was no evidence of an effect by the Rev/RRE system on L2 mRNA 
expression. The cytoplasmic : nuclear ratios of each L2 species as assessed from the 
original autoradiographs were comparable in the d/338/RRE/ev and J/338/rrv 
infections; similarly, uniform ratios were found in the ¿/309/RRE/rv and d  1309/rev 
infections.
Fig. 7,5. Analysis of L1 and L2 RNA 
species from infected KB8a cells.
Fig. 7.5. Analysis of LI and L2 R N A  species from infected KB8a cells. RNA 
was extracted at 44 hr post infection from the cytoplasm (lanes A, C, E) and 
nucleus (B, D, F) of KB8a cells infected with <//312 (A, B) <//338/RRErev (C, D), 
or dl33S/rev (E, F). 5 /xg of RNA were hybridised with excess antisense riboprobe 
transcribed from the Ad5 13721-14291 Hind III-Kpn I fragment in pGEM3.Ll- 
37L2-5' (table 2.1). All other details were as for fig. 7.3.
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The pGEM3.Ll-37L2-5' probe is protected by the common 3’ ends of LI mRNAs, 
and by the 5' end of the L2-III 3' exon (6.3.3 and fig. 6.4c(i)). Levels of the L2-III 
species are too low for accurate quantitation in the infections with <//338-derived 
recombinants, but no obvious difference in levels is apparent between the 
<//338/RRErev and d/338/rrv infections (fig. 7.5). Comparison of LI levels detected 
as the »350 nt fragment shows that the cytoplasmic : nuclear RNA ratios for the 
d/338/RRErev and d/338/rrv infections are indistinguishable. This indicates that the 
Rev/RRE system has no effect on the cytoplasmic expression of LI mRNA in this 
context, a result consistent with that obtained for L2 mRNA.
7.3.4 Analysis of L4 and E3 species from infected KB8a cells
As further controls for the L3 analysis, the expression o f mRNA from late region 
L4 was examined (processed L4 mRNAs, like L1/L2 mRNAs, do not carry the 
RRE, and were therefore not expected to be affected by Rev/RRE-specific effects). 
A 312 nt fragment of the probe transcribed from pGEM3.L4-5' is protected by 
sequences at the 5' end of the L4-100K 3' exon (fig. 6.4c(ii) & 6.3.3). If the levels 
of L4-100K RNA are compared for the <//338/RRErrv and <//338/rrv infections (fig. 
7.6a), a dramatic difference in the cytoplasmic levels is apparent. The nuclear 
levels, however, are very similar. The cytoplasmic : nuclear ratio of RNA levels is 
therefore much greater for the d/338/RRErrv infection, suggesting that the 
Rev/RRE system is facilitating the cytoplasmic expression of L4-100K mRNA. This 
result was surprising, as the position of the RRE in the Ad5 genome precludes its 
incorporation into processed L4-100K mRNA, although it will be present in the 
unspliced primary transcript.
To extend the L4-5’ analysis to other L4 species and mRNAs from the adjacent E3 
transcription unit the pGEM4.E3/L4 probe (table 2.1) was employed (5.3.3 and fig. 
5.5b). As shown in fig. 7.6b, the cytoplasmic : nuclear ratio for total L4 mRNA 
(802 nt fragment) appears slightly higher in the d/338/RRErpv infection than in the
A B
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Fig. 7.6. Analysis of L4 and E3 species from infected KB8a cells.
(a) L4-5' probe: RNA was extracted at 44 hr post infection from the cytoplasm 
(lanes A-E) and nucleus (F-J) of KB8a cells infected with <//312 (A, F), 
<//309/RRErrv (B, G), d/338/RRErrv (C, H), <//309/rev (D, I), or <//338/rrv (E, J). 
5 ng of RNA were hybridised with excess antisense riboprobe transcribed from the 
Ad5 23286-24369 Pst I-Pst I fragment in pGEM3.L4-5*. (table 2.1).
(b) L4/E3 probe: RNA was extracted at 44 hr post infection from the cytoplasm 
(lanes A, C, E) and nucleus (B, D, F) of KB8a cells infected with dl3\2 (A, B), 
d/338/RRErrv (C, D), or <//338/r*v (E, F). 5 Mg of RNA were hybridised with 
excess antisense riboprobe transcribed from the Ad5 27331-28137 EcoR l-Bgl II 
fragment in pGEM4.E3/L4 (table 2.1).
All other details were as for fig. 7.3.
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dl33S/rev infection, confirming that the Rev/RRE system is able to facilitate the 
cytoplasmic expression of LA mRNA species. However, the magnitude of the 
change in ratio is much smaller than was detected with the L4-100K probe. This 
may be due to an unequal effect of Rev/RRE on the cytoplasmic expression of 
different LA species; a weak effect or no effect on LA 33K and/or pVIII expression 
could mask a relatively strong effect on 100K when the probe used hybridises with 
sequences common to all three.
The two E3 species detected by this probe appear to show different patterns of 
response to the Rev/RRE system (fig. 7.6b). The cytoplasmic : nuclear RNA level 
ratio of the E3 species that protects a 372 nt probe fragment (fig. 5.5b) is similar 
for the <//338/RRErev and dt33&/rev infections. However, the ratio for the E3 
species that protects a 570 nt fragment is markedly greater for the <//338/RRErev 
infection, indicating Rev/RRE mediated accumulation. This difference in response 
to Rev between E3 mRNAs may be a consequence of the different patterns of 
expression of the two species. The 372 nt fragment defines a 'conventional' E3 
RNA expressed at early times in infection from the E3 promoter, whereas the 
570 nt fragment defines an mRNA that is expressed predominantly at late times 
from the major late transcription unit (Tollefson el al., 1992), and could therefore 
be expected to behave similarly to LA.
7.3.5 Analysis of L5 RNA species from infected KB8a cells
To determine if the Rev/RRE-mediated effect on cytoplasmic RNA expression 
detected for L4 extended to L5, a probe transcribed from pGEM2.L5 (table 2.1) 
was employed. Fragments of 800 nt and 1091 nt are protected by the 3' ends of the 
two major L5 mRNA species (fig. 7.7b). As shown in fig. 7.7a, the cytoplasmic : 
nuclear RNA level ratios of the 800 nt species are not increased for the 
<//338/RRErev infection with respect to the dl33%/rev infection (levels of the 1091 nt
Fig. 7 .7 , Analysis of L5 RNA species 
from infected KB8a cells
(a)
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Fig. 7.7. Analysis of L5 RNA species from infected KB8a cells, (a) RNA was
extracted at 44 hr post infection from the cytoplasm (lanes A-D) and nucleus (E-H) 
of KB8a cells infected with d/309/RRE/rv (A, E). d/338/RRE/rv (B, F), <//309/rev 
(C, G), or d/338/rev (D, H). 5 /xg of RNA were hybridised with excess antisense 
ri bop robe transcribed from the Ad5 31933-33096 Hind Ill-Sma I fragment in 
pGEM2.L5 (table 2.1). All other details were as for fig. 7.3. (b) Map of viral 
mRNA regions that protect L5 riboprobe.
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species are too low to quantify). This result indicates that the Rev/RRE-mediated 
facilitation of cytoplasmic RNA expression does not extend to L5.
7.3.6 Analysis of IVa2 R N A  species from infected KB8a cells
Although L I, L2, L4 and L5 mRNAs do not carry the RRE in their mature forms, 
the major late primary transcript from which they are derived does contain the 
response element. Therefore the Ll/2/4/5 control experiments described above are 
not entirely independent of the RRE; indeed the L4 analysis provided evidence of a 
significant Rev response. As a completely independent control, IVa2 RNA 
expression was examined. IVa2 is transcribed from its own promoter (fig. 1.4) 
active during the late phase of infection. Since the RRE will not be incorporated 
into IVa2 RNA at any stage of gene expression, no Rev/RRE-mediated effect was 
expected. pGEM3.IVa2 probe fragments of 87 nt and 241 nt are protected by the 
first and second exons of the IVa2 mRNA respectively (fig. 7.8b). As shown in fig. 
7.8a, the cytoplasmic : nuclear RNA level ratios of the 241 nt species in the 
<//338/RRErev and <//338/rev infections were similar, indicating that the cytoplasmic 
expression of IVa2 mRNA is unaffected by the presence of Rev/RRE system acting 
in trans.
7.4. Discussion
The results presented in this chapter demonstrate that the HIV-1 Rev/RRE 
regulatory system has a functional effect on adenovirus gene expression in the test 
system employed. In the context of the <//338/RRErev recombinant virus, the 
Rev/RRE system was shown to complement partially a defect in cytoplasmic late 
RNA expression caused by deletion of the E1B 55K gene. Unexpectedly, the 
strongest effect observed was on expression of L4-100K mRNA. The cytoplasmic : 
nuclear ratio of RNA levels was markedly increased for this species when expressed 
from <//338/RRErrv, in comparison with expression from dl33S/rev. Similar but 
smaller effects were also noted on the expression of L3 pVI and hexon mRNAs, and
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Fig. 7.8. Analysis of IVa2 RNA species from infected KB8a cells, (a) RNA was
extracted at 44 hr post infection from the cytoplasm (lanes A-E) and nucleus (F-J) 
of KB8a cells infected with dl312 (A, F), d/309/RRE/rv (B, G), <#338/RRE/vv (C, 
H), dnQ9/rev (D, I), or d/338/rev (E, J). 5 ng of RNA were hybridised with excess 
antisense riboprobe transcribed from the Ad5 5186-5792 BsiE ll-Xho I fragment in 
pGEM3.IVa2 (table 2.1). All other details were as for fig. 7.3. (i) Short 
autoradiograph exposure, (ii) Long exposure, (b) Map of viral mRNA regions that 
protect IVa2 riboprobe.
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on an E3 species expressed from the major late promoter. The effect on L3 
expression can be explained by the presence in L3 mRNAs of the RRE, which can 
bind the Rev protein in the nucleus to facilitate cytoplasmic mRNA expression. 
However, in the cases o f L4 and E3, the RRE (although initially present) is in a 
region of the primary transcript removed from these mRNAs during processing. To 
explain the effects on LA and E3, it is necessary to propose that Rev/RRE can 
determine the fate of an RNA before excision of the RRE (excision of sequences S' 
to the L4-100K sequences was demonstrated by the normal size of the protected 
fragment from the pGEM3.L4-5' probe). For example, L4-100K RNA may be 
committed to a specific nuclear export pathway by Rev/RRE action before 
processing is complete. This could be mediated by the type of RRE-nucleated 
ordered assembly of Rev molecules along an RNA chain described by Heaphy et al. 
(1991) and Wingfield et al. (1991). Such a process could package the RNA for 
interaction with a specific nuclear export pathway (or block splice site usage and 
prevent further splicing o f LA-100K RNA to smaller L4 species).
Despite the clear difference in the cytoplasmic : nuclear level ratio of L4-100K 
mRNA between the d/338/RRErev and d/338/rev infections, no significant 
difference in 100K protein levels was observed in the SDS-PAGE analysis of 
corresponding infections at a similar time point (fig. 7.2). However, as discussed in 
chapter 1, Rev may be a multifunctional protein required at several different stages 
of the gene expression pathway. It is possible that a Rev/RRE-mediated 
commitment to nuclear export of RNA is linked to Rev-dependent cytoplasmic 
events that lead to efficient translation. D'Agostino et al. (1992) have suggested that 
Rev-dependent HIV mRNAs follow a transport pathway distinct from that of 
cellular mRNAs and interact comparatively slowly with the translation machinery ; 
Rev is envisaged as acting to improve the efficiency of this interaction. Indeed, 
Arrigo and Chen (1991) and D'Agostino et al. (1992) have shown that in the 
absence of Rev or the RRE, Rev-dependent mRNAs are not efficiently loaded onto
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polysomes but are instead associated with smaller 40-80 S complexes and/or 
sequestered in a cytoplasmic subcompartment. Rev/RRE could therefore act by 
releasing these mRNAs for interaction with the translational machinery. If excision 
of the RRE occurs after Rev/RRE-mediated commitment to nuclear export, 
transport may occur, but the mRNA will be unable to bind Rev in the cytoplasm. 
Without Rev binding, the transported mRNA may not be efficiently translated. This 
interpretation of the data implies that one of several potential Rev activities has been 
isolated in the d/338/RRErev system.
It is unclear why the most pronounced effect of Rev/RRE was on L4-100K mRNA. 
It was originally expected that any responses to Rev/RRE would be confined to L3, 
since the position of RRE insertion places the response element in the pVI, hexon, 
and 23K exons. However, the magnitudes of the effects observed on L3 were 
smaller than the L4-100K response, whereas no effects were observed for LI, L2 or 
L5. The lack of any detectable effect on LI and L2 may be a result of the pattern of 
adenovirus RNA processing. Since cleavage, polyadenylation and splicing, or at 
least commitment to these events, occur co-transcriptionally, transcripts that give 
rise to LI and L2 mRNAs may be cleaved and polyadenylated 5' to L3 and 
therefore not contain the RRE at any stage of expression. The differences between 
the comparatively large effect observed for L4-100K and the smaller effect found 
for overall L4 expression may be explained by differences in the dependence of 
individual RNA species on mechanisms that facilitate nuclear export. Leppard 
(1993) has shown that major late L I, L2 and L3 RNA species that contain intronic 
sequences or unused splice sites are more dependent on E1B 55K for efficient 
cytoplasmic expression than related, fully processed RNAs. Similarly, L4-100K 
mRNA is more likely than other L4 species to be dependent on Rev/RRE for 
efficient cytoplasmic expression in the absence of E1B 55K.

In the preceding chapters I have described experiments designed to test the function 
of the HIV-1 Rev/RRE system in an Ad5 context. More specifically, these 
experiments were directed towards examining the potential functional analogy 
between the HIV-1 Rev and Ad5 E1B 55K proteins. Six Ad5 recombinant viruses 
containing an HIV-1 rev cassette, the HIV-1 RRE, and the Ad5 E1B 55K gene in 
various combinations were constructed and isolated to provide the reagents needed 
to address this question. The four recombinants containing a rev cassette were 
shown to express functional Rev protein by a CAT reporter gene assay. Very 
recently, it has been shown in this laboratory that infection with the d/309/rev 
recombinant induces Env protein synthesis from a simian immunodeficiency virus 
env expression vector transfected into HEK-293 cells (C. Caravokyri, personal 
communication). This result independently confirms the functional activity of the 
Rev protein expressed from this system. This experiment also illustrates the 
potential usefulness of the rev-recombinants as general purpose Rev expression 
systems for experiments in ElA-complementing cells.
Using the six recombinant viruses, the effects of the Rev/RRE system on adenovirus 
gene expression were analysed at the protein and RNA levels. These analyses 
focused on three specific areas of investigation. Firstly, the effects of inserting the 
RRE into region L3 of the adenovirus genome were assessed. The patterns of viral 
late protein expression in cells infected with d/309 and d/309/RRE were similar and 
levels of individual viral late proteins did not differ significantly between parallel 
infections with the two viruses. Furthermore, the cytoplasmic levels of L3, LA and 
E3 RNA species in these infections were comparable. From these results, it was 
concluded that insertion of the RRE does not detectably affect adenovirus gene 
expression. Secondly, the effects of inserting a rev expression cassette into early 
region E1A of the genome were evaluated. No significant Rev-specific effects on 
viral gene expression were detected by either protein or RNA analysis. Recombinant
virus d/309/rev displayed an atypical pattern of protein expression characterised by 
the synthesis of a novel protein and the absence of another. These changes were 
clearly not Rev-specific, since both d/309/RRErev and dl33S/rev infections 
produced the normal array of viral proteins. These results could reflect 
uncharacterised changes introduced into the genome during virus construction (any 
such changes have no effect on virus growth), or might indicate selective virion 
protein processing by the viral protease (an explanation for which it is difficult to 
envisage a mechanism). Thus it was concluded that insertion of the rev construct 
and the expression of active Rev protein in the absence of the RRE do not 
significantly perturb adenovirus gene expression (except, obviously, ElA 
expression).
Having established that neither Rev nor the RRE alone had any effect on AdS gene 
expression, the effects of the complete Rev/RRE system on adenovirus gene 
expression in the presence or absence of E1B S5K were investigated. No Rev/RRE- 
speciflc differences in the pattern of viral protein expression were observed. 
However, RNA analyses showed that the cytoplasmic : nuclear RNA ratios for L3, 
L4 and E3-late mRNAs (but not L I, L2, L5 or E3-early species) were elevated in 
d/338/RRErev infections, with respect to the ratios in parallel J/338/rrv infections. 
This apparent Rev-mediated increase in cytoplasmic levels of responsive adenovirus 
mRNAs did not restore expression to wild type levels. However, full 
complementation could not be expected in these experiments due to the pleiotropic 
effects of E1B 55K deletion observed at this time point, which resulted in reduced 
nuclear as well as cytoplasmic viral RNA levels.
Although the response of L3 mRNA to the Rev/RRE system can be explained by a 
conventional mechanism in which Rev-RRE binding mediates a process such as 
facilitated nuclear mRNA export, the effects on L4 and E3-late species are more 
difficult to interpret since the RRE is removed during processing from the primary
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transcripts that give rise to these mRNAs. A mechanism was suggested (7.4, above) 
in which a Rev/RRE-mediated process results in commitment of L4 and E3-late 
species to, for example, a facilitated nuclear export pathway before processing is 
complete. It was further envisaged that several mechanisms might operate to 
determine the relative responses of different species to the Rev/RRE system. The 
presence of intron sequences and unused splice sites (potential nuclear retention 
signals) in certain mRNAs could make them more responsive to Rev/RRE in the 
same way that such species show a greater dependence on E1B SSK function 
(Leppard, 1993). This could explain the unusually large effect observed for L4- 
100K mRNA. The lack of effect on LI and L2 RNA species transcribed 5' to L3 
may be explained in terms of the pattern of adenovirus RNA processing. Co- 
transcriptional commitment to splicing and polyadenylation may lead to production 
of mature LI and L2 mRNAs before transcription of the RRE is completed. It is 
also possible that Rev/RRE-mediated facilitation of cytoplasmic mRNA expression 
is limited in range to species close to the RRE even if the RRE is removed from the 
mature message. Heaphy et al. (1991) and Wingfield et al. (1991) have suggested 
that Rev function is dependent on polymerisation of Rev molecules along RNA 
from a nucleation site in the RRE. RNA regions such as L5 may be too far away 
from the RRE in the primary transcript to be reached by the polymeric 'coating' of 
Rev molecules. Indeed, the distance in the Ad5 genome from the RRE insertion site 
in L3 to the end of the L5 region is more than 11.3 kbp (greater than the entire 
length of the HIV-1 genome).
One apparent difference between the mechanism suggested here for Rev/RRE 
function in adenovirus and the normal operation of the system in HIV is the way 
mRNAs that do not contain the RRE are handled. For example, cytoplasmic 
expression of the HIV tat and rev mRNAs (from which the RRE has been removed 
by splicing) is not elevated by Rev. However, the multiply-spliced HIV mRNAs, as 
well as lacking the RRE, do not contain the m-acting repression sequences (unused
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splice sites, intronic sequences, or more specific sequences - see 1.6 , above) found 
in the unspliced and singly-spliced mRNAs. Conversely, adenovirus L4-100K 
mRNA, which showed the most marked response to the Rev/RRE system, contains 
unused splice sites that could mediate retention of mRNA in the nucleus. Thus 
adenovirus mRNAs such as L4-100K are in this respect similar to the Rev- 
responsive incompletely-spliced HIV mRNAs and would be expected to behave 
similarly if commitment to cytoplasmic expression can indeed occur before RRE 
excision.
As also noted earlier (7.4), the observed difference in the cytoplasmic : nuclear 
ratio for L4-100K mRNA between <//338/RREr«*v and d/338/rev infections was not 
reflected in a difference in protein levels. However Rev/RRE action may be 
required at several stages of a facilitated gene expression pathway, including nuclear 
RNA export and polysome loading of responsive mRNAs. If Rev/RRE action leads 
to a commitment to nuclear export before RRE excision, mRNAs transported to the 
cytoplasm via a Rev-mediated pathway may not be efficiently translated in the 
absence of Rev binding (precluded by removal of the RRE). Thus levels of L4- 
100K protein in the d/338/RRErrv infection will be similar to the levels of protein 
translated from the background levels of cytoplasmic mRNA exported from the 
nucleus in the d/338/rev infection by more conventional mechanisms. If this 
interpretation is correct, then a single facet of Rev function (facilitation of mRNA 
transport) has been isolated in these experiments.
8,2. Implications for the Rev / E1B 55K analogy
It is possible from the results presented in this thesis to draw some general 
conclusions about the potential functional analogy between Rev/RRE and E1B 55K. 
Rev/RRE can function in the context of an adenovirus system to augment the 
cytoplasmic accumulation of certain mRNAs. However, not all of the Ad mRNAs 
known to be dependent on E1B 55K are affected (presumably reflecting the chosen
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site of insertion of the RRE) and the degree of augmentation varies between 
different mRNA species, suggesting an unequal dependence of these species on 
mechanisms that facilitate cytoplasmic RNA accumulation (as has been observed for 
55K). It therefore appears that the Rev/RRE and E1B 55K systems act to overcome 
difficulties in viral gene expression in similar ways and that the HIV-1 system can, 
to an extent, compensate for the lack of the E1B 55K system in an Ad infection.
It was not possible to draw definite conclusions on any changes in levels of protein 
translated from L3 mRNAs whose cytoplasmic accumulation was enhanced by the 
Rev/RRE system. The effect on cytoplasmic accumulation of hexon mRNA was 
small and a corresponding effect on protein synthesis might reasonably be expected 
to be difficult to detect. pVI protein, whose mRNA levels were also enhanced by 
the Rev/RRE system, could not be unambiguously identified in these experiments. 
As already discussed, the non-correspondence between RNA levels and protein 
synthesis for the L4-100K mRNA that apparently accumulates in the cytoplasm 
under the influence of Rev/RRE can be explained if Rev has multiple functions in 
the gene expression pathway that can be separated. An implication of this 
explanation is that the multiple activities of Rev are interdependent. If an mRNA 
transported to the cytoplasm by a Rev/RRE-facilitated mechanism also requires Rev 
for efficient polysome loading, then these processes must be linked in some way. 
One possibility is that inefficient polysome loading is intrinsic to Rev-dependent 
HIV mRNAs. However, the results discussed above suggest that Ad L4-100K 
mRNA that accumulates in the cytoplasm by a Rev/RRE-mediated process is not 
efficiently translated, a result suggested to be due to RRE excision after 
commitment to nuclear export. If this interpretation is correct, then poor translation 
in the absence of Rev/RRE binding may be a consequence of the transport 
mechanism, since it occurs with a non-HIV RNA species. Possibly, Rev acts to 
transport dependent RNAs directly into a nuclear subcompartment in which they are 
retained without further Rev activity. Such a mechanism of action appears more
complex than that of E1B 55K, whose effects appear to be confined to nuclear 
export (probably by induction of RNA release from the nuclear matrix) and possibly 
cytoplasmic stabilisation of late mRNAs (see 1.9.6-1.9.7).
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Several further experiments could be conducted in order to test and extend the 
hypotheses and conclusions presented in this thesis. One rather unlikely possibility 
not entirely ruled out by existing experiments is that the RRE has a small Rev- 
independent cis-acting effect on cytoplasmic RNA accumulation that becomes 
apparent in a d/338 (55K") background (the experiments using the d/309 background 
described in chapter 5 were designed to test for a negative, rather than a positive 
effect of the RRE on gene expression). Ideally, a d/338-derived El A-deficient virus 
would be used as a parallel control for the RNase protection assays in KB8a cells 
(see below). It would, however, be possible to repeat the experiments described in 
chapter 5 using dl338 and d/338/RRE to test the effects of the RRE in a d/338 
background.
Insertion of the RRE at other positions in the major late transcription unit would 
allow the effects to be compared with those of insertion in L3. However, due to the 
complexity of the pattern of gene expression from both strands of the adenovirus 
genome, the number of insertion sites that are theoretically suitable is strictly 
limited; even at such sites insertion could prove to disrupt gene expression in 
practice. It would also be useful to construct a recombinant based on dl338 that, 
like the rev-recombinants employed in this study, is deficient in El A function and 
therefore has comparable expression levels in KB8a cells (an unsuccessful attempt to 
construct such a virus was in fact made in the course of the project but could not be 
repeated for lack of time). This would serve as a better negative control for the 
d/338/RRErev experiments than dl338/rev. An alternative and much more laborious 
approach would be to construct helper-independent rev-recombinants with the rev
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expression cassette inserted in a nonessential region of the genome. Such viruses 
could be used in experiments in noncomplementing cells (e.g. HeLa), where direct 
comparison could be made with ElA-intact J/309, d/338, d/309/RRE and 
d/338/RRE. However, Rev-expressing viruses competent for efficient replication in 
normal cells would be subject to additional safety considerations and perhaps to a 
higher level of containment. It was for these reasons that ElA-deficient rather than 
ElA-competent recombinants were originally designed and constructed.
In general, the analysis of Rev/RRE function in the recombinant viral systems 
already available could be extended by the use of additional riboprobes to detect a 
wider range of adenovirus RNA species. It would be especially useful to analyse 
directly the levels of L4-33K and pVIII mRNAs. Moreover, if antibodies could be 
obtained to proteins such as L3-pVI, which were difficult to detect in total protein 
extracts, the RNase protection assays could be correlated directly with protein 
expression. This would enable the translational fate of mRNAs that retain the RRE 
(rather than having it excised), and whose cytoplasmic accumulation is augmented 
by the Rev/RRE system, to be assessed.

Adachi, A., Gendelman, H.E., Koenig, S., Folks, T., Willey, R., Rabson, A., & 
Martin, M.A. (1986) Production of acquired immunodeficiency syndrome- 
associated retrovirus in human and nonhuman cells transfected with an infectious 
molecular clone. J. Virol. 59 284-291
Adami, G., & Babiss, L.E. (1991) DNA template effect on RNA splicing: two 
copies of the same gene in the same nucleus are processed differently. EM BO J. 10 
3457-3465
Akusjirvi, G., & Persson, H. (1981) Controls of RNA splicing and termination in 
the major late adenovirus transcription unit. Nature 292 420-426
Akusjarvi, G. (1993) Proteins with transcription regulatory properties encoded by 
human adenoviruses. Trends Microbiol. 1 163-170
Anderson, C.W., Schmitt, R.C., Smart, J.E., & Lewis, J.B. (1984) Early region 
IB of adenovirus 2 encodes two coterminal proteins of 495 and 155 amino acid 
residues. J. Virol. 50 387-396
Arrigo, S.J., Weitsman, S., Rosenblatt, J.D., & Chen, I.S.Y. (1989) Analysis of 
rev gene function on human immunodeficieny virus type 1 replication in lymphoid 
cells by using a quantitative polymerase chain reaction method. J. Virol. 63 4875- 
4881
Arrigo, S.J., & Chen, I.S.Y. (1991) Rev is necessary for translation but not 
cytoplasmic accumulation of HIV-1 vtf, vpr, and env/vpu 2 RNAs. Genes Dev. 5 
808-819
Arrigo, S.J., Heaphy, S., & Haines, J.K. (1992) In vivo binding of wild-type and 
mutant human immunodeficiency virus type 1 Rev proteins: implications for 
function. J. Virol. 66 5569-5575
171
Babiss, L.E., Young, C.S.H., Fisher, P.B., & Ginsberg, H.S. (1983) Expression 
of adenovirus Ela and Elb gene products and the Escherichia coli XGPRT gene in 
KB cells. J. Virol. 46 454-465
Babiss, L.E., & Ginsberg, H.S. (1984) Adenovirus type 5 early region lb gene 
product is required for efficient shutoff of host protein synthesis. J. Virol. 50 202- 
212
Babiss, L.E., Ginsberg, H.S., & Darnell, J.E. (1985) Adenovirus E1B proteins are 
required for accumulation of late viral mRNA and for effects on cellular mRNA 
translation and transport. Mol. Cell. Biol. 5 2552-2558
Barr£-Sinoussi, F., Chermann, J.C ., Rey, F., Nugeyre, M.T., Chamaret, S., 
Gruest, J ., Dauguet, C., Axler-Blin, C ., V6zinet-Brun, F., Rouzioux, C., 
Rozenbaum, W., & Montagnier, L. (1983) Isolation of a T-lymphotropic retrovirus 
from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 
230 868-871
Bartel, D .P., Zapp, M.L., Green, M.R., & Szostak, J.W. (1991) HIV-1 Rev 
regulation involves recognition of non-Watson-Crick base pairs in viral RNA. Cell 
67 529-536
Berger, J., Aepinus, C., Dobrovnik, M., Fleckenstein, B., Hauber, J., & Bohnlein,
E. (1991) Mutational analysis of functional domains in the HIV-1 Rev trans- 
regulatory protein. Virology 183 630-635
172
Bevec, D., Dobrovnik, M., Hauber, J., & Bohnlein, E. (1992) Inhibition of human 
immunodeficiency virus type 1 replication in human T cells by retroviral-mediated 
gene transfer of a dominant-negative Rev trans-activator. Proc. Nail. Acad. Sci. 
USA 89 9870-9874
Bimboim, H.C., & Doly, J. (1979) A rapid alkaline extraction procedure for 
screening recombinant plasmid DNA. Nucleic Acids Res. 7 1513-1525
Blobel, G. (1985) Gene gating: a hypothesis. Proc. Natl. Acad. Sci. USA 82 8527- 
8529
Bogerd, H., & Greene, W.C. (1993) Dominant negative mutants of human T-cell 
leukemia virus type I Rex and human immunodeficiency virus type 1 Rev fail to 
multimerize in vivo. J. Virol. 67 2496-2502
Bos, J., Polder, L.J., Bernards, R., Schrier, P.I., van den Elsen, P.J., van der Eb, 
A.J., & van Ormondt, H. (1981) The 2.2 kb Elb mRNA of human Adl2 and Ad5 
codes for two tumor antigens starting at different AUG triplets. Cell 27 121-131
Bradford, M.M. (1976) A rapid and sensitive method for the quantitation of 
microgram quantities of protein utilizing the principle of protein dye binding. Anal. 
Biochem. 72 248-254
Bridge, E., & Ketner, G. (1989) Redundant control of adenovirus late gene 
expression by early region 4. J. Virol. 63 631-638
Bridge, E., & Ketner, G. (1990) Interaction of adenoviral E4 and Elb products in 
late gene expression. Virology 174 345-353
1 7 3
Bridge, E., Hemstrom, C., & Pettersson, U. (1991) Differential regulation of 
adenovirus late transcriptional units by the products of early region 4. Virology 183 
260-266
Carter, K.C., Bowman, D., Carrington, W., Fogarty, K., McNeil, J.A., Fay,
F.S., & Lawrence, J.B. (1993) A three-dimensional view of precursor messenger 
RNA metabolism within the mammalian nucleus. Science 259 1330-1335
Chanda, P.K., Natuk, R.J., Mason, B.B., Bhat, B.M ., Greenberg, L., Dheer, 
S.K., Molnar-Kimber, K.L., Mizutani, S., Lubeck, M .D., Davis, A.R. & Hung, 
P.P. (1990) High level expression of the envelope glycoproteins of the human 
immunodeficiency virus type 1 in presence of rev gene using helper-independent 
adenovirus type 7 recombinants. Virology 175 535-547
Chang, D.D., & Sharp, P.A. (1989) Regulation by HIV Rev depends upon 
recognition of splice sites. Cell 59 789-795
Chang, D.D., & Sharp, P.A. (1990) Messenger RNA transport and HIV rev 
regulation. Science 249 614-615
Chinnadurai, G., Chinnadurai, S., & Brusca, J. (1979) Physical mapping of a 
large-plaque mutation of adenovirus type 2. J. Virol. 32 623-628
Chroboczek, J., Bieber, F., & Jacrot, B. (1992) The sequence of the genome of 
adenovirus type 5 and its comparison with the genome of adenovirus type 2. 
Virology 186 280-285
1 7 4
Cicjek, E.M., Nordstrom, J.L., Tsai, M-J., & O'Malley, B.W. (1982) Ribonucleic 
acid precursors are associated with the chick oviduct nuclear matrix. Biochemistry 
21 4945-4953
Cochrane, A., Kramer, R., Ruben, S., Levine, J., & Rosen, C.A. (1989a) The 
human immunodeficiency virus rev protein is a nuclear phosphoprotein. Virology 
171 264-266
Cochrane, A.W., Golub, E., Volsky, D., Ruben, S., & Rosen, C.A. (1989b) 
Functional significance of phosphorylation to the human immunodeficiency virus 
Rev protein. J. Virol. 63 4438-4440
Cochrane, A.W., Perkins, A., & Rosen, C.A. (1990a) Identification of sequences 
important in the nucleolar localization of human immunodeficiency virus Rev: 
relevance of nucleolar localization to function. J. Virol. 64 881-885
Cochrane, A.W., Chen, C-H., & Rosen, C.A. (1990b) Specific interaction of the 
human immunodeficiency virus Rev protein with a structured region in the env 
mRNA. Proc. Natl. Acad. Sci. USA 87 1198-1202
Cochrane, A.W., Jones, K.S., Beidas, S., Dillon, P.J., Skalka, A.M., & Rosen, 
C.A. (1991) Identification and characterization of intragenic sequences which 
repress human immunodeficiency virus structural gene expression. J. Virol 65 5305- 
5313
Constantoulakis, P., Campbell, M., Felber, B.K., Nasioulas, G., Afonina, E., & 
Pavlakis, G.N. (1993) Inhibition of Rev-mediated HIV-1 expression by an RNA 
binding protein encoded by the interferon-inducible 9-27 gene. Science 259 1314- 
1318
1 7 5
Cook. K.S., Fisk, G.J., Hauber, J., Usman, N., Daly, T.J., & Rusche, J.R. 
(1991) Characterization of HIV-1 REV protein: binding stoichiometry and minimal 
RNA substrate. Nucleic Acids Res. 19 1577-1583
Cullen, B.R., Hauber, J., Campbell, K., Sodroski, J.G., Haseltine, W.A., & 
Rosen, C.A. (1988) Subcellular localization of the human immunodeficiency virus 
/ram-acting art gene product. J. Virol. 62 2498-2501
Cullen, B.R. (1991) Regulation of human immunodeficiency virus replication. 
Anna. Rev. Microbiol. 45 219-50
Cullen, B.R., & Malim, M.H. (1991) The HIV-1 Rev protein: prototype of a novel 
class of eukaryotic post-transcriptional regulators. TIBS 16 346-350
Cutt, J.R., Shenk, T., & Hearing, P. (1987) Analysis of adenovirus early region 4- 
encoded polypeptides synthesized in productively infected cells. J. Virol 61 543-552
Daefler, S., Klotman, M.E., & Wong-Staal, F. (1990) Trans-activating rev protein 
of the human immunodefiency virus 1 interacts directly and specifically with its 
target RNA. Proc. Natl. Acad. Sci. USA 87 4571-4575
D'Agostino, D.M., Felber, B.K., Harrison, J.E., & Pavlakis, G.N. (1992) The 
Rev protein of human immunodeficieny virus type 1 promotes polysomal 
association and translation of gaglpol and vpu/env mRNAs. Mol. Cell. Biol. 12 
1375-1386
Daly, T.J., Cook, K.S., Gray, G.S., Maione, T.E., & Rusche, J.R. (1989) 
Specific binding of HIV-1 recombinant Rev protein to the Rev-responsive element 
in vitro. Nature 342 816-819
Daly, T.J., Rusche, J.R., Maione, T.E., & Frankel, A.D. (1990) Circular 
dichroism studies of the HIV-1 Rev protein and its specific RNA binding site. 
Biochemistry 29 9791-9795
Dayton, A.I., Terwilliger, E.F., Potz, J., Kowalski, M., Sodroski, J.G., & 
Haseltine, W.A. (1988) Cis-acting sequences responsive to the rev gene product of 
the human immunodeficieny virus. J. AIDS 1 441-452
Dayton, E.T., Powell, D.M., & Dayton, A.I. (1989) Functional analysis of CAR, 
the target sequence for the Rev protein of HIV-1. Science 246 1625-1629
Dayton, E.H., Konings, D.A.M., Powell, D.M., Shapiro, B.A., Butini, L., 
Maizel, J.V., & Dayton, A.I. (1992) Extensive sequence-specific information 
throughout the CAR/RRE, the target sequence of the human immunodeficiency 
virus type 1 Rev protein. J. Virol. 66 1139-1151
Dix, I., & Leppard, K.N. (1992) Open reading frames 1 and 2 of adenovirus region 
E4 are conserved between human serotypes 2 and 5. J. Gen. Virol. 73 2975-2976
Dix, I., & Leppard, K.N. (1993) Regulated splicing of adenovirus type 5 E4 
transcripts and regulated cytoplasmic accumulation of E4 mRNA. J. Virol. 67 3226- 
3231
Dyson, N., & Harlow, E. (1992) Adenovirus El A targets key regulators of cell 
proliferation. In: Cancer surveys volume 12: Tumour Suppressor Genes, the Cell
176
177
Cycle and Cancer. A.J. Levine, ed. (Cold Spring Harbor Laboratory Press) pp 161- 
195
Eastman, A. (1987) An improvement to the novel rapid assay for chloramphenicol 
acetyltransferase gene expression. BioTechniques 5 730-732
Emerman, M., Vazeux, R., & Peden, K. (1989) The rev gene product of the 
human immunodefiency virus affects envelope-specific RNA localization. Cell 57 
1155-1165
Fankhauser, C ., Izaurralde, E., Adachi, Y., Wingfield, P., & Laemmli, U.K. 
(1991) Specific complex of human immunodeficiency virus type 1 Rev and 
nucleolar B23 proteins: dissociation by the Rev response element. Mol. Cell. Biol. 
I I  2567-2575
Feinberg, M.B., Jarret, R.F., Aldovini, A., Gallo, R.C., & Wong-Staal, F. (1986) 
HTLV-III expression and production involve complex regulation at the levels of 
splicing and translation of viral RNA. Cell 46 807-817
Feinberg, M.B., & Trono, D. (1992) Intracellular immunization: rra/u-dominant 
mutants of HIV gene products as tools for the study and interruption of viral 
replication. AIDS Res. Human Retroviruses 6 1013-1022
Felber, B.K., Hadzopoulou-Cladaras, M., Cladaras, C., Copeland, T., & Pavlakis,
G.N. (1989) rev protein of human immunodeficiency virus type 1 affects the 
stability and transport of the viral mRNA. Proc. Natl. Acad. Sci. USA 86 1495- 
1499
1 7 8
Flint, S.J. (1986) Regulation of adenovirus mRNA formation. Adv. Vims. Res. 31 
169-228
Gallo, R., Wong-Staal, F ., Montagnier, L., Haseltine, W.A., & Yoshida, M. 
(1988) HIV/HTLV gene nomenclature. Nature 333 504
Gibson (1984) Studies on the Epstein-Barr virus genome. PhD thesis, Cambridge 
University, England.
Goh, W.C., Sodroski, J.G., Rosen, C.A., 8t Haseltine, W.A. (1987) Expression of 
the art gene product of human T-lymphotropic virus type III (HTLV-III/LAV) in 
Bacteria. J. virol. 61 633-637
Gorman, C.M., Moffat, L.F., & Howard, B.H. (1982) Recombinant genomes 
which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. 
Biol. 2 1044-1051
Graham, F.L., Smiley, J., Russell, W.C., & Naim, R. (1977) Characteristics of a 
human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 
36 59-72
Gutman, D., & Goldenberg, C.J. (1988) Virus-specific splicing inhibitor in extracts 
from cells infected with HIV-1. Science 241 1492-1495
Hadzopoulou-Cladaras, M., Felber, B.K., Cladaras, C., Athanassopoulos, A., Tse, 
A., & Pavlakis, G.N. (1989) The rev (trslart) protein of human immunodefiency 
virus type 1 affects viral mRNA and protein expression via a cis-acting sequence in 
the env region. J. virol. 63 1265-1274
1 7 9
Halbert, D.N., Cutt, J.R., & Shenks, T. (1985) Adenovirus early region 4 encodes 
functions required for efficient DNA replication, late gene expression, and host cell 
shutoff. J. Virol. 56 250-257
Hammarskjöld, M-L., Heimer, J ., Hammarskjöld, B., Sangwan, I., Albert, L., & 
Rekosh, D. (1989) Regulation of human immunodeficiency virus env expression by 
the rev gene product. J. Virol. 63 1959-1966
Hanahan, D. (1983) Studies on transformation of Escherichia coli with plasmids. J. 
Mol. Biol. 166 557-580
Handa, H., Kingston, R.E., & Sharp, P.A. (1983) Inhibition of adenovirus early 
region IV transcription in vitro by a purified viral DNA binding protein. Nature 302 
545-547
Hauber, J., Bouvier, M., Malim, M.H., & Cullen, B.R. (1988) Phosphorylation of 
the rev gene product of human immunodeficiency virus type 1. J. Virol. 62 4801- 
4804
Heaphy, S., Dingwall, C., Emberg, I., Gait, M.J., Green, S.M., Kam, J., Lowe, 
A.D., Singh, M., & Skinner, M.A. (1990) HIV-1 regulator of virion expression 
(Rev) protein binds to an RNA stem-loop structure located within the Rev response 
element region. Cell 60 685-693
Heaphy, S., Finch, J.T., Gait, M.J., Kam, J., & Singh, M. (1991) Human 
immunodeficiency virus type 1 regulator of virion expression, rev, forms 
nucleoprotein filaments after binding to a purine-rich "bubble" located within the 
rev-responsive region of viral mRNAs. Proc. Natl. Acad. Sci. USA 88 7366-7370
Holland, S.M., Ahmad, N., Maitra, R.K., Wingfield, P., & Venkatesan, S. (1990) 
Human immunodeficiency virus Rev protein recognizes a target sequence in Rev- 
responsive element RNA within the context of RNA secondary structure. J. Virol. 
64 5966-5975
Holland, S.M., Chavez, M., Gerstberger, S., & Venkatesan, S. (1992) A specific 
sequence with a bulged guanosine residue(s) in a stem-bulge-stem structure of Rev- 
responsive element RNA is required for irons activation by human 
immunodeficiency virus type 1 Rev. J. Virol. 66 3699-3706
Hope, T.J., Huang, X., McDonald, D., & Parslow, T.G. (1990a) Steroid-receptor 
fusion of the human immunodeficiency virus type 1 Rev transactivator: Mapping 
cryptic functions of the arginine-rich motif. Proc. Natl. Acad. Sci. USA 87 7787- 
7791
Hope, T.J., McDonald, D., Huang, X., Low, J., & Parslow, T.G. (1990b) 
Mutational analysis of the human immunodeficiency virus type 1 Rev transactivator: 
essential residues near the amino terminus. J. Virol. 64 5360-5366
Hope, T.J., Bond, B.L., McDonald, D., Klein, N.P., & Parslow, T.G. (1991) 
Effector domains of human immunodeficiency virus type 1 Rev and human T-cell 
leukaemia virus type 1 Rex are functionally interchangeable and share an essential 
peptide motif. J. Virol. 65 6001-6007
Hope, T.J., Klein, N.P., Elder, M.E., & Parslow, T.G. (1992) /ra/u-dominant 
inhibition of human immunodeficiency virus type 1 Rev occurs through formation 
of inactive protein complexes. J. Virol. 66 1849-1855
Horwitz, M.S. (1990a) Adenoviridae and their replication. In: Virology, second 
edition. Fields, B.N., Knipe, D.M., Chanock, R.M., Hirsch, M.S., Melnick, J.L., 
& Monath, T.P., eds. (Raven Press Ltd., New York) pp. 1679-1721
Horwitz, M.S. (1990b) Adenoviruses. In: Virology, second edition. Fields, B.N., 
Knipe, D.M., Chanock, R.M., Hirsch, M.S., Melnick, J.L ., & Monath, T.P., eds. 
(Raven Press Ltd., New York) pp. 1723-1740
Huang, M-M., & Hearing, P. (1989) Adenovirus early region 4 encodes two gene 
products with redundant effects in lytic infection. J. Virol. 63 2605-2615
Huang, X., Hope, T.J., Bond, B.L., McDonald, D., Grahl, K., & Parslow, T.G. 
(1991) Minimal Rev-response element for type 1 human immunodefiency virus. J. 
Virol. 65 2131-2134
Itoh, M., Inoue, J-i, Toyoshima, H., Akizawa, T., Higashi, M., & Yoshida, M. 
(1989) HTLV-1 rex and HIV-1 rev act through similar mechanisms to relieve 
suppression of unspliced RNA expression. Oncogene 4 1275-1279
Ivey-Hoyle, M., & Rosenberg, M. (1990) Rev-dependent expression of human 
immunodefiency virus type 1 gpl60 in Drosophila melanogaster cells. Mol. Cell. 
Biol. 10 6152-6159
Iwai, S., Pritchard, C ., Mann, D.A., Kam, J., & Gait, M.J. (1992) Recognition of 
the high affinity binding site in rev-responsive element RNA by the human 
immunodeficiency virus type-1 rev protein. Nucleic Acids Res. 20 6465-6472
Jones, N., & Shenk, T. (1979) Isolation of adenovirus type 5 host range deletion 
mutants defective for transformation of rat embryo cells. Cell 17 683-689
1 8 2
Kjems, J., Brown, M., Chang, D.D., & Sharp, P.A. (1991a) Structural analysis of 
the interaction between the human immunodeficiency virus Rev protein and the Rev 
response element. Proc. Natl. Acad. Sci. USA 88 683-687
Kjems, J., Frankel, A.D., & Sharp, P.A. (1991b) Specific regulation of mRNA 
splicing in vitro by a peptide from HIV-1 Rev. Cell 67 169-178
Kjems, J., Calnan, B.J., Frankel, A.D., & Sharp, P.A. (1992) Specific binding of 
a basic peptide from HIV-1 Rev. EMBOJ. 11 1119-1129
Knight, D.M., Flomerfelt, F.A., & Ghrayeb, J. (1987) Expression of the art/trs 
protein of HIV and study of its role in viral envelope synthesis. Science 236 837- 
840
Krausslich, H-G. (1992) Genetic analysis and gene expression of human 
immunodeficiency virus. Curr. Opinion Genetics Dev. 2 82-89
Kubota, S., Tetsuya, N., Cullen, B.R., Maki, M., & Hatanaka, M. (1991) Effects 
of chimeric mutants of human immunodeficiency virus type 1 Rev and human T-cell 
leukemia virus type I Rex on nucleolar targeting signals. J. Virol. 65 2452-2456
Kubota, S., Furuta, R., Maki, M., & Hatanaka, M (1992) Inhibition of human 
immunodeficiency virus type 1 Rev function by a Rev mutant which interferes with 
nuclear/nucleolar localization of Rev. J. Virol. 66 2510-2513
Lazinski, D., Grzadzielska, E., & Das, A. (1989) Sequence-specific recognition of 
RNA hairpins by bacteriophage antiterminators requires a conserved arginine-rich 
motif. Cell 59 207-218
1 8 3
Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the 
head of bacteriophage T4. Nature 111 680-685
Lawrence, J.B., Singer, R.H., & Marselle, L.M. (1989) Highly localized tracks of 
specific transcripts within interphase nuclei visualised by in situ hybridization. Cell 
493-502
Le, S-Y., Malim, M.H., Cullen, B.R., & Maizel, J.V. (1990) A highly conserved 
RNA folding region coincident with the Rev response element of primate 
immunodeficiency viruses. Nucleic Acids Res. 18 1613-1623
Lechner, R.L., & Kelly, T.J. (1977) The structure of replicating adenovirus 2 DNA 
molecules. Cell 12 1007-1020
Leppard, K.N. (1993) Selective effects on adenovirus late gene expression of 
deleting the E lb 55K protein. J. Gen. Virol. 74 575-582
Leppard, K.N., & Shenk, T. (1989) The adenovirus E1B 55kd protein influences 
mRNA transport via an intranuclear effect on RNA metabolism. EMBO J. 8 2329- 
2336
Logan, J., & Shenk, T. (1984) Adenovirus tripartite leader sequence enhances 
translation of mRNAs late after infection. Proc. Natl. Acad. Sci. USA 81 3655-3659
Lu, X., Heimer, J., Rekosh, D., & Hammarskjöld, M-L. (1990) U1 small nuclear 
RNA plays a direct role in the formation of a rev-regulated human immunodefiency 
virus env mRNA that remains unspliced. Proc. Natl. Acad. Sci. USA 87 7598-7602
1 8 4
Maddon, P.J., Dalgleish, A.G., McDougal, J.S., Clapham, P.R., Weiss, R.A., & 
Axel, R. (1986) The T4 gene encodes the AIDS virus receptor and is expressed in 
the immune system and the brain. Cell 47 333-348
Maldarelli, F ., Martin, M.A., & Strebel, K. (1991) Identification of 
posttransenptionally active inhibitory sequences in human immunodeficiency virus 
type 1 RNA: novel level of gene regulation. J. Virol. 65 5732-5743
Malette, P., Yee, S-P., & Branton, P.E. (1983) Studies on the phosphorylation of 
the 58 000 dalton early region IB protein of human adenovirus type 5. J. Gen. 
Virol. 64 1069-1078
Malim, M.H., Hauber, J ., Le, S-Y., Maizel, J.V ., & Cullen, B.R. (1989a) The 
HIV-1 rev irons-activator acts through a structured target sequence to activate 
nuclear export of unspliced viral mRNA. Nature 338 254-257
Malim, M.H., Bohnlein, S., Hauber, J., & Cullen, B.R. (1989b) Functional 
dissection of the HIV-1 Rev mz/u-activator - derivation of a /ra/is-dominant 
repressor of Rev function. Cell 58 205-214
Malim, M.H., Tiley, L.S., McCam, D.F., Rusche, J.R., Hauber, J., & Cullen, 
B.R. (1990) HIV-1 structural gene expression requires binding of the Rev trans- 
activator to its RNA target sequence. Cell 60 675-683
Malim, M.H., & Cullen, B.R. (1991) HIV-1 structural gene expression requires the 
binding of multiple Rev monomers to the viral RRE: implications for HIV-1 
latency. Cell 65 241-248
Malim, M .H., McCam, D.F., Tiley, L.S., & Cullen, B.R. (1991) Mutational 
definition of the human immunodeficiency virus type 1 Rev activation domain. J. 
Virol. 65 4248-4254
Mariman, E.C.M, van Eekelen, C.A.G., Reinders, R.J., Berns, & van
Venrooij (1982) Adenoviral heterogenous nuclear RNA is associated with the host 
nuclear matrix during splicing. J. Mol. Biol. 154 103-119
McDonald, D., Hope, T.J., & Parslow, T.G. (1992) Posttranscriptional regulation 
by the human immunodeficiency virus type 1 Rev and human T-cell leukemia virus 
type I Rex proteins through a heterologous RNA binding site. J. Virol. 66 7232- 
7238
McDougal, J., Kennedy, M., Sligh, J., Cort, S., Mawie, A., & Nicholson, J. 
(1986) Binding of the HTLV-III/LAV to T4+ T cells by a complex of the 110K 
viral protein and the T4 molecule. Science 231 382-385
Melton, D.A., Krieg, P.A., Rebagliati, M.R., Maniatis, T., Zinn, K., & Green, 
M.R. (1984) Efficient in vitro synthesis of biologically active RNA and RNA 
hybridization probes from plasmids containing a bacteriophage SP6 promoter. 
Nucleic Acids Res 12 7035-7056
Mermer, B., Felber, B.K., Campbell, M., & Pavlakis, G.N. (1990) Identification 
of ira/uv-dominant HIV-1 rev protein mutants by direct transfer of bacterially 
produced proteins into human cells. Nucleic Acids Res. 18 2037-2044
Messing, J., Gronenbom, B., Müller-Hill, B., & Hofschneider, P. H. (1977) 
Filamentous coliphage M13 as a cloning vehicle: Insertion of a Hindu fragment of
1 8 5
1 8 6
the lac regulatory region in M13 replicative form in vitro. Proc. Natl. Acad. Sci. 
USA 74 3642-3646
Montell, C., Fisher, E.F., Caruthers, M.H., & Berk, A.J. (1984) Control of 
adenovirus E1B mRNA synthesis by a shift in the activities of RNA splice sites. 
Mol. Cell. Biol. 4 966-972
Moore, M., Schaack, J., Baim, S.B., Morimoto, R.I., & Shenk, T. (1987) Induced 
heat shock mRNAs escape the nucleocytoplasmic transport block in adenovirus- 
infected HeLa cells. Mol. Cell. Biol. 7 4302-4312
Moran, E., & Mathews, M.B. (1987) Multiple functional domains in the adenovirus 
E1A gene. Cell 4» 177-178
Nalin, C.M., Purcell, R.D ., Antelman, D., Mueller, D., Tomchak, L., 
Wegrzynski, B., McCamey, E., Toome, V., Kramer, R., & Hsu, M-C. (1990) 
Purification and characterization of recombinant Rev protein of human 
immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 87 7593-7597
Neumann, J.R., Morency, C .A ., & Russian, K.O. (1987) A novel rapid assay for 
chloramphenicol acetyltransferase gene expression. BioTechniques 5 444-447
Ohman, K., Nordqvist, K., & Akusjarvi, G. (1993) Two adenovirus proteins with 
redundant activities in virus growth facilitates tripartite leader mRNA accumulation. 
Virology 194 50-58
Olsen, H.S., Nelbock, P., Cochrane, A.W., & Rosen, C.A. (1990a) Secondary 
structure is the major determinant for interaction of HIV rev protein with RNA. 
Science 247 845-848
1 8 7
Olsen, H.S., Cochrane, A.W., Dillon, P .J., Nalin, C.M., & Rosen, C.A. (1990b) 
Interaction of the human immunodeficiency virus type 1 Rev protein with a 
structured region in env mRNA is dependent on multimer formation mediated 
through a basic stretch of amino acids. Genes Dev. 4 1357-1364
Olsen, H.S., Cochrane, A.W., & Rosen, C. (1992) Interaction of cellular factors 
with intragenic cis-acting repressive sequences within the HIV genome. Virology 
191 709-715
Omelles, D.A., & Shenk, T. (1991) Localization of the adenovirus early region IB 
55-kilodalton protein during lytic infection: association with nuclear viral inclusions 
requires the early region 4 34-kilodalton protein. J. Virol. 65 424-439
Perkins, A., Cochrane, A.W., Ruben, S.M., & Rosen, C.A. (1989) Structural and 
functional characterization of the human immunodeficiency virus rev protein. J. 
AIDS 2 256-263
Pilder, S., Moore, M., Logan, J., & Shenk, T. (1986) The adenovirus E1B-55K 
transforming polypeptide modulates transport or cytoplasmic stabilisation of viral 
and host cell mRNAs. Mol. Cell. Biol. 6 470-476
Rosen, C.A., & Haseltine, W.A. (1988) Selective regulation of HIV gene 
expression by the art gene product. In: The Control of Human Retrovirus Gene 
Expression, R. Franza, B.R. Cullen, F. Wong-Staal, eds. (Cold Spring Harbor, 
New York: Cold Spring Harbor Laboratory), pp. 23-26
Rosen, C .A ., Terwilliger, E., Dayton, A., Sodroski, J.G., & Haseltine, W.A. 
(1988) Intragenic cis-acting art gene-responsive sequences of the human 
immunodeficiency virus. Biochemistry 85 2071-2075
Rosenfeld, P.J., O’Neill, E.A., Wides, R.J., & Kelly, T.J. (1987) Sequence- 
specific interactions between cellular DNA-binding proteins and the adenovirus 
origin of DNA replication. Mol. Cell. Biol. 7 875-886
Sambrook, J ., Fritsch, E.F., & Maniatis, T. (1989) Molecular cloning, a laboratory 
manual, second edition. (Cold Spring Harbor Laboratory Press)
Samulski, R.J., & Shenk, T. (1988) Adenovirus E1B 55-A/r polypeptide facilitates 
timely cytoplasmic accumulation of adeno-associated virus mRNAs. J. Virol. 62 
206-210
Samow, P ., Hearing, P., Anderson, C.W., Halbert, D.N., Shenk, T., & Levine, 
A.J. (1984) Adenovirus early region IB 58,000-dalton tumor antigen is physically 
associated with an early region 4 25,000-dalton protein in productively-infected 
cells. J. Virol. 49 692-700
Schröder, H.C., Bachmann, M., Diehl-Seifert, B., & Müller, W.G. (1987) 
Transport of mRNA from nucleus to cytoplasm. Prog. Nucleic Acid Res. 34 89-142
Schwartz, S ., Felber, B.K., & Pavlakis, G.N. (1992a) Distinct RNA sequences in 
the gag region of human immunodeficiency virus type 1 decrease RNA stability and 
inhibit expression in the absence of Rev protein. J. Virol. 66 150-159
Schwartz, S., Campbell, M., Nasioulas, G., Harrison, J., Felber, B.K., & 
Pavlakis, G.N. (1992b) Mutational inactivation of an inhibitory sequence in human
1 8 9
immunodeficiency virus type 1 results in Rev-independent gag expression. J. Virol. 
66 7176-7182
Shaw, G., & Kamen, R. (1986) A conserved AU sequence from the 3' untranslated 
region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46 659-667
Smiley, J.K., Young, M.A., & Flint, S.J. (1990) Intranuclear location of the 
adenovirus type 5 E1B 55-kilodalton protein. J. Virol. 64 4558-4564
Smith, D.H., Kegler, D.M., & Ziff, E.B. (1985) Vector expression of adenovirus 
type 5 E la proteins: evidence for Ela autoregulation. Mol. Cell. Biol. 5 2684-2696
Sodroski, J., Goh, W .C ., Rosen, C., Dayton, A., Terwilliger, E., & Haseltine, W. 
(1986) A second post-transcriptional /ram-activator gene required for HTLV-III 
replication. Nature 321 412-417
Stillman, B. (1989) Initiation of eukaryotic DNA replication in vitro. Annu. Rev. 
Cell Biol. 5 197-245
Tan, R., Chen, L., Buettner, J.A., Hudson, D., & Frankel, A.D. (1993) RNA 
recognition by an isolated a-helix. Cell 73 1031-1040
Tiley, L.S., Malim, M.H., & Cullen, B.R. (1991) Conserved functional 
organization of the human immunodeficiency virus type 1 and visna virus Rev 
proteins. J. Virol. 65 3877-3881
Tiley, L.S., Malim, M .H., Tewary, H.K., Stocldey, P.G., & Cullen, B.R. (1992) 
Identification of a high-affinity RNA-binding site for the human immunodeficiency 
virus type 1 Rev protein. Proc. Natl. Acad. Sei. USA 89 758-762
1 9 0
Tollefson, A.E., Scaria, A., Saha, S ., & Wold, W.S.M. (1992) The 11,600-MW 
protein encoded by region E3 of adenovirus is expressed early but is greatly 
amplified at late stages of infection. J. Virol. 66 3633-3642
Trono, D., Sc Baltimore, D. (1990) A human cell factor is essential for HIV-1 Rev 
action. EMBOJ. 9 4155-4160
Vaishnav, Y.N., Sc Wong-Staal, F. (1991) The biochemistry of AIDS. Anna. Rev. 
Biochem. 60 577-630
Venkatesan, S., Gerstberger, S.M., Park, H., Holland, S.M., & Nam, Y-S. (1992) 
Human immunodeficiency virus type 1 Rev activation can be achieved without Rev- 
responsive element RNA if Rev is directed to the target as a Rev/MS2 fusion 
protein which tethers the MS2 operator RNA. J. Virol. 66 7469-7480
Venkatesh, L.K., Sc Chinnadurai, G. (1990) Mutants in a conserved region near the 
carboxy-terminus of HIV-1 Rev identify functionally important residues and exhibit 
a dominant negative phenotype. Virology 178 327-330
Venkatesh, L.K., Mohammed, S., Sc Chinnadurai, G. (1990) Functional domains 
of the HIV-1 rev gene required for /rum-regulation and subcellular localization. 
Vtrvlogy 176 39-47
Virtanen, A., Gilardi, P., Naslund, A., LeMoullec, J.M., Pettersson, U., Sc 
Perricaudet, M. (1984) mRNAs from human adenovirus 2 early region 4. J. Virol. 
51 822-831
1 9 1
Virtanen, A. & Pettersson, U. (1985) Organization o f  early region IB of human 
adenovirus type 2: identification of four differentially spliced mRNAs. J. Virol. 54 
383-391
Weichselbraun, I., Farrington, G.K., Rusche, J.R ., Bôhnlein, E., & Hauber, J. 
(1992) Definition of the human immunodeficiency virus type 1 Rev and human T- 
cell leukemia virus type I Rex protein activation domain by functional exchange. J. 
Virol. 66 2583-2587
Weinberg, D.H., & Ketner, G. (1986) Adenoviral early region 4 is required for 
efficient viral DNA replication and for late gene expression. J. Virol. 57 833-838
White, E., Cipriani, R., Sabbatini, P., & Denton, A. (1991) Adenovirus E1B 19- 
kilodalton protein overcomes the cytotoxicity of El A proteins. J. Virol. 65 2968- 
2978
White. E., Sabbatini, P., Debbas, M., Wold, W .S.M ., Rusher, D .I., & Gooding, 
L.R. (1992) The 19-kilodalton adenovirus E1B transforming protein inhibits 
programmed cell death and prevents cytolysis by tumor necrosis factor a. Mol. 
Cell. Biol. 12 2570-2580
Williams, J., Karger, B.D., Ho, Y.S., Castiglia, C .L ., Mann, T ., & Flint, S.J. 
(1986) The adenovirus E1B 495R protein plays a role in regulating the transport and 
stability of the viral late messages. Cancer Cells 4 275-284
Winberg, G., & Shenk, T. (1984) Dissection of overlapping functions within the 
adenovirus type 5 El A gene. EMBO J. 3 1907-1912
1 9 2
Wingfield, P.T., Stahl, S.J., Payton, M.A., Venkatesan, S., Misra, M., & Steven, 
A.C. (1991) HIV-1 Rev expressed in recombinant Escherichia coli: purification, 
polymerisation, and conformational properties. Biochemistry 30 7527-7534
Wold, W.S.M., & Gooding, L.R. (1991) Region E3 of adenovirus: a cassette of 
genes involved in host immunosurveillance and virus-cell interactions. Virology 184 
1-8
Wong-Staal, F. (1990) Human immunodeficiency viruses and their replication. In: 
Virology, second edition. Fields, B.N., Knipe, D.M., Chanock, R.M., Hirsch, 
M.S., Melnick, J.L., & Monath, T.P., eds. (Raven Press Ltd., New York) pp. 
1529-1543
Xing, Y., Johnson, C.V., Dobner, P.R., & Lawrence, J.B. (1993) Higher level 
organization of individual gene transcription and RNA splicing. Science 259 1326- 
1330
Yew, P.R., Kao, C.C., & Berk, A.J. (1990) Dissection of functional domains in 
the adenovirus-2 early lB-55K-polypeptide by suppression linker insertional 
mutagenesis. Virology 179 795-805
Yew, P.R., & Berk, A.J. (1992) Inhibition of p53 transactivation required for 
transformation by adenovirus early IB protein. Nature 357 82-85
Yoshida, K., Venkatesh, L., Kuppuswamy, M., & Chinnadurai, G. (1987) 
Adenovirus transforming 19-Kd T antigen has an enhancer-dependent trans- 
activation function and relieves enhancer repression mediated by viral and cellular 
genes. Genes Dev. 1 645-658
1 9 3
Zapp, M.L., *  Green, M.R. (1989) Sequence-specific RNA binding by the HIV-1 
Rev protein. Nature 342 714-716
Zapp, M.L., Hope, T.J., Parslow, T.G., *  Green. M.R. (1991) Oligomerisation 
and RNA binding domains of the type 1 hum*, immunodeficiency virus Rev 
protein: a dual function for an arginine-rich binding motif. Proc. No,!. Acad. Sci. 
USA 88 7734-7738
THE BRITISH LIBRARY
BRITISH THESIS SERVICE
TITLE CONSTRUCTION AND ANALYSIS OF ADENOVIRUS/HIV-1 REV RECOMBINANTS
AUTHOR Richard Dafydd
WILLIAMS
DEGREE PhD
AWAR DING Warwick University
BODY
DATE 1993
THESIS DX182473 
NUMBER
THIS THESIS HAS BEEN MICROFILMED EXACTLY AS RECEIVED
The quality of this reproduction is dependent upon the quality of the original thesis 
submitted for microfilming. Every effort has been made to ensure the highest quality 
of reproduction. Some pages may have indistinct print, especially if the original 
papers were poorly produced or if awarding body sent an inferior copy. If pages are 
missing, please contact the awarding body which granted the degree.
Previously copyrighted materials Gournals articles, published texts etc.) are not 
filmed.
This copy of the thesis has been supplied on condition that anyone who consults it is 
understood to recognise that it's copyright rests with its author and that no 
information derived from it may be published without the author's prior written 
consent.
Reproduction of this thesis, other than as permitted under the United Kingdom 
Copyright Designs and Patents Act 1988, or under specific agreement with the 
copyright holder, is prohibited.

